Ensembl,Gene,Gene synonym,Gene description,Uniprot,Chromosome,Position,Protein class,Biological process,Molecular function,Disease involvement,Evidence,HPA evidence,UniProt evidence,NeXtProt evidence,RNA tissue specificity,RNA tissue distribution,RNA tissue specificity score,RNA tissue specific nTPM,RNA single cell type specificity,RNA single cell type distribution,RNA single cell type specificity score,RNA single cell type specific nTPM,RNA cancer specificity,RNA cancer distribution,RNA cancer specificity score,RNA cancer specific FPKM,RNA brain regional specificity,RNA brain regional distribution,RNA brain regional specificity score,RNA brain regional specific nTPM,RNA blood cell specificity,RNA blood cell distribution,RNA blood cell specificity score,RNA blood cell specific nTPM,RNA blood lineage specificity,RNA blood lineage distribution,RNA blood lineage specificity score,RNA blood lineage specific nTPM,RNA cell line specificity,RNA cell line distribution,RNA cell line specificity score,RNA cell line specific nTPM,RNA mouse brain regional specificity,RNA mouse brain regional distribution,RNA mouse brain regional specificity score,RNA mouse brain regional specific nTPM,RNA pig brain regional specificity,RNA pig brain regional distribution,RNA pig brain regional specificity score,RNA pig brain regional specific nTPM,Antibody,Reliability (IH),Reliability (Mouse Brain),Reliability (IF),Subcellular location,Secretome location,CCD Protein,CCD Transcript,Blood concentration - Conc. blood IM [pg/L],Blood concentration - Conc. blood MS [pg/L],Subcellular main location,Subcellular additional location,Antibody RRID,Pathology prognostics - Breast cancer,Pathology prognostics - Cervical cancer,Pathology prognostics - Colorectal cancer,Pathology prognostics - Endometrial cancer,Pathology prognostics - Glioma,Pathology prognostics - Head and neck cancer,Pathology prognostics - Liver cancer,Pathology prognostics - Lung cancer,Pathology prognostics - Melanoma,Pathology prognostics - Ovarian cancer,Pathology prognostics - Pancreatic cancer,Pathology prognostics - Prostate cancer,Pathology prognostics - Renal cancer,Pathology prognostics - Stomach cancer,Pathology prognostics - Testis cancer,Pathology prognostics - Thyroid cancer,Pathology prognostics - Urothelial cancer,Tissue RNA - adipose tissue [nTPM],Tissue RNA - adrenal gland [nTPM],Tissue RNA - amygdala [nTPM],Tissue RNA - appendix [nTPM],Tissue RNA - basal ganglia [nTPM],Tissue RNA - bone marrow [nTPM],Tissue RNA - breast [nTPM],Tissue RNA - cerebellum [nTPM],Tissue RNA - cerebral cortex [nTPM],Tissue RNA - cervix [nTPM],Tissue RNA - choroid plexus [nTPM],Tissue RNA - colon [nTPM],Tissue RNA - duodenum [nTPM],Tissue RNA - endometrium 1 [nTPM],Tissue RNA - epididymis [nTPM],Tissue RNA - esophagus [nTPM],Tissue RNA - fallopian tube [nTPM],Tissue RNA - gallbladder [nTPM],Tissue RNA - heart muscle [nTPM],Tissue RNA - hippocampal formation [nTPM],Tissue RNA - hypothalamus [nTPM],Tissue RNA - kidney [nTPM],Tissue RNA - liver [nTPM],Tissue RNA - lung [nTPM],Tissue RNA - lymph node [nTPM],Tissue RNA - medulla oblongata [nTPM],Tissue RNA - midbrain [nTPM],Tissue RNA - olfactory bulb [nTPM],Tissue RNA - ovary [nTPM],Tissue RNA - pancreas [nTPM],Tissue RNA - parathyroid gland [nTPM],Tissue RNA - pituitary gland [nTPM],Tissue RNA - placenta [nTPM],Tissue RNA - pons [nTPM],Tissue RNA - prostate [nTPM],Tissue RNA - rectum [nTPM],Tissue RNA - retina [nTPM],Tissue RNA - salivary gland [nTPM],Tissue RNA - seminal vesicle [nTPM],Tissue RNA - skeletal muscle [nTPM],Tissue RNA - skin 1 [nTPM],Tissue RNA - small intestine [nTPM],Tissue RNA - smooth muscle [nTPM],Tissue RNA - spinal cord [nTPM],Tissue RNA - spleen [nTPM],Tissue RNA - stomach 1 [nTPM],Tissue RNA - testis [nTPM],Tissue RNA - thalamus [nTPM],Tissue RNA - thymus [nTPM],Tissue RNA - thyroid gland [nTPM],Tissue RNA - tongue [nTPM],Tissue RNA - tonsil [nTPM],Tissue RNA - urinary bladder [nTPM],Tissue RNA - vagina [nTPM],Tissue RNA - white matter [nTPM],Cell RNA - A-431 [nTPM],Cell RNA - A549 [nTPM],Cell RNA - AF22 [nTPM],Cell RNA - AN3-CA [nTPM],Cell RNA - ASC diff [nTPM],Cell RNA - ASC TERT1 [nTPM],Cell RNA - BEWO [nTPM],Cell RNA - BJ [nTPM],Cell RNA - BJ hTERT+ [nTPM],Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM],Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM],Cell RNA - CACO-2 [nTPM],Cell RNA - CAPAN-2 [nTPM],Cell RNA - Daudi [nTPM],Cell RNA - EFO-21 [nTPM],Cell RNA - fHDF/TERT166 [nTPM],Cell RNA - GAMG [nTPM],Cell RNA - HaCaT [nTPM],Cell RNA - HAP1 [nTPM],Cell RNA - HBEC3-KT [nTPM],Cell RNA - HBF TERT88 [nTPM],Cell RNA - HDLM-2 [nTPM],Cell RNA - HEK 293 [nTPM],Cell RNA - HEL [nTPM],Cell RNA - HeLa [nTPM],Cell RNA - Hep G2 [nTPM],Cell RNA - HHSteC [nTPM],Cell RNA - HL-60 [nTPM],Cell RNA - HMC-1 [nTPM],Cell RNA - HSkMC [nTPM],Cell RNA - hTCEpi [nTPM],Cell RNA - hTEC/SVTERT24-B [nTPM],Cell RNA - hTERT-HME1 [nTPM],Cell RNA - hTERT-RPE1 [nTPM],Cell RNA - HUVEC TERT2 [nTPM],Cell RNA - JURKAT [nTPM],Cell RNA - K-562 [nTPM],Cell RNA - Karpas-707 [nTPM],Cell RNA - LHCN-M2 [nTPM],Cell RNA - MCF7 [nTPM],Cell RNA - MOLT-4 [nTPM],Cell RNA - NB-4 [nTPM],Cell RNA - NTERA-2 [nTPM],Cell RNA - OE19 [nTPM],Cell RNA - PC-3 [nTPM],Cell RNA - REH [nTPM],Cell RNA - RH-30 [nTPM],Cell RNA - RPMI-8226 [nTPM],Cell RNA - RPTEC TERT1 [nTPM],Cell RNA - RT4 [nTPM],Cell RNA - SCLC-21H [nTPM],Cell RNA - SH-SY5Y [nTPM],Cell RNA - SiHa [nTPM],Cell RNA - SK-BR-3 [nTPM],Cell RNA - SK-MEL-30 [nTPM],Cell RNA - SuSa [nTPM],Cell RNA - T-47d [nTPM],Cell RNA - THP-1 [nTPM],Cell RNA - TIME [nTPM],Cell RNA - U-138 MG [nTPM],Cell RNA - U-2 OS [nTPM],Cell RNA - U-2197 [nTPM],Cell RNA - U-251 MG [nTPM],Cell RNA - U-266/70 [nTPM],Cell RNA - U-266/84 [nTPM],Cell RNA - U-698 [nTPM],Cell RNA - U-87 MG [nTPM],Cell RNA - U-937 [nTPM],Cell RNA - WM-115 [nTPM],Blood RNA - basophil [nTPM],Blood RNA - classical monocyte [nTPM],Blood RNA - eosinophil [nTPM],Blood RNA - gdT-cell [nTPM],Blood RNA - intermediate monocyte [nTPM],Blood RNA - MAIT T-cell [nTPM],Blood RNA - memory B-cell [nTPM],Blood RNA - memory CD4 T-cell [nTPM],Blood RNA - memory CD8 T-cell [nTPM],Blood RNA - myeloid DC [nTPM],Blood RNA - naive B-cell [nTPM],Blood RNA - naive CD4 T-cell [nTPM],Blood RNA - naive CD8 T-cell [nTPM],Blood RNA - neutrophil [nTPM],Blood RNA - NK-cell [nTPM],Blood RNA - non-classical monocyte [nTPM],Blood RNA - plasmacytoid DC [nTPM],Blood RNA - T-reg [nTPM],Blood RNA - total PBMC [nTPM],Brain RNA - amygdala [nTPM],Brain RNA - basal ganglia [nTPM],Brain RNA - cerebellum [nTPM],Brain RNA - cerebral cortex [nTPM],Brain RNA - hippocampal formation [nTPM],Brain RNA - hypothalamus [nTPM],Brain RNA - medulla oblongata [nTPM],Brain RNA - midbrain [nTPM],Brain RNA - olfactory bulb [nTPM],Brain RNA - pons [nTPM],Brain RNA - spinal cord [nTPM],Brain RNA - thalamus [nTPM],Brain RNA - white matter [nTPM],Single Cell Type RNA - Adipocytes [nTPM],Single Cell Type RNA - Alveolar cells type 1 [nTPM],Single Cell Type RNA - Alveolar cells type 2 [nTPM],Single Cell Type RNA - Astrocytes [nTPM],Single Cell Type RNA - B-cells [nTPM],Single Cell Type RNA - Basal keratinocytes [nTPM],Single Cell Type RNA - Basal prostatic cells [nTPM],Single Cell Type RNA - Basal respiratory cells [nTPM],Single Cell Type RNA - Basal squamous epithelial cells [nTPM],Single Cell Type RNA - Bipolar cells [nTPM],Single Cell Type RNA - Breast glandular cells [nTPM],Single Cell Type RNA - Breast myoepithelial cells [nTPM],Single Cell Type RNA - Cardiomyocytes [nTPM],Single Cell Type RNA - Cholangiocytes [nTPM],Single Cell Type RNA - Club cells [nTPM],Single Cell Type RNA - Collecting duct cells [nTPM],Single Cell Type RNA - Cone photoreceptor cells [nTPM],Single Cell Type RNA - Cytotrophoblasts [nTPM],Single Cell Type RNA - dendritic cells [nTPM],Single Cell Type RNA - Distal enterocytes [nTPM],Single Cell Type RNA - Distal tubular cells [nTPM],Single Cell Type RNA - Ductal cells [nTPM],Single Cell Type RNA - Early spermatids [nTPM],Single Cell Type RNA - Endometrial ciliated cells [nTPM],Single Cell Type RNA - Endometrial stromal cells [nTPM],Single Cell Type RNA - Endothelial cells [nTPM],Single Cell Type RNA - Enteroendocrine cells [nTPM],Single Cell Type RNA - Erythroid cells [nTPM],Single Cell Type RNA - Excitatory neurons [nTPM],Single Cell Type RNA - Exocrine glandular cells [nTPM],Single Cell Type RNA - Extravillous trophoblasts [nTPM],Single Cell Type RNA - Fibroblasts [nTPM],Single Cell Type RNA - Gastric mucus-secreting cells [nTPM],Single Cell Type RNA - Glandular and luminal cells [nTPM],Single Cell Type RNA - granulocytes [nTPM],Single Cell Type RNA - Granulosa cells [nTPM],Single Cell Type RNA - Hepatic stellate cells [nTPM],Single Cell Type RNA - Hepatocytes [nTPM],Single Cell Type RNA - Hofbauer cells [nTPM],Single Cell Type RNA - Horizontal cells [nTPM],Single Cell Type RNA - Inhibitory neurons [nTPM],Single Cell Type RNA - Intestinal goblet cells [nTPM],Single Cell Type RNA - Ionocytes [nTPM],Single Cell Type RNA - Kupffer cells [nTPM],Single Cell Type RNA - Langerhans cells [nTPM],Single Cell Type RNA - Late spermatids [nTPM],Single Cell Type RNA - Leydig cells [nTPM],Single Cell Type RNA - Macrophages [nTPM],Single Cell Type RNA - Melanocytes [nTPM],Single Cell Type RNA - Microglial cells [nTPM],Single Cell Type RNA - monocytes [nTPM],Single Cell Type RNA - Muller glia cells [nTPM],Single Cell Type RNA - NK-cells [nTPM],Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM],Single Cell Type RNA - Oligodendrocytes [nTPM],Single Cell Type RNA - Pancreatic endocrine cells [nTPM],Single Cell Type RNA - Paneth cells [nTPM],Single Cell Type RNA - Peritubular cells [nTPM],Single Cell Type RNA - Plasma cells [nTPM],Single Cell Type RNA - Prostatic glandular cells [nTPM],Single Cell Type RNA - Proximal enterocytes [nTPM],Single Cell Type RNA - Proximal tubular cells [nTPM],Single Cell Type RNA - Respiratory ciliated cells [nTPM],Single Cell Type RNA - Rod photoreceptor cells [nTPM],Single Cell Type RNA - Sertoli cells [nTPM],Single Cell Type RNA - Skeletal myocytes [nTPM],Single Cell Type RNA - Smooth muscle cells [nTPM],Single Cell Type RNA - Spermatocytes [nTPM],Single Cell Type RNA - Spermatogonia [nTPM],Single Cell Type RNA - Squamous epithelial cells [nTPM],Single Cell Type RNA - Suprabasal keratinocytes [nTPM],Single Cell Type RNA - Syncytiotrophoblasts [nTPM],Single Cell Type RNA - T-cells [nTPM],Single Cell Type RNA - Theca cells [nTPM],Single Cell Type RNA - Undifferentiated cells [nTPM],Single Cell Type RNA - Urothelial cells [nTPM]
ENSG00000267335,AC008687.1,,Novel protein,,19,49022953-49036895,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,Evidence at transcript level,,,Tissue enriched,Detected in some,6,pituitary gland: 17.1,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,A-431: 1.6;HMC-1: 4.4;U-138 MG: 1.6;U-251 MG: 6.0,,,,,,,,,HPA038925,Uncertain,,Approved,Cytosol,Secreted - unknown location,NA,NA,,,Cytosol,,HPA038925: AB_2676272,,,,,,,,,,,,,,,,,,0,0,0.1,0,0,0,0,0.1,0.5,0,0,0,0.7,0,0,0,0,0,0,0.2,0.1,0,0,0,0,0.1,0.1,0,0,2.8,0,17.1,0.2,0.2,0,0,0,0,0,0,0,0,0,0.1,0,0,0.3,0.1,0,0,0,0,0,0,0.2,1.6,0.6,0.1,0,0.1,0,0.9,0,0,0,0.2,0,0.7,0,0.1,0,0.1,0.5,0,0,0,0.1,0.4,0,0.1,0,0,0,4.4,0,0,0,0,0,0,0,0.4,0,0.3,0,0,0,0,0.1,0,0.1,0,0,0,0.1,0.1,0.2,0.2,0,0.6,0,0.2,0,0,1.6,1.3,0.3,6,0.3,1.3,0,0.1,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.1,0.5,0.2,0.1,0.1,0.1,0,0.2,0.1,0.1,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0
ENSG00000183760,ACP7,"FLJ16165, PAPL, PAPL1","Acid phosphatase 7, tartrate resistant (putative)",Q6ZNF0,19,39083913-39111493,"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins",,Hydrolase,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Group enriched,Detected in some,5,brain: 6.3;lymphoid tissue: 2.6;skin 1: 6.0,Not detected,Not detected,,,Group enriched,Detected in some,5,cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4,GAMG: 33.3;U-87 MG: 45.5,Low region specificity,Detected in many,,,Not detected,Not detected,,,HPA042613,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA042613: AB_10963214,unprognostic (6.35e-2),unprognostic (1.97e-1),unprognostic (1.48e-1),unprognostic (6.74e-3),unprognostic (1.92e-3),unprognostic (1.41e-1),unprognostic (3.41e-1),unprognostic (4.94e-3),unprognostic (2.66e-1),unprognostic (2.15e-1),unprognostic (1.50e-1),unprognostic (9.81e-2),unprognostic (1.51e-5),unprognostic (4.36e-3),unprognostic (5.08e-2),unprognostic (2.31e-2),unprognostic (2.42e-1),0,0,2.5,0,3.3,0,0.2,6.3,3,0.5,0.9,0,0,0,0.4,0.8,0,0.2,0,2,2.4,0,0,0,0,4,3.8,1.8,0,0,0.3,0,0,5.1,0.3,0,0,0.5,0,0,6,0,0,2.2,0,0.1,0,3.1,0,0,0,2.6,0.1,0.6,4.7,5.2,0,0,0.1,0,0,0,0,1.2,0.6,0.8,0.4,5.2,0,0,0,33.3,0.3,0,1,0.7,0,0,0,0,0,0,0,0.1,0.1,0.1,9.5,0.3,0,0.1,0,0,0,0.2,2,0,0,0,0.2,0.2,0,0,0,0,0.1,0,0,0,0,0,0,0.6,0,0,6.1,1.1,0,0,0,0,0,45.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.5,3.3,6.3,3,2,2.4,4,3.8,1.8,5.1,2.2,3.1,4.7,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.1,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0.3,0.1,0.2,0.1,0,0,0,0.1,0,0,0.1
ENSG00000168615,ADAM9,"CORD9, KIAA0021, MCMP, MDC9, Mltng",ADAM metallopeptidase domain 9,Q13443,8,38996754-39105445,"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins",,"Hydrolase, Metalloprotease, Protease","Cancer-related genes, Cone-rod dystrophy",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Cell type enhanced,Detected in all,,Pancreatic endocrine cells: 179.4,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Immune cell enhanced,Detected in some,,classical monocyte: 4.0,Low lineage specificity,Detected in many,,,Low cell line specificity,Detected in all,,,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA004000,,,Approved,"Endoplasmic reticulum,Vesicles",Secreted - unknown location,NA,NA,,740000,Vesicles,Endoplasmic reticulum,HPA004000: AB_1844584,prognostic unfavorable (1.14e-4),prognostic unfavorable (2.25e-4),unprognostic (1.32e-3),unprognostic (1.27e-1),unprognostic (2.86e-1),unprognostic (1.40e-1),prognostic unfavorable (7.21e-6),unprognostic (5.77e-2),unprognostic (1.55e-1),unprognostic (1.48e-2),prognostic unfavorable (2.52e-5),unprognostic (5.83e-2),prognostic unfavorable (3.99e-4),unprognostic (2.80e-1),unprognostic (5.76e-2),unprognostic (2.27e-1),unprognostic (1.23e-2),33.4,28.2,7.2,29.1,7.5,2.1,21.7,8.4,9.2,35.1,10.7,33.2,24.7,29.9,15.3,29.9,19.4,47.5,28.9,5.9,14.3,35.2,13.6,51.8,9.8,10.2,7.1,5.3,17,12.8,52.9,7.9,47.8,8.8,35.2,42.2,18.7,55.3,35.1,24.3,15.1,23.2,52.1,9.4,24.2,44.6,11.2,9.3,5.9,40.3,25.2,13.3,56.7,24.5,10.6,188.3,163.6,63.5,32.6,117.2,374,67,259.6,382.4,191.7,177.9,82.7,147.1,10.1,86.1,247.2,156.7,79.5,30.8,249.7,373.2,6.9,21.5,12.1,102.8,73,226.4,8.9,19.1,287.5,139.2,193.3,212.7,341,268.9,15.2,21.5,53.2,406.2,25,7.2,4.4,8.3,175.2,46.7,3.8,106.3,27.6,299.3,62.4,6.4,11.5,78.4,90.9,57.8,72.9,67.3,12,374.2,109.9,97.9,213.9,124.1,12.9,29.5,7.7,175.8,12,72.1,0.3,4,0.5,0.1,1.3,0,0,0,0.1,2.5,0,0,0.1,0.5,0.8,0.6,0.3,0.1,0.9,7.2,7.5,8.4,9.2,5.9,14.3,10.2,7.1,5.3,8.8,9.4,9.3,10.6,14.4,48.1,37,16,3.8,35.9,66.6,78.3,26.7,19.3,23.4,9.8,49.7,24.3,82.1,35,20.9,24.1,8.9,44.4,3.9,90.2,14.4,42.1,35.3,20.5,10.7,2.5,47.5,115.4,85.1,42,80.5,82.1,5.1,26.4,25,7.5,125.9,5,38,32.2,44.7,60.2,44.8,7.8,28.6,54.7,21.4,33.7,21.8,17.5,1,30.7,26.7,179.4,30.6,24.8,5.2,108.7,24.9,41.1,51.9,25.1,13.1,31.3,31.9,4.3,2.5,20.2,21.5,34.3,5.6,11.2,32.7,103.8
ENSG00000063761,ADCK1,FLJ39600,AarF domain containing kinase 1,Q86TW2,14,77800109-77935014,"Enzymes, Predicted secreted proteins",,"Kinase, Serine/threonine-protein kinase, Transferase",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Cell type enhanced,Detected in many,,Cone photoreceptor cells: 20.9;Oligodendrocytes: 29.0,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in all,,,Low cell line specificity,Detected in many,,,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA051012, HPA055014",Uncertain,,Uncertain,Nucleoplasm,Secreted - unknown location,NA,NA,,,Nucleoplasm,,"HPA051012: AB_2681310, HPA055014: AB_2682672",unprognostic (6.36e-2),unprognostic (7.09e-2),unprognostic (6.00e-2),unprognostic (1.76e-1),unprognostic (2.24e-1),unprognostic (1.46e-1),prognostic unfavorable (1.70e-4),prognostic favorable (4.11e-5),unprognostic (2.33e-1),unprognostic (1.64e-1),unprognostic (4.57e-3),unprognostic (1.38e-1),prognostic favorable (5.82e-6),unprognostic (6.30e-3),unprognostic (2.06e-1),unprognostic (9.57e-2),unprognostic (4.06e-1),4.4,8.1,8.2,3.7,8.8,5.3,4.3,8.3,10,4.2,8.9,6.7,7.5,4.8,5.2,6.1,4.4,3.9,8.2,8.7,8.6,6.7,8.6,4,4.1,10,8.5,8.7,4.8,6.8,6.6,8.4,5.2,9.8,6.5,5.9,3.8,6.7,5.4,9,5.9,5.7,6.4,8,7.3,6.1,4.6,9,5.2,6,5.3,4.8,5.2,4,11.2,5.5,9.1,4.4,17.4,13,6.5,6.2,5.7,7.9,4.5,5.6,4.7,12.4,12,8.5,9.5,7.5,10.2,27,9.3,2.9,6.3,9.1,2.8,4.9,7.5,12.2,4.5,6.6,7.7,16.2,1.9,5.7,4.4,7.1,10.1,11.4,7.4,5.9,24.5,5.8,7.6,9.6,17.5,10.2,9.1,0.7,9,6.6,13.9,10.4,6,10.6,14.7,5.9,6.8,20.9,9.4,6.8,4.6,3.4,8.9,4.6,6.4,7.7,6.3,6.6,7.7,5.8,1.3,4,1.4,4.2,6,2.9,1.4,1.6,2.4,7.4,3,1.9,3.4,0.3,3.2,2.5,5.5,3.1,2.5,8.2,8.8,8.3,10,8.7,8.6,10,8.5,8.7,9.8,8,9,11.2,1.9,0,3.7,10.1,1.8,0.9,1.8,3.9,2.8,5.9,2.9,3,5.7,4.3,2.8,0,20.9,8.2,4.2,4,3.9,4.4,1.5,2,2.4,1.4,1.8,2.1,10.3,5.1,4.2,2.4,6.6,2.4,1.3,5,1.8,6.6,9.6,8.4,11.7,4,4.1,4.4,1.5,0.8,1.5,5.1,0,5.6,2.5,4,3.1,11.6,29,2.8,1.3,1.9,3.2,1.5,3,3.8,2.4,9.3,0,2.1,1.6,1.8,9.9,4.3,1.4,5.3,2.2,4.6,5.4,1.2
ENSG00000153292,ADGRF1,"GPR110, hGPCR36, PGR19",Adhesion G protein-coupled receptor F1,Q5T601,6,46997708-47042350,"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,4,esophagus: 17.6;kidney: 19.3;urinary bladder: 43.0,Group enriched,Detected in some,4,Collecting duct cells: 108.5;Pancreatic endocrine cells: 98.9;Urothelial cells: 363.7,Low cancer specificity,Detected in many,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,A-431: 31.2;CAPAN-2: 113.3;HaCaT: 25.3;PC-3: 36.6;RPTEC TERT1: 50.9;RT4: 132.6,Not detected,Not detected,,,Not detected,Not detected,,,HPA038438,Approved,,,,Secreted - unknown location,NA,NA,,,,,HPA038438: AB_10672645,unprognostic (4.83e-4),unprognostic (1.38e-1),unprognostic (1.64e-1),unprognostic (6.71e-3),unprognostic (1.95e-3),unprognostic (3.02e-3),unprognostic (7.76e-2),unprognostic (2.63e-2),unprognostic (2.90e-1),unprognostic (4.20e-2),unprognostic (3.64e-3),unprognostic (1.99e-1),prognostic favorable (1.35e-5),unprognostic (7.41e-2),unprognostic (8.39e-2),unprognostic (1.76e-1),unprognostic (1.08e-2),0.1,0,0,0.2,0,0,0.4,0,0,1.7,0,0.3,0,0.2,0.1,17.6,0.8,6.1,0,0,0,19.3,0,3.6,0,0,0,0,0,0.2,0.1,0,0,0,3,0.1,0,3.2,1.7,0,0,3.3,0,0,0,1.5,0.6,0,0.1,6.2,0,5.9,43,6.5,0,31.2,0.1,0.6,0.1,0,0,0,0,0,0,0,0,113.3,0,2,0,0,25.3,0,7.9,0,0,0,0,0.1,0,0,0,0,0,0,0,1.2,0,0,0,0,0,0,0,0,0,0.1,20.5,36.6,0,0,0,50.9,132.6,0,0,0,4.2,0,0,0.5,0,0,0.1,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,21.8,0,0.1,0,25.4,0,0.6,0,5.5,1.9,0.7,12.8,13.6,108.5,0,0,0,1.5,23.5,30.8,0,7,5,0.7,0,0,0.1,18.9,0.1,0.8,3.6,46.9,1.3,0,0,0,0.1,0,0.1,0.6,0,0,0,0.2,0.3,0.7,0,0,0,0,0,0,0,98.9,0,0,0,39.1,1.2,0.7,14.6,0,0,0.2,1.1,0,0.2,2.6,0,0.1,1,0.1,0.2,363.7
ENSG00000106624,AEBP1,ACLP,AE binding protein 1,Q8IUX7,7,44104345-44114562,"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins","Transcription, Transcription regulation","Calmodulin-binding, DNA-binding, Repressor","Disease variant, Ehlers-Danlos syndrome",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Cell type enhanced,Detected in many,,Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Immune cell enriched,Detected in some,5,plasmacytoid DC: 7.6,Lineage enriched,Detected in many,5,dendritic cells: 7.6,Cell line enhanced,Detected in many,,ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9,Low region specificity,Detected in all,,,Region enhanced,Detected in all,,spinal cord: 57.6,"CAB009966, HPA047724, HPA063595, HPA064970",Supported,,Supported,"Nucleoplasm,Vesicles,Cytosol",Secreted - unknown location,NA,NA,,2700000,Vesicles,"Nucleoplasm, Cytosol","CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394",unprognostic (1.70e-2),unprognostic (5.42e-2),unprognostic (1.66e-2),unprognostic (1.45e-1),prognostic unfavorable (1.60e-4),unprognostic (1.13e-1),unprognostic (7.00e-2),unprognostic (8.79e-2),unprognostic (2.52e-1),unprognostic (3.27e-2),unprognostic (1.26e-1),unprognostic (1.94e-1),prognostic unfavorable (9.31e-9),unprognostic (2.88e-3),unprognostic (9.58e-2),unprognostic (1.17e-2),unprognostic (6.28e-3),175,60.5,70,60.4,48.7,10.7,154.4,44.7,45.2,291.1,33.6,89.1,19.3,271.1,60.1,66.4,201.5,157.3,100.4,46.9,109.6,69.2,20.5,167.5,45.9,125,62.9,29,255.8,29.1,10.2,43.6,89.8,73.9,113,25.3,1.3,51.1,215.5,21.5,76.3,79.8,120.3,81.7,54.8,71.8,40.7,63.1,74,84.4,14.2,16.9,139.9,199.7,81.5,0.6,0,44.5,0.1,141.1,49.6,1,193,126,21.6,4.5,0,0.1,5.3,20.9,208.9,0.2,0.1,2.4,3.5,9.1,0.6,0,13.3,0.1,0,39.6,0.1,0.3,75.8,0,72.9,0.1,1.1,9.7,145,8.3,0.3,0,0.2,86.9,16.1,19.1,0,0.4,71.3,1.7,1.7,5,0,4.9,25.3,0.1,0.3,85.9,41.9,0.4,14.4,34.1,0,86.2,0.5,0.3,1,0.9,102.8,0.4,0.2,117.9,0,0,0,0.3,0,0.2,1.5,0.2,0,0,1.4,0.9,0.5,0,0.1,0,7.6,0,0.3,70,48.7,44.7,45.2,46.9,109.6,125,62.9,29,73.9,81.7,63.1,81.5,23.6,0,2.5,32.3,11.8,34.5,5.7,1.3,1.8,0.8,2,14.6,26.4,1.5,1.4,7.3,0,2,22.7,0,0,0.9,3.1,3.3,103,18,0,1.3,0.1,0,3.3,263.2,8.6,2.9,2.5,33.3,30.4,0.6,3.6,0,0.3,0,0,1.8,42,18,151.6,3.2,85.4,17.8,1,0.2,1,6,0.3,0.4,0,508.9,9.7,16.9,0,2.2,2.2,0.8,39.5,23.6,173.4,4,4.6,1.5,27.4,3.4,4.8,28.7,0,2.4
ENSG00000196711,ALKAL1,"AUGB, FAM150A, UNQ9433",ALK and LTK ligand 1,Q6UXT8,8,52534037-52565430,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,,gallbladder: 2.4;thyroid gland: 2.4;urinary bladder: 1.6,Cell type enriched,Detected in some,4,Distal tubular cells: 5.9,Cancer enhanced,Detected in many,,thyroid cancer: 2.8,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,CAPAN-2: 1.4,Not detected,Not detected,,,Low region specificity,Detected in all,,,HPA027368,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA027368: AB_10602317,,,unprognostic (1.18e-1),unprognostic (1.13e-4),,,,unprognostic (9.47e-2),,unprognostic (9.64e-2),unprognostic (1.52e-1),unprognostic (6.60e-2),unprognostic (1.70e-4),unprognostic (4.48e-2),unprognostic (1.71e-1),unprognostic (1.34e-1),unprognostic (9.58e-3),0,0,0,0.3,0,0,0,0.1,0.2,1.2,0,0.8,0.6,0,0,0,0.2,2.4,0,0,0.1,0.1,0.2,0.3,0,0.4,0.2,0,0,0.3,0,0,0,0.5,0.5,0.1,0,0.8,0,0,0,0.5,0.7,0.2,0,0.4,0.1,0.1,0,2.4,0,0,1.6,0.1,0.3,0,0,0,0,0,0,0,0,0,0,0,0,1.4,0,0,0,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0.4,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.2,0,0.1,0.4,0.2,0,0.5,0.2,0.1,0.3,0,0,0,0,0,0,0,0,0,0,1.4,0.3,0,0,1.3,0,0,0,0,0,5.9,0.1,0,0.8,0.1,0,0,0,0,0.9,0,0.3,0,1.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000189292,ALKAL2,"AUGA, FAM150B",ALK and LTK ligand 2,Q6UX46,2,279558-288851,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,adrenal gland: 207.1,Cell type enhanced,Detected in some,,Breast myoepithelial cells: 20.3;Ductal cells: 37.0;Endometrial ciliated cells: 24.0;Glandular and luminal cells: 50.3;Granulosa cells: 64.3;Proximal tubular cells: 28.1,Cancer enhanced,Detected in many,,renal cancer: 5.7,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,20,AF22: 138.8,Low region specificity,Detected in some,,,Group enriched,Detected in many,5,amygdala: 4.3;basal ganglia: 3.0;cerebral cortex: 2.5;hippocampal formation: 3.4;spinal cord: 2.3,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (1.39e-3),unprognostic (1.44e-2),unprognostic (2.41e-2),unprognostic (2.03e-3),unprognostic (2.88e-1),unprognostic (3.73e-2),unprognostic (1.34e-2),unprognostic (2.72e-2),unprognostic (1.40e-1),unprognostic (1.11e-1),unprognostic (2.07e-1),unprognostic (7.06e-2),unprognostic (1.47e-1),unprognostic (3.35e-1),unprognostic (9.29e-3),unprognostic (5.19e-2),unprognostic (3.68e-1),24.4,207.1,4.9,2,7,0.7,26.9,3.9,2.9,4.8,4.2,8.2,3.8,26.7,13.5,2,26.5,10.8,1.8,3.3,4.4,21.3,4.5,34.3,0.9,4,2.8,3,75,64.9,2.3,8.7,9.7,3.7,6.6,6.6,0.4,5.4,2.6,1.5,14.3,7.8,10,2.7,12.4,17.5,35.8,5.3,1.7,10.5,0.5,1.7,4.8,5.4,5.6,0,0,138.8,0.1,0.8,0,0.3,0.2,0,0,0,0.6,0,0.4,1.3,0,0,0.2,0.5,0,0,0.5,0.3,0,0.1,0.7,0.9,0.1,0,0,0,0,0,0,0,1.3,0.1,0,0,0.1,0,0.2,2.4,0,0,6.8,0.4,0,0,0,0.1,1.1,0,0,0,2.8,0,0.5,0,0.1,0.1,0.2,0.2,0.3,0.7,0.1,0.3,0.5,0.1,0,0,0,0,0.1,0.1,0.2,0.1,0.1,0,0,0.2,0.1,0,0.1,0,0.1,0.2,0.1,4.9,7,3.9,2.9,3.3,4.4,4,2.8,3,3.7,2.7,5.3,5.6,2.5,0,11,0,1.7,0,0,0,0,0,14.6,20.3,0,0,0,1.8,0,0.1,1.4,0,3.9,37,0,24,6.3,4.5,0,0,0,0.7,0.1,3.1,0,50.3,0,64.3,0,0,0.1,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0,0,3.9,0,0,0,0,0,28.1,0,0,0,0,10.3,0,0,0,0,0.1,0.6,0.9,0,0
ENSG00000166839,ANKDD1A,FLJ25870,Ankyrin repeat and death domain containing 1A,Q495B1,15,64911902-64958691,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Astrocytes: 209.6;Leydig cells: 61.8;Peritubular cells: 78.6,Low cancer specificity,Detected in many,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in some,,,Low lineage specificity,Detected in many,,,Cell line enhanced,Detected in many,,Karpas-707: 24.1;RT4: 17.7;U-266/84: 25.4,Low region specificity,Detected in some,,,Region enhanced,Detected in all,,cerebellum: 13.8,HPA040757,Approved,,Approved,Nucleoplasm,Secreted - unknown location,NA,NA,,,Nucleoplasm,,HPA040757: AB_10960566,unprognostic (3.72e-4),unprognostic (1.86e-1),unprognostic (6.07e-3),unprognostic (3.25e-2),unprognostic (4.78e-1),unprognostic (2.49e-1),unprognostic (1.14e-1),unprognostic (1.22e-3),unprognostic (5.11e-3),unprognostic (5.57e-2),unprognostic (4.37e-2),unprognostic (1.60e-1),unprognostic (3.15e-7),unprognostic (1.06e-1),unprognostic (1.98e-1),unprognostic (8.04e-3),unprognostic (1.64e-2),3,9,4.6,2.7,4.6,2.7,1.5,1.8,5.5,2.3,0.3,1.2,1.2,2.2,1.9,3.6,4,2.9,2.2,3.8,2.8,0.8,0.4,2.6,4.9,4.9,2.5,5.4,3.9,4.4,4.4,1.2,1.6,4.1,2.3,0.4,2.8,2.4,2.1,1.2,3.3,1.8,1.6,1.8,10.8,1.7,3.6,3.2,0.8,2.6,0.1,1.3,3,2,2.7,1.2,3.7,1.6,1.6,2.7,2.1,6.9,1.6,4.4,1.7,2.5,2.1,1.7,1.6,1.9,3.8,1.4,1.3,3.7,0.3,1.4,0.7,1.1,1.5,4.6,1.5,2,1.2,2.5,1.6,0.5,1.1,0.6,0.9,1.2,1.7,0.3,24.1,0.5,3.5,0.6,2.6,2.2,0.6,1.7,0.8,1,12.1,0.2,17.7,3.2,4.5,1,1.2,1.8,1.5,1.2,1.5,1.8,3.2,3.3,2.8,1.6,6.4,25.4,1.2,3.6,3,1,0.5,0.4,0,1,0.9,0.3,0.4,0.5,1.4,0.7,0.3,0.3,0.4,0.7,3.1,0.9,0,2.1,0.4,4.6,4.6,1.8,5.5,3.8,2.8,4.9,2.5,5.4,4.1,1.8,3.2,2.7,8,0,1.3,209.6,1.5,5.6,4.2,1.1,4,11.2,0.7,1,1.4,1.5,1.3,0,12.5,3.1,3.8,0.1,0,0.9,1.1,1.7,9.6,12.7,1.2,0,37.7,2.3,5.6,6.5,0,3.6,5.7,1.1,5.3,0,5.4,3.3,24.6,0,2,6,25.4,4.1,61.8,7.1,10.6,19.7,1.1,28.9,5.2,30.2,10.7,2.8,0.1,78.6,6.2,2.7,0,0.3,0.2,8.2,13.1,11.8,7.1,2.6,1.3,0.8,3.7,2.2,3,3.3,0.1,5.2
ENSG00000131471,AOC3,"HPAO, VAP-1, VAP1",Amine oxidase copper containing 3,Q16853,17,42851184-42858130,"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins",Cell adhesion,Oxidoreductase,"Cancer-related genes, FDA approved drug targets",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,,adipose tissue: 426.5,Group enriched,Detected in many,4,Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,17,ASC diff: 307.5,Not detected,Not detected,,,Low region specificity,Detected in some,,,"HPA000980, CAB025797",Enhanced,,Approved,"Golgi apparatus,Cytosol",Secreted - unknown location,NA,NA,,240000000,Cytosol,Golgi apparatus,"CAB025797: , HPA000980: AB_1078170",unprognostic (2.20e-1),unprognostic (4.49e-2),prognostic unfavorable (3.68e-4),unprognostic (2.97e-2),unprognostic (1.17e-1),unprognostic (2.64e-1),unprognostic (2.22e-1),unprognostic (2.15e-2),unprognostic (1.48e-1),unprognostic (4.00e-2),unprognostic (2.95e-1),unprognostic (9.02e-2),prognostic unfavorable (1.79e-5),unprognostic (5.61e-2),unprognostic (1.67e-1),unprognostic (8.39e-2),prognostic unfavorable (6.98e-4),426.5,48.8,2.6,32.2,2.9,1.5,170.6,2.4,4.4,50.3,4,157.1,17.4,95.9,33.8,88.8,85.6,51.1,36.7,2.9,2.4,23.3,19.3,220.5,12.5,2.8,2.7,2.4,26.7,12.1,8.5,5.4,28.3,2.8,59.6,41.4,1.8,14.8,104.6,17.9,21.8,58.1,146.1,2.2,21.6,67.2,12.9,2.4,5.9,28.5,23.1,4,143.3,51.4,3.1,0.1,1.5,0.2,1,307.5,0.3,5,0.3,0.1,0.2,0.8,0.9,0,0.7,0.7,0.1,0.2,0.5,0.8,0.2,0.8,1.5,5.7,0.4,0.5,18.4,0.8,0.3,1,3.3,1,0.3,0.8,0,0.2,2.2,0.3,1.7,0.6,0.2,0.2,1.4,0.7,0.1,0.4,0.7,0.8,3,0.1,2.2,0.3,0.4,0,0.2,2,2.2,0.1,0.1,0,0.3,2.7,1.2,0.4,4.8,5.9,0.6,0.4,2.1,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,2.6,2.9,2.4,4.4,2.9,2.4,2.8,2.7,2.4,2.8,2.2,2.4,3.1,58.2,3.2,6,0,0.5,2.9,0.1,0,2.2,0,1.1,2.2,9.5,0,1.9,0,0,0.1,0.4,0.1,0,0.2,4.5,0.8,2.3,12.3,0,0,0.4,0.2,0.1,11.3,0,1.4,1.3,2.1,20.7,0.2,1.4,0,0.3,0.1,0,1.4,2.7,2.6,3.4,0.9,3.6,3.7,0,0.2,0,0,0.1,0.2,0,74.9,0,0.4,0.1,1.4,1,0.4,118.3,2.6,93,1.1,1.3,0.7,1.8,0.3,0.6,74.6,0.1,0.3
ENSG00000112175,BMP5,,Bone morphogenetic protein 5,P22003,6,55753653-55875590,"Predicted intracellular proteins, Predicted secreted proteins","Chondrogenesis, Differentiation, Osteogenesis","Cytokine, Developmental protein, Growth factor",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,5,placenta: 71.9,Group enriched,Detected in some,8,Cardiomyocytes: 17.7;Fibroblasts: 28.9;Microglial cells: 26.2;Smooth muscle cells: 26.3,Cancer enhanced,Detected in many,,lung cancer: 2.8,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,11,AF22: 27.6;U-2 OS: 20.9,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (2.84e-4),,unprognostic (9.07e-4),unprognostic (3.50e-1),unprognostic (1.27e-1),unprognostic (6.21e-2),unprognostic (1.58e-1),unprognostic (2.39e-3),,unprognostic (1.29e-1),unprognostic (1.20e-1),unprognostic (6.76e-2),unprognostic (4.43e-3),unprognostic (3.15e-1),unprognostic (1.26e-1),unprognostic (1.30e-1),unprognostic (4.76e-2),1.6,1,0.2,1,0.2,0.2,1.1,0.6,0.7,0,2.5,6.2,8.4,0,0,0.9,0,2.3,3.3,0.1,0.2,2.4,3.2,13,0.4,2,0.9,0.2,0,1.6,1.1,3.6,71.9,3,14.2,7.5,0,1.2,0,4.5,0,9.8,0.3,0,0,3.3,0,0.2,0.3,1,12.4,0.2,9.4,0.3,1.1,0,0,27.6,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0.2,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.5,0,0,0,2.2,0,0.4,0,0,1.1,0,0,0,0,20.9,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0.2,0.6,0.7,0.1,0.2,2,0.9,0.2,3,0,0.2,1.1,1.8,0,3,0,0,0,0.2,0,0,0,0.4,1,17.7,0,0,0,0,1,0.1,0,0,0,0.1,0,0,1.2,0,2.7,0.4,0,0.8,28.9,0,0,0,0,2.2,0,2.4,0,0.1,0,0,0,0,0.2,0,0.4,0,26.2,0,0,0,0,0.1,1.2,0,0,0,0.1,0,0,0.1,0,0,2.6,26.3,0,0.1,0.3,0,1.9,0.6,0,0,0.1
ENSG00000186191,BPIFB4,"C20orf186, dJ726C3.5, LPLUNC4",BPI fold containing family B member 4,P59827,20,33079644-33111751,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,14,pituitary gland: 8.5,Cell type enhanced,Detected in single,,Basal respiratory cells: 2.5,Low cancer specificity,Detected in some,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4,HSkMC: 2.3;U-2 OS: 3.6,Not detected,Not detected,,,Not detected,Not detected,,,HPA047388,,,Approved,"Actin filaments,Cytosol",Secreted - unknown location,NA,NA,,,"Actin filaments, Cytosol",,HPA047388: ,,unprognostic (1.32e-1),,unprognostic (1.16e-1),unprognostic (1.61e-1),unprognostic (2.75e-2),unprognostic (1.31e-3),unprognostic (4.70e-2),unprognostic (3.42e-2),unprognostic (2.03e-1),unprognostic (3.98e-4),,,unprognostic (1.31e-1),unprognostic (1.82e-1),,unprognostic (8.97e-2),0.3,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0.1,0,0,0,0.2,8.5,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0,0,0.6,2.3,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,2.5,0,0,0,0,0.3,0,0.7,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0.1,0,0,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0.1,0,0,0.1,0.1,0,0.7,0,0,0,0,0,0,0.1
ENSG00000120055,C10orf95,FLJ14280,Chromosome 10 open reading frame 95,,10,102449837-102451543,Predicted secreted proteins,,,,Evidence at transcript level,Evidence at transcript level,,,Tissue enhanced,Detected in many,,fallopian tube: 9.7,Cell type enhanced,Detected in many,,Endometrial ciliated cells: 30.1;Rod photoreceptor cells: 18.4;Syncytiotrophoblasts: 38.0,Low cancer specificity,Detected in many,,,Low region specificity,Detected in some,,,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in all,,,Cell line enhanced,Detected in many,,HEK 293: 11.8;JURKAT: 11.7,Low region specificity,Detected in single,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (2.31e-1),unprognostic (7.76e-3),unprognostic (3.19e-1),unprognostic (5.62e-3),unprognostic (4.02e-1),unprognostic (5.03e-2),unprognostic (1.08e-1),unprognostic (5.98e-2),unprognostic (1.50e-2),unprognostic (1.01e-1),unprognostic (4.42e-2),unprognostic (2.39e-2),unprognostic (1.03e-1),unprognostic (1.66e-1),unprognostic (2.14e-1),unprognostic (1.22e-2),unprognostic (4.80e-3),0.5,1.5,0.7,1.8,0.7,2,0.2,2.8,1,0.7,0.7,1.2,2.5,1.2,0.4,1.3,9.7,1.4,0.6,0.7,0.5,1.4,0.4,3.5,3,0.3,0.4,1,1.1,4.7,0.1,1.3,0.7,1.2,1.6,0.4,4.8,4,0.1,0.7,4.1,2.3,0,0,2.6,3.6,0.7,0.7,0,5.3,0,0.5,0.6,0.5,0.3,5.7,1.1,0.1,2.3,0,0,4.9,0.2,0,0,0,4.4,9.8,5,2.2,0,0.7,9.8,0,0.4,0,4.3,11.8,3.2,4.7,3.7,0,4.4,3,0.1,1.8,0,0.1,3.1,0,11.7,5.6,4.1,0,4.5,2.4,4.2,2.2,2,3.3,7,0.1,5.4,1.1,2,8.8,1.3,2.4,1.5,3.1,1.7,4.8,0.3,0.4,0.2,1,0.2,0.5,3.5,2.9,3.3,0.2,6.5,0.1,2.1,1.2,1.7,7.8,0.6,7.4,10.7,8.4,7.9,3.6,8.3,11.7,9.9,0.9,10.1,0.3,6.3,9.6,4.9,0.7,0.7,2.8,1,0.7,0.5,0.3,0.4,1,1.2,0,0.7,0.3,0.3,0,3.2,0.7,3.1,1.5,4.3,0.5,0,4.6,2.4,2.5,0.1,2.8,4.2,5.5,10.4,2.3,6.4,2.5,3.9,1.5,0.1,30.1,0.7,1,1.2,1.3,0.7,1.1,1.7,0.3,1.5,4,0,0.8,0.4,0.3,2.3,3.3,0.7,3.7,4.1,1,1,0.5,0.6,1.4,0,0,2.2,2.7,6.2,0,0,0.7,0.4,0.7,2.5,3.3,2,4.2,8.7,18.4,0,0.9,0.5,0.7,1.4,1.9,1.6,38,3.2,0.7,3.2,2.9
ENSG00000174370,C11orf45,"FLJ43646, MGC35558",Chromosome 11 open reading frame 45,Q8TAV5,11,128899565-128906035,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in some,,Basal squamous epithelial cells: 5.7;Hofbauer cells: 8.7;Kupffer cells: 5.9;Late spermatids: 8.2,Low cancer specificity,Detected in many,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,HBEC3-KT: 11.2;U-937: 8.9,,,,,,,,,HPA039716,Approved,,Approved,Cytosol,Secreted - unknown location,NA,NA,,,Cytosol,,HPA039716: AB_10672892,unprognostic (8.32e-2),unprognostic (3.93e-2),unprognostic (5.99e-3),unprognostic (1.35e-3),unprognostic (1.01e-1),unprognostic (9.93e-2),unprognostic (4.50e-5),unprognostic (1.97e-2),unprognostic (4.78e-2),unprognostic (3.10e-1),unprognostic (2.80e-1),unprognostic (9.27e-2),unprognostic (2.55e-9),unprognostic (2.37e-1),unprognostic (2.60e-2),unprognostic (6.87e-2),unprognostic (7.22e-2),0.6,3.4,1.7,0.7,3.8,0.8,0.9,0.6,1.6,1,0.9,0.7,1.4,0.5,0.6,2.9,1,2,4.5,1.1,1.7,1.1,0.5,2.6,0.8,1.7,1.6,1,0.9,2.6,3.9,2.4,2.1,2.6,1.1,0.9,0.2,1.6,2.9,0.1,6.7,0.9,0.5,1.2,1.6,1.8,1.1,1.5,2.4,1.8,0.2,0.9,1.2,1.3,1.7,2.4,4.5,0,0,0.3,0.4,1.6,0.8,4.7,1.7,4.2,6.3,5.8,0,3.2,0.5,4.2,2.3,2.4,11.2,0.8,0,1.1,0.3,2.7,0,0.2,0,0,0.3,1.5,1.3,0.9,3.8,1,3.5,0,0.2,2,1.2,2.6,2.4,1.8,1,3.9,1.1,4.6,0.5,3.9,1.1,0,0.2,1.8,5,0.3,1.2,0.8,4.4,0.5,0,6.2,0,0.8,0.1,0,0,0.8,8.9,0.2,0,0.6,0,0,0.2,0.1,0.1,0.1,0.1,0.9,0.1,0.2,0.1,0,0,0,0.2,0,0.2,1.7,3.8,0.6,1.6,1.1,1.7,1.7,1.6,1,2.6,1.2,1.5,1.7,0.1,0,0.5,0,0,2.8,1.3,0.9,5.7,0,0.3,0.4,1.7,0,0.2,0,0,2,0,0.1,1.9,1,2,0.3,0.1,0.2,0,0,0.3,0.8,2.1,0.3,0,0.5,1.3,0.3,0.4,0,8.7,0,0.2,0.1,0,5.9,0.8,8.2,0,2.2,0,2.8,0.6,0,0,0,0,1.3,0.1,0,0,0.1,0,0.1,0.1,0,0,0,0.4,1.5,1.7,3,0.9,1.2,0.2,0.1,0.2,1.1
ENSG00000189227,C15orf61,LOC145853,Chromosome 15 open reading frame 61,A6NNL5,15,67521131-67530146,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,skeletal muscle: 24.0,Cell type enhanced,Detected in all,,Early spermatids: 222.6;Spermatocytes: 258.9,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in all,,,Low cell line specificity,Detected in all,,,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA062820,,,Approved,"Nucleoli,Vesicles,Cytosol",Secreted - unknown location,NA,NA,,,"Nucleoli, Vesicles",Cytosol,HPA062820: AB_2684874,unprognostic (1.35e-1),unprognostic (9.42e-3),unprognostic (2.11e-1),unprognostic (5.41e-2),unprognostic (2.40e-1),unprognostic (2.49e-1),unprognostic (1.49e-1),unprognostic (3.87e-3),unprognostic (8.95e-2),unprognostic (4.01e-2),unprognostic (1.04e-2),unprognostic (8.45e-2),prognostic favorable (5.31e-5),unprognostic (2.42e-2),unprognostic (9.78e-2),unprognostic (1.42e-1),unprognostic (8.32e-2),3.9,3.8,2.5,1.6,6.1,5.4,3.6,7.5,4.5,2.7,0,2.2,2.8,2.4,1.9,2.1,2.9,1.5,5,3.8,2.6,3.1,2.5,2.3,1.3,1.3,3,3.8,2.8,4.2,4.4,5.1,2,2.3,2.5,2.2,10.9,2.6,2.1,24,4,1.9,1.4,0.6,1.7,2.4,7.8,1.8,1.4,2.8,8.4,1,2.3,2.4,2.5,4.2,4.4,1.1,4.9,5,7.2,3.1,1.8,3.2,3.3,2.6,3.4,2.9,3.5,3.8,2,3.9,4.9,4.4,1.2,2.7,2.1,10.4,3.7,3.3,4.6,3.2,4.6,3,7.5,3.4,1.1,4,2.4,1.6,10.6,4.3,7.6,1,2.4,3.8,7.6,1.8,3.3,5.6,5.1,2.5,13,2.3,2.9,6.4,4.8,3.2,3,6.1,2.1,2.7,7.1,1.6,4.4,6.8,5.5,4.7,7.1,11.2,8.5,1.9,9,2.2,7.9,4.3,7.8,4.5,3.7,5.2,5.3,5.9,4.5,4.8,3.6,6.2,5,0.5,3.8,3.2,4.9,4,3.5,2.5,6.1,7.5,4.5,3.8,2.6,1.3,3,3.8,2.3,0.6,1.8,2.5,28,22.4,13.5,4.9,23.1,67.2,32.6,32.3,120.7,75.5,55.7,82.3,74.5,18.6,14.3,16.5,37.5,42.6,23.8,38.6,80.3,25.1,222.6,17.5,24.2,26.8,27.1,11.8,14.8,29.8,31.9,56.8,15.8,17.1,34.8,15.2,22.9,44.7,30.5,13.5,15.7,47.5,48.8,24.8,25.6,42.6,41,19.9,37.4,3.7,15.6,97.1,23.7,5,8.5,27.6,48.4,25.6,37.4,63.3,49,77.1,8.4,93.9,32.9,38.2,38.7,258.9,52.1,62.7,60.9,20.5,34.4,28.9,39.2,20
ENSG00000184471,C1QTNF8,"CTRP8, UNQ5829",C1q and TNF related 8,P60827,16,1088226-1096244,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,5,brain: 2.5;fallopian tube: 1.9;pituitary gland: 2.0,Cell type enhanced,Detected in some,,Astrocytes: 1.0;Endometrial ciliated cells: 2.7,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Not detected,Not detected,,,HPA056438,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA056438: AB_2683134,,,unprognostic (8.65e-2),,unprognostic (2.56e-2),,,,,,,,,unprognostic (5.46e-2),,,,0,0.3,1.1,0,0.7,0,0,0.9,0.4,0,0.3,0,0,0,0,0,1.9,0,0,0.3,1.5,0,0,0.1,0,1.5,1.3,0.1,0,0,0,2,0,1.2,0,0,0,0,0,0,0,0,0,2.5,0,0,0.4,0.9,0,0,0,0,0,0,1,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.1,0.7,0.9,0.4,0.3,1.5,1.5,1.3,0.1,1.2,2.5,0.9,1,0,0,0,1,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,2.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000205863,C1QTNF9B,CTRP9B,C1q and TNF related 9B,B2RNN3,13,23891099-23897502,Predicted secreted proteins,,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,brain: 8.1;skin 1: 18.0;testis: 8.9,Cell type enhanced,Detected in some,,Adipocytes: 4.3;Early spermatids: 2.3;Endothelial cells: 1.4;Late spermatids: 2.1,Cancer enhanced,Detected in single,,prostate cancer: 0.8,Region enriched,Detected in many,4,hippocampal formation: 8.1,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,JURKAT: 4.8;OE19: 3.6,,,,,,,,,HPA056632,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA056632: AB_2683197,unprognostic (3.43e-1),unprognostic (3.42e-1),unprognostic (2.18e-2),unprognostic (9.51e-2),unprognostic (2.18e-1),unprognostic (4.10e-2),unprognostic (2.43e-1),unprognostic (3.32e-3),unprognostic (1.52e-2),unprognostic (7.26e-2),unprognostic (3.01e-3),unprognostic (7.04e-2),unprognostic (5.56e-3),unprognostic (3.89e-1),unprognostic (1.82e-1),unprognostic (1.35e-1),unprognostic (1.34e-1),1.2,0.7,1.2,0.6,1.2,0.2,0.4,0.5,1.3,0.3,0.5,0.4,0.5,0.7,0,1.7,0.3,0.8,3.5,8.1,1.8,0.2,0.1,0.4,0.2,0.5,0.9,0.6,0.4,0.6,0.1,1.1,0.6,0.5,4.3,0.1,0.7,1.6,0.2,4.1,18,0.2,0.7,0.5,1.3,0.8,8.9,1.4,0,0.5,2,0,0.6,0.1,1,0.7,1.7,0.6,0.7,0,0,0.2,0.2,0,0,0,0.7,1,0.1,0,0,1.3,1.7,0,0,0,1,1.4,0.3,0.9,0.9,0.1,0.1,0.4,0,0,0,0,0.8,0,4.8,0.4,0.9,0,1.1,0.2,0,1.1,3.6,1.6,0.6,0.8,1.3,0,0,2,0,1,0,1.7,0.4,0.5,0.2,0.1,1.6,0.4,0,1,1.4,0.2,0.7,1.9,0.6,0.3,0,0.2,0.4,0.3,0.3,0.1,0.2,0,0,0.1,0.5,0.1,0.1,0,0.4,0.4,0.7,0,0.1,1.2,1.2,0.5,1.3,8.1,1.8,0.5,0.9,0.6,0.5,0.5,1.4,1,4.3,0,0,0,0,0.3,0,0,0,0,0,0,0.8,0,0,0,0,0,0,0.1,0,0,2.3,0,0.2,1.4,0,0,0,0,0,0.1,0,0.1,0,0,0,0,0,0,0.3,0,0,0,0,2.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.1,0.3,0.9,0,0.3,0,0,0.4,0,0
ENSG00000205929,C21orf62,"B37, C21orf120, PRED81",Chromosome 21 open reading frame 62,Q9NYP8,21,32790673-32813743,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in some,,choroid plexus: 16.6;epididymis: 8.5;ovary: 14.3,Group enriched,Detected in many,4,Cholangiocytes: 44.3;Distal tubular cells: 23.5;Skeletal myocytes: 26.2,Cancer enriched,Detected in some,6,glioma: 11.0,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,9,AF22: 3.8;RPTEC TERT1: 2.3,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA016899,Enhanced,,,,Secreted - unknown location,NA,NA,,,,,HPA016899: AB_1845704,unprognostic (1.31e-1),unprognostic (3.84e-2),unprognostic (1.23e-1),unprognostic (4.37e-3),unprognostic (9.56e-2),unprognostic (3.05e-3),unprognostic (2.95e-2),unprognostic (1.17e-1),unprognostic (3.27e-1),unprognostic (1.85e-1),unprognostic (1.80e-1),unprognostic (1.78e-1),prognostic favorable (1.14e-4),unprognostic (2.59e-1),unprognostic (1.65e-1),unprognostic (1.13e-1),unprognostic (3.07e-2),0.7,0.3,3.8,0.4,2,0.6,0.1,2.2,1.9,0,16.6,0.1,0.1,0,8.5,0.2,0.7,0.4,0.2,2.4,6.2,7,0.2,0.1,0.2,3.2,4.6,1.2,14.3,4.2,0,3.4,0,3,3.6,0,1,0.1,0.2,0.1,0.2,0.4,0.2,2.2,0.2,0.3,0.3,4.2,0,0.1,0.1,1.1,0,0.1,6,0,0,3.8,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0.2,0.2,0,0,0,0.1,0.1,0,0,0,0,0,0,0,0.1,0,0.1,0,0.1,0,0,0,0,0,0.1,2.3,0,0.1,0,0,0,0,0,0,0.1,0,0.1,0,0.1,0,0.1,0,0,0.1,0.3,0,0.8,0.1,0,0,0,0.1,0,0.1,0.1,0,0.1,0.2,0.1,0.7,0.2,0,0.1,0.3,0,3.8,2,2.2,1.9,2.4,6.2,3.2,4.6,1.2,3,2.2,4.2,6,0,0,0,2.9,0.5,0.9,0.8,0.4,0,5.9,0,0,0.2,44.3,0.3,5.5,6.2,1.2,1.3,0.1,23.5,0.2,1.5,0,0,0.8,3,0,0.8,0,0.4,3.6,0,0,0,0.2,2.5,0.2,0.3,0,1.4,0,0,1.3,1.9,0.3,4.1,0.4,3.6,0,1,5.8,4.1,4,4.7,0,0,1.9,0,0.5,0.1,2.6,0.2,7.1,0,26.2,1.7,1,1,0,1,0.3,1.1,0.2,0.2,0.4
ENSG00000187944,C2orf66,UNQ6411,Chromosome 2 open reading frame 66,,2,196804417-196809355,Predicted secreted proteins,,,,Evidence at transcript level,Evidence at transcript level,,,Tissue enhanced,Detected in some,,adrenal gland: 4.0;brain: 5.9;pituitary gland: 3.8,Cell type enriched,Detected in some,7,Early spermatids: 36.9,Cancer enhanced,Detected in single,,glioma: 0.7,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,HEL: 9.0;RT4: 2.2;TIME: 2.1,Not detected,Not detected,,,Low region specificity,Detected in some,,,HPA020869,Uncertain,,Uncertain,"Nucleoplasm,Cytosol",Secreted - unknown location,NA,NA,,,Nucleoplasm,Cytosol,HPA020869: AB_1851545,unprognostic (1.19e-1),unprognostic (4.85e-2),unprognostic (6.95e-2),unprognostic (1.19e-1),unprognostic (3.48e-2),unprognostic (1.61e-2),unprognostic (6.80e-3),unprognostic (3.05e-2),unprognostic (1.95e-1),unprognostic (4.10e-3),unprognostic (4.54e-4),unprognostic (1.98e-1),unprognostic (1.75e-5),unprognostic (1.84e-1),unprognostic (2.30e-1),unprognostic (1.38e-2),unprognostic (1.86e-2),2.8,4,2.1,0.2,1.8,0.1,0.5,1.4,2.2,0,1.5,0.2,0,0.1,0.4,0.2,0.6,0.3,0.4,2,5.9,0.2,0.1,0.3,0,2.2,2.4,1.8,0.3,0.5,0.1,3.8,0,2.4,0.3,0.1,1.9,0.1,0.1,0,1.2,0.3,0,1.7,0.1,0.2,1.5,2.7,0.1,0.1,0,0.1,0.3,0.2,2.3,0,0.1,0.2,0.8,0.2,0.2,0,0.3,0.2,0.2,0.2,0.1,0.1,0.1,0,0,0,0,0,0.8,0.2,0.2,0.4,9,0.3,0.1,0,0.1,0.8,0.2,1.2,0.2,0,0.1,0.6,0,0,0,0.4,0,0,0.1,0,0.1,0.5,0,0,0,0.4,2.2,0.3,0,0,0,0.2,0.3,0,0.1,2.1,0.1,0.1,0,0.8,0,0,0,0.1,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.1,1.8,1.4,2.2,2,5.9,2.2,2.4,1.8,2.4,1.7,2.7,2.3,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,36.9,0,0.1,0,0,0,0.9,0,0,0,0,0,0,0,0,0,0,0,1.3,0,0,0,0,4.9,0.3,0.1,0,0,0,0,0,2.5,0.2,0,0,0,0,0,0,0,0,0,0,0,0.3,0.1,0,0.3,0,0.1,0,0,0,0.1
ENSG00000262484,CCER2,,Coiled-coil glutamate rich protein 2,I3L3R5,19,38908980-38912158,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,testis: 4.9,Cell type enriched,Detected in some,8,Melanocytes: 617.2,Group enriched,Detected in many,5,glioma: 5.1;testis cancer: 1.9;urothelial cancer: 5.1,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,A549: 1.4;THP-1: 1.4,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,HPA069716,Uncertain,,,,Secreted - unknown location,NA,NA,,8800,,,HPA069716: AB_2686183,unprognostic (6.58e-2),unprognostic (2.24e-2),unprognostic (5.03e-3),unprognostic (2.49e-2),unprognostic (1.05e-1),unprognostic (2.76e-3),unprognostic (3.88e-2),unprognostic (2.16e-1),unprognostic (5.97e-2),unprognostic (1.45e-1),unprognostic (4.08e-3),unprognostic (3.82e-2),unprognostic (1.01e-9),unprognostic (1.75e-2),unprognostic (3.87e-2),unprognostic (3.61e-1),prognostic favorable (2.32e-4),0.5,0.6,2.2,0.2,2.3,0.7,0.8,2.2,3.4,0.9,1.8,0.8,0.3,0.7,0.3,1.2,1.1,0.1,0.6,2.2,2.1,1.3,3,0.5,0.3,2.8,2.2,2.1,0.8,0.5,0.2,2.5,0.1,2.4,1.4,0.1,1,0.9,0.2,2.3,3.9,0.9,0.1,2,1.1,0.6,4.9,2.2,0.4,1.2,0,0.1,0.9,0.8,2.3,0.1,1.4,0.3,0.1,0.2,0,0.2,0,0,0,0,0.1,0.5,1,0.1,0,0,0.1,0.2,0,0,0.4,0.4,0,0.3,0,0,0.6,0.5,0.1,0.2,0.1,0,0,0,0.9,0.2,0.9,0,0.9,0.2,0.4,0.3,0,0.2,0.7,0.1,0.2,0.1,0.6,0.4,0.2,0.1,0.1,0,0.1,1,1.4,0,0,0.7,0,0,0.6,0.5,0.2,0.1,0.7,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.2,2.3,2.2,3.4,2.2,2.1,2.8,2.2,2.1,2.4,2,2.2,2.3,0.1,3.2,0,3.9,0.1,76.9,0.1,0.1,0,2.5,0.4,0.5,0.4,1.5,0.1,1.8,4.2,0.4,0.4,0.3,0,0,1.4,0.3,0.2,0.6,1.2,0.4,2.3,0,0.1,0.8,0,0.5,0,0.3,0,0.6,0.2,0,3.3,0.2,0,0.3,7.2,4.9,0.3,0.2,617.2,0,0,1.3,0,3.5,2.2,0.1,0.2,0,0,0.1,0.2,0.2,0.4,3.8,0,0.4,0.7,1.1,2.1,0,3,0.3,0.4,0.2,0.6,0.1
ENSG00000157211,CDCP2,,CUB domain containing protein 2,Q5VXM1,1,54132968-54153770,"Predicted membrane proteins, Predicted secreted proteins",,,,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Evidence at transcript level,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,HPA031143,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA031143: AB_10611819,unprognostic (1.08e-1),unprognostic (5.16e-2),,unprognostic (1.71e-2),unprognostic (2.36e-2),unprognostic (1.25e-2),unprognostic (4.73e-2),unprognostic (5.29e-2),unprognostic (2.86e-2),unprognostic (2.57e-1),unprognostic (1.33e-1),unprognostic (1.67e-2),unprognostic (7.67e-6),unprognostic (2.37e-1),unprognostic (1.48e-1),unprognostic (5.12e-1),unprognostic (2.21e-2),0,0,0.1,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000139610,CELA1,ELA1,Chymotrypsin like elastase 1,Q9UNI1,12,51328442-51346679,"Enzymes, Predicted intracellular proteins, Predicted secreted proteins",,"Hydrolase, Protease, Serine protease",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,5,adrenal gland: 2.2;pancreas: 6.6,Cell type enhanced,Detected in some,,Exocrine glandular cells: 16.6;Extravillous trophoblasts: 2.9;Kupffer cells: 7.9;NK-cells: 3.1,Cancer enhanced,Detected in single,,testis cancer: 0.5,Not detected,Not detected,,,Immune cell enhanced,Detected in many,,basophil: 12.4;naive CD4 T-cell: 12.3,Group enriched,Detected in many,8,granulocytes: 12.4;T-cells: 12.3,Cell line enriched,Detected in some,4,BEWO: 5.4,Low region specificity,Detected in all,,,Not detected,Not detected,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (3.54e-2),unprognostic (1.64e-1),,unprognostic (4.73e-2),unprognostic (2.73e-1),unprognostic (1.70e-1),,unprognostic (1.52e-1),,unprognostic (1.13e-1),unprognostic (3.59e-2),,unprognostic (3.83e-3),unprognostic (2.52e-1),unprognostic (1.46e-1),,,0,2.2,0.1,0.2,0.1,0.2,0,0.1,0.2,0,0,0,0,0,0,0,0,0,0,0.1,0.3,0,0,0,0.8,0.1,0.1,0,0,6.6,0,0,0.4,0.1,0,0,0,0,0,0,0,0,0,0.1,0.3,0,0.2,0.1,0.5,0,0,0.2,0,0,0.1,0,0,0,0,0,0,5.4,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0,0,0,0,0,0.1,0,0,0,0,0,1.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,1.2,0,0,0,0,0,0,0,0,0,0.5,0,12.4,1.6,0.1,1,0.8,0.4,0.3,2.7,0.8,1,0,12.3,5.9,0.2,0.2,1,0,0.3,1.2,0.1,0.1,0.1,0.2,0.1,0.3,0.1,0.1,0,0.1,0.1,0.1,0.1,0,0,0.5,0,0.2,0,0,0,0,0,0,0,0.8,0,0,0,0,0.4,0.5,0,0,0,0,0,0,0.1,0,0,0.2,16.6,2.9,0,0,0,0,0,0.4,0.1,0.8,0,0.1,0,0,7.9,0,0,0,1.4,0,0,1.8,0,3.1,0,0.1,0.1,0,0,0.1,0,0,0,0,0,0,0,0.8,0,0.9,0,0,0.5,1.4,0.2,0,0
ENSG00000147869,CER1,DAND4,"Cerberus 1, DAN family BMP antagonist",O95813,9,14719724-14722733,Predicted secreted proteins,,Cytokine,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,epididymis: 1.0,Not detected,Not detected,,,Cancer enriched,Detected in single,82,testis cancer: 17.3,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,5,HEL: 4.0;NTERA-2: 7.0;SCLC-21H: 2.6,Not detected,Not detected,,,Low region specificity,Detected in single,,,HPA019917,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA019917: AB_1846539,,,,,unprognostic (2.98e-2),,,,,,unprognostic (5.36e-2),,,,unprognostic (5.99e-2),,,0,0,0,0,0.2,0,0,0.4,0.2,0,0,0,0.1,0.1,1,0,0,0,0,0,0.2,0.3,0,0,0,0.2,0.1,0,0,0.1,0,0,0,0.4,0,0,0,0,0,0,0,0.2,0,0.1,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,2.6,0,0,0,0,0.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0.4,0.2,0,0.2,0.2,0.1,0,0.4,0.1,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0.5,0,0.3,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.8,0.1,0
ENSG00000172824,CES4A,"CES8, FLJ37464",Carboxylesterase 4A,Q5XG92,16,66988589-67009758,"Predicted intracellular proteins, Predicted secreted proteins",,"Hydrolase, Serine esterase",,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,fallopian tube: 17.1;skin 1: 13.7,Cell type enhanced,Detected in many,,Breast glandular cells: 44.4;Excitatory neurons: 53.6;Oligodendrocytes: 37.6;Respiratory ciliated cells: 47.1,Cancer enhanced,Detected in many,,renal cancer: 5.3,Region enhanced,Detected in many,,white matter: 10.1,Immune cell enhanced,Detected in some,,non-classical monocyte: 3.5,Low lineage specificity,Detected in many,,,Cell line enhanced,Detected in some,,HDLM-2: 19.1;HMC-1: 5.2;PC-3: 4.5;SiHa: 7.8;SK-BR-3: 5.7;U-266/70: 5.9,Not detected,Not detected,,,,,,,HPA035701,Approved,,Approved,Cytosol,Secreted - unknown location,NA,NA,,,Cytosol,,HPA035701: AB_10696357,unprognostic (6.34e-2),unprognostic (2.09e-1),unprognostic (3.18e-1),unprognostic (3.26e-2),unprognostic (1.99e-1),unprognostic (6.20e-2),unprognostic (2.12e-2),unprognostic (2.04e-2),unprognostic (5.78e-3),unprognostic (3.93e-2),unprognostic (2.02e-3),unprognostic (3.15e-2),prognostic unfavorable (2.35e-6),unprognostic (1.20e-1),unprognostic (2.23e-1),unprognostic (1.74e-2),unprognostic (1.33e-3),2.3,1.5,0.6,0.9,1.6,1.2,2.5,0,2.4,1,0,0.6,0.8,0.5,3.9,1.1,17.1,0.8,2.5,2.1,1,2.5,8.5,1.5,0.7,1.7,1.2,2.1,1,1.1,3.1,3.6,1,2.7,0.9,0.7,0.8,4.4,2.1,4.9,13.7,0.8,0.3,0,0.5,1.4,0.8,0.8,0.7,2.8,0.2,0.9,1.2,0.7,10.1,0.2,1.5,0.1,0,0.9,0.8,0,0.4,0.7,0.1,0,0,2.3,0,0,1.5,0,0.7,0,0.2,0,19.1,0,0,1.2,0,0.1,0,5.2,1.8,3.5,0.2,0,0,1.1,0,0,0,0,0,0.3,0,0,0.8,4.5,0.2,0,1.1,0,0.3,1.4,0.9,7.8,5.7,0,0.1,0,0.3,0.3,0,0,0,0,5.9,2.2,0,1.4,0,0,0,1.4,0,0.5,2.5,0.5,0.6,1,0.5,0.8,0,0.9,0.2,0,0,3.5,1.2,0.3,0.7,0.6,1.6,0,2.4,2.1,1,1.7,1.2,2.1,2.7,0,0.8,10.1,0.4,0,11.4,2,3.5,5.4,5.7,5,3.4,23.1,44.4,7.7,2.8,4.3,7.3,5.5,14.6,4.7,3.9,4.1,1.9,0.9,1.7,9.9,1.4,1,9,0,53.6,1.6,0.9,3.9,3.1,11.1,9.5,4.9,1.1,22.1,5.6,0,29.7,1.8,4.1,4.1,2.1,1.2,13.7,3.2,0,4.7,5.7,8.3,4.1,6.6,37.6,0.9,9.7,12.8,1.3,3.5,5.8,1.5,47.1,15.3,0,1.5,1.8,32.1,11.8,4.1,5.3,4.5,3.3,13.5,3.5,7.5
ENSG00000136698,CFC1,"CRYPTIC, HTX2","Cripto, FRL-1, cryptic family 1",P0CG37,2,130592165-130599575,"Disease related genes, Human disease related genes, Predicted secreted proteins",Gastrulation,Developmental protein,"Disease variant, Heterotaxy",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,,brain: 17.9;pancreas: 30.9;pituitary gland: 59.8,Group enriched,Detected in some,4,Bipolar cells: 14.9;Enteroendocrine cells: 20.5,Cancer enriched,Detected in some,7,pancreatic cancer: 4.3,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,13,RPMI-8226: 12.1;SCLC-21H: 6.7;SuSa: 4.0,,,,,,,,,HPA041773,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA041773: AB_2677664,,,,,unprognostic (6.65e-2),,,,,,unprognostic (2.19e-3),unprognostic (1.11e-3),,,unprognostic (2.01e-1),,,0.8,0.6,4.7,0,2,0,0,2.7,3.2,0.1,0,0.2,0,0.2,0.1,0,1.5,0,0.9,1.1,17.9,0,0,0.1,0,3.8,4.1,1.6,0,30.9,0,59.8,0,4.2,7.3,0.1,3,0,0,0,0,0,0,4.1,0,10.8,0.6,6.5,5.6,0,0,0,0,0,5.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,12.1,0,0,6.7,0,0,0,0,4,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.7,2,2.7,3.2,1.1,17.9,3.8,4.1,1.6,4.2,4.1,6.5,5.4,0,0,0,0.3,0,0,0,0,0,14.9,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.3,0.1,20.5,0,1.3,0,0,0.1,0,0,0,0,0,0,0,0,0.5,0.3,0,0,0,0,0,0,0,0,0,1,0,0,0.1,0.9,0,0,0,1,0,0,0,3.7,0,0,0,0,0.7,0,0,0,0,0,0,0
ENSG00000152093,CFC1B,,"Cripto, FRL-1, cryptic family 1B",P0CG36,2,130521197-130528604,Predicted secreted proteins,Gastrulation,Developmental protein,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,pituitary gland: 2.4,Cell type enriched,Detected in single,9,Bipolar cells: 1.8,Not detected,Not detected,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA041773,Approved,,,,Secreted - unknown location,NA,NA,,,,,HPA041773: AB_2677664,,,,,,,,,,,,,,,,,,0.1,0,0,0,0,0,0,0,0.2,0,0,0,0,0.1,0,0,0.2,0,0.1,0,0,0,0,0,0,0.1,0,0,0,0.7,0,2.4,0,0.3,0.9,0.1,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0.1,0,0,0.3,0,0,0.1,0,0,0,0,0,0,0,0,0,1.8,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0.1,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000121898,CPXM2,"CPX2, UNQ676","Carboxypeptidase X, M14 family member 2",Q8N436,10,123706207-123940267,"Enzymes, Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,choroid plexus: 68.7,Cell type enhanced,Detected in many,,Early spermatids: 106.8;Late spermatids: 202.5;Oligodendrocytes: 35.6;Peritubular cells: 79.0,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,17,BJ: 18.4;fHDF/TERT166: 71.8;SuSa: 28.0,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,HPA048375,Uncertain,,,,Secreted - unknown location,NA,NA,,62000,,,HPA048375: AB_2680377,unprognostic (1.50e-1),unprognostic (3.66e-1),unprognostic (2.58e-2),unprognostic (4.02e-3),unprognostic (2.69e-2),unprognostic (6.48e-2),unprognostic (1.32e-2),unprognostic (1.32e-2),unprognostic (1.26e-1),unprognostic (8.57e-2),unprognostic (4.42e-2),unprognostic (2.14e-1),prognostic favorable (9.02e-4),unprognostic (3.48e-2),unprognostic (2.54e-2),unprognostic (1.27e-1),unprognostic (1.16e-3),29.4,6.5,4.9,6,6.4,0,21,9.3,3.5,5.7,68.7,52,6.3,10.3,60.4,18.5,16.1,11.3,13.3,3.5,11.7,11,2.4,7.1,2.8,16.3,10.8,0.8,16.9,5.2,2.5,11,1.2,11.8,15.3,7,0.5,9.4,12.9,3.8,7.2,15,57.5,18.6,17,20.1,9.7,11,7.9,15.1,8,6.7,28.5,9.2,19.1,0,0,0,0,0,0,0.1,18.4,0.7,1.1,0.1,0,0,0,0,71.8,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,2.2,0.1,0,0,0,0,0.1,0,0,0,0.1,0.3,0,0,0,0,0.1,0,0,0.1,0,0,0.2,0.1,28,0.5,0,0,0.1,0.1,0.3,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.9,6.4,9.3,3.5,3.5,11.7,16.3,10.8,0.8,11.8,18.6,11,19.1,22.3,0,0.6,0.3,0.1,2.2,0,0.2,6.2,0,0.3,0.4,2.4,0,0,1.8,0,8.3,0.1,0.2,1.9,0.4,106.8,0.2,0.2,26.1,0,0,5,0.2,0.3,23,1.1,0.3,0,0.1,16.8,0,0.3,1.7,0.5,0.7,0,0,2.7,202.5,10.8,0.6,3.6,0,0,0,0,1,35.6,0.1,0.1,79,1.4,0,0.4,0,0,0.1,0,1.6,2,1.3,1.9,0.6,2,5.1,0.2,0,2.7,0.2
ENSG00000106113,CRHR2,"CRF-RB, CRF2, HM-CRF",Corticotropin releasing hormone receptor 2,Q13324,7,30651942-30700129,"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,,brain: 6.2;choroid plexus: 17.7,Cell type enhanced,Detected in some,,Cardiomyocytes: 3.0;Excitatory neurons: 8.2;Horizontal cells: 13.5;Inhibitory neurons: 4.9;Smooth muscle cells: 2.3,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in many,,basal ganglia: 8.1,Low region specificity,Detected in many,,,HPA073345,,,Supported,Plasma membrane,Secreted - unknown location,NA,NA,,,Plasma membrane,,HPA073345: ,unprognostic (7.14e-2),unprognostic (4.20e-1),unprognostic (1.68e-1),unprognostic (1.24e-3),unprognostic (5.69e-2),unprognostic (8.58e-2),unprognostic (6.00e-2),unprognostic (1.86e-4),unprognostic (2.01e-1),unprognostic (3.07e-1),unprognostic (5.90e-4),unprognostic (4.02e-2),unprognostic (8.29e-4),unprognostic (3.73e-3),unprognostic (2.84e-3),unprognostic (1.81e-1),unprognostic (3.84e-1),0.5,0.1,1.4,0,1.1,0,0.6,0.4,6.2,0.3,17.7,0.2,0.3,0.3,0,0.2,0.5,0.1,1.4,2.4,0.8,0.1,0,0.1,0,1.5,1.1,0.3,0.4,1.8,0.1,4.2,0,1,0.2,0.1,2.5,0.3,1.3,1.2,0.2,0.3,0.1,0.3,0,0.2,0.8,2,0,0.7,2.2,0,0.3,0.2,2.6,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0.2,0,0.4,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0.5,0,0,0,0,0.1,0,0.1,0.2,0,0,0,0,0.1,0,0,0.1,0,0.1,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4,1.1,0.4,6.2,2.4,0.8,1.5,1.1,0.3,1,0.3,2,2.6,0.3,0,0,0.7,0,0,0,0,0,1.6,0,0,3,0,0,0,0,0,0,0,0,0,1.7,0,0,0.1,0,0,8.2,0,0,0.1,0,0,0,0,0,0,0,13.5,4.9,0,0,0,0,1.1,0,0,0,1,0,0.1,0,0.5,0.6,0,0,0,0,0,0,0.1,0,0.2,0,0,2.3,0.1,0.2,0,0,0,0,0,0,0
ENSG00000121005,CRISPLD1,"Cocoacrisp, DKFZp762F133, LCRISP1",Cysteine rich secretory protein LCCL domain containing 1,Q9H336,8,74984505-75034558,"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,breast: 29.7,Cell type enhanced,Detected in many,,Breast myoepithelial cells: 36.1;Endometrial ciliated cells: 62.2;Oligodendrocyte precursor cells: 81.4,Cancer enhanced,Detected in many,,glioma: 30.8,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,AF22: 134.4;SH-SY5Y: 72.0;SuSa: 27.5,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA024725,Uncertain,,,,Secreted - unknown location,NA,NA,,8200,,,HPA024725: AB_1847238,unprognostic (2.16e-1),unprognostic (5.88e-2),unprognostic (4.01e-2),unprognostic (3.78e-2),unprognostic (3.85e-2),unprognostic (1.65e-1),unprognostic (2.09e-4),unprognostic (6.81e-2),unprognostic (1.58e-2),unprognostic (5.96e-2),unprognostic (2.35e-1),unprognostic (2.24e-1),unprognostic (1.65e-1),unprognostic (7.39e-3),unprognostic (2.38e-1),unprognostic (1.77e-2),unprognostic (1.23e-1),2.7,1.3,8.7,2.5,3.7,1.5,29.7,4.8,4.6,6.3,2.8,2.1,0.7,8.7,5,5,7.5,10.1,8.9,4,15.4,2.2,2.1,2.3,2.9,6,7.6,1.6,5.7,2.4,19.4,1.2,7.8,7.7,24.8,1.6,3.1,19.4,2.6,0.5,2,1.2,7.1,6.7,2.1,0.9,3.8,4.3,9.5,15.3,1.2,1.1,2.5,1.1,10.8,0,1.7,134.4,0,0,0,4.5,0,0,1.6,1.9,0.8,0,0,19,0,2.2,0.1,11.3,0.1,0,0.1,5.2,0.2,5.1,0,3,0,1,7.2,0.3,0.1,1,16.6,0,1,0,0,0,0.1,0.9,0.2,13.9,0,5,0,18.5,0.2,0,0,0.8,72,0,0.1,8,27.5,10.4,6.4,0,3.8,19.6,0.2,0.5,2.4,0.9,0,4.6,0,13.8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,8.7,3.7,4.8,4.6,4,15.4,6,7.6,1.6,7.7,6.7,4.3,10.8,1,3.2,0,12.7,0,0.8,6.1,1.4,17.6,1.6,10.3,36.1,0.4,0,5.4,1.8,0,22.7,0.3,0,0,0,15.3,62.2,4.9,3.2,0,3,15.7,0,3.8,9.2,0,22.4,3.8,1.8,23.6,0.1,2,0,11.1,0,0,0.9,0,1.5,4.1,0.4,7.2,1.9,0,8.8,0,81.4,0.9,0,0,1.5,0,9.4,0,0.2,22.5,0.9,0,0.4,1.5,1.3,6,2.5,1,12,0.4,6.3,0,2.3
ENSG00000154639,CXADR,CAR,CXADR Ig-like cell adhesion molecule,P78310,21,17513043-17593579,"Predicted membrane proteins, Predicted secreted proteins, Transporters","Cell adhesion, Host-virus interaction","Host cell receptor for virus entry, Receptor",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Basal keratinocytes: 323.4;Proximal enterocytes: 263.0;Suprabasal keratinocytes: 343.8,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Immune cell enhanced,Detected in single,,basophil: 1.0,Low lineage specificity,Detected in single,,,Cell line enhanced,Detected in many,,CACO-2: 93.4;Hep G2: 63.0;NTERA-2: 109.1;RT4: 104.4,,,,,Low region specificity,Detected in all,,,"HPA003342, CAB005103, HPA030411, HPA030412",Enhanced,,Enhanced,"Plasma membrane,Cell Junctions",Secreted - unknown location,NA,NA,,18000,"Plasma membrane, Cell Junctions",,"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992",unprognostic (3.75e-1),unprognostic (1.03e-1),unprognostic (6.45e-3),unprognostic (2.10e-1),unprognostic (1.56e-1),prognostic favorable (3.50e-4),unprognostic (1.32e-1),unprognostic (2.52e-1),unprognostic (1.94e-1),unprognostic (2.15e-1),unprognostic (3.48e-3),unprognostic (1.04e-1),unprognostic (9.35e-2),unprognostic (3.89e-3),unprognostic (2.20e-1),unprognostic (8.27e-2),unprognostic (5.71e-3),1.7,2.9,7.5,2.8,11.4,2.6,9.9,7.3,10.7,7.8,19.3,22.7,42.7,5.4,15.3,14.7,10.7,18.5,9.4,10.1,13.5,8.4,49.7,13.7,0.7,11,7.8,9.5,0.4,16,6.8,4.8,0.3,9.7,15.2,25.8,4.9,15.6,14.3,0.5,53.8,43,3.3,10.4,2.4,31.2,12.6,8.6,1.5,22.3,0,4.1,25.8,11,18.6,16.8,9,44.6,0.1,0,0,26.7,0.2,0.2,0.7,2.7,93.4,14.6,6.2,19.7,0,13.3,28.1,22.8,6.2,1,9.3,19,0.1,24.1,63,2.9,1.8,0.1,0,24.6,1.3,0.4,10.8,9,5.5,0.3,0.4,0,1.1,3.7,0.1,109.1,15.2,0,0.1,15.2,12.5,38.7,104.4,18.5,12.3,10.9,12.6,6.7,45.8,25.4,0.3,0.5,0.2,25.8,0.4,6.6,4.5,7.7,0.4,3.6,0.1,0.6,1,0.1,0.1,0.1,0,0.2,0,0.6,0.1,0,0.1,0.6,0.2,0.3,0.2,0,0,0.1,0.2,7.5,11.4,7.3,10.7,10.1,13.5,11,7.8,9.5,9.7,10.4,8.6,18.6,0.2,141.1,79,2.6,1,323.4,172.7,110.6,132.6,16.9,58.6,28.2,29.8,161.5,106.6,103,27.1,0.8,0.3,238.4,5.9,130,5.3,118.9,8.3,4.8,80.8,9.9,60.4,93.7,0.2,8.6,94.3,128.9,5.7,1.1,47.8,127.7,0.6,0,43,107.5,81.4,22.9,13.1,7.7,2.1,3.3,23.2,40.3,0.7,13.4,0,78.9,161.4,93.4,155.3,0,1.6,125.1,263,4,85.6,11.2,6.6,0.2,5.3,6.4,24.5,117,343.8,0.7,4.3,0.5,107,202.7
ENSG00000167536,DHRS13,"MGC23280, SDR7C5",Dehydrogenase/reductase 13,Q6UX07,17,28897781-28903079,"Predicted intracellular proteins, Predicted secreted proteins",,Oxidoreductase,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in all,,bone marrow: 42.2,Cell type enhanced,Detected in many,,Erythroid cells: 106.1,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Immune cell enriched,Detected in many,5,neutrophil: 55.3,Lineage enriched,Detected in all,5,granulocytes: 55.3,Cell line enhanced,Detected in all,,SK-BR-3: 69.5,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA022991,Uncertain,,Approved,Vesicles,Secreted - unknown location,NA,NA,,,Vesicles,,HPA022991: AB_1853865,unprognostic (8.87e-2),unprognostic (1.64e-1),unprognostic (1.91e-1),unprognostic (2.35e-1),unprognostic (1.21e-2),unprognostic (6.37e-2),prognostic unfavorable (3.39e-6),unprognostic (2.38e-1),unprognostic (4.74e-2),unprognostic (5.65e-2),unprognostic (1.20e-2),unprognostic (7.57e-2),unprognostic (1.73e-2),unprognostic (3.72e-2),unprognostic (2.63e-1),unprognostic (7.22e-3),unprognostic (2.55e-1),2.9,7.1,10.8,5.7,8.5,42.2,5.5,16.3,9.6,6.4,10.4,4.9,4.5,3,6.6,8.8,4.2,2.9,2.8,8.2,13.4,8.2,23.8,4.8,6.7,12.4,11.9,7.8,3.6,6.7,7.9,6.4,4.5,13.8,19.6,3.7,8.4,12.8,10.7,1.3,7.4,4,2.3,9.8,10.3,6,3.1,14.8,4.6,4.8,2.4,6.9,9.6,6.4,13.4,12.1,7.6,17.4,22.2,2.6,3.8,16.8,6.4,8.3,11.6,17.7,23.5,7.1,32.8,10.7,1.4,13.4,10.5,24.8,7.1,4.9,33.5,23.9,18.4,13.9,13,6.5,9.5,2.1,2.8,6.3,7.3,7.7,8.1,3.6,22.7,42.3,11,2.3,21.7,20.9,15.9,10.7,31.4,1,32.8,16.4,25.5,21.8,20.2,24.8,20.8,10.1,69.5,13.9,9.1,46.4,15.2,1.2,3.7,11.1,9,8.9,25.5,25.7,20.7,11,11.9,9.4,0.9,4.4,3.1,8.5,6.9,10.4,7.1,10.8,10.7,5.9,8.6,10.9,8.1,55.3,9.4,6.8,3.2,11.4,5.8,10.8,8.5,16.3,9.6,8.2,13.4,12.4,11.9,7.8,13.8,9.8,14.8,13.4,2.4,3.2,4.2,2.3,6.7,1.5,10.2,12.3,12,6.1,7.1,5.7,0.4,8.6,5.4,7.3,2.1,27.7,4.4,4.3,9.8,10.6,11.9,3.4,1.1,4.5,3,106.1,0.7,2.7,22.2,2.1,7.7,6.3,1.3,1.2,6.4,5.5,6.2,5,4.4,4.2,2,0.8,3,5.2,1.2,2.1,5.4,1,15.5,8.2,10.3,3,1,2.5,2.4,0.4,12.8,11.5,2.8,3.2,2.2,5,6.6,0.9,1.1,6.1,22.5,9.4,1.7,13.5,7,0.5,6.4,5.8
ENSG00000187630,DHRS4L2,SDR25C3,Dehydrogenase/reductase 4 like 2,Q6PKH6,14,23969874-24006408,"Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins",,Oxidoreductase,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in all,,liver: 137.3,Cell type enhanced,Detected in all,,Hepatocytes: 204.2;Proximal enterocytes: 326.4;Proximal tubular cells: 581.7,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in all,,,Low lineage specificity,Detected in all,,,Low cell line specificity,Detected in many,,,,,,,,,,,HPA023972,Uncertain,,Approved,"Nuclear membrane,Vesicles",Secreted - unknown location,NA,NA,,,Vesicles,Nuclear membrane,HPA023972: AB_1854890,unprognostic (1.41e-2),unprognostic (2.83e-3),unprognostic (1.25e-1),unprognostic (2.68e-2),unprognostic (1.47e-1),unprognostic (2.53e-1),unprognostic (6.02e-2),unprognostic (3.97e-3),unprognostic (7.34e-2),prognostic favorable (3.21e-4),unprognostic (1.57e-2),unprognostic (1.46e-2),unprognostic (1.36e-3),unprognostic (6.00e-2),unprognostic (2.38e-1),unprognostic (2.00e-1),unprognostic (3.65e-2),26.4,39.8,29.1,14.7,29.6,11.6,30.8,28.6,38.7,24.5,30.5,33.8,34.7,19.9,13,38.7,18.7,10.7,38.4,28.7,28.6,123.7,137.3,22.6,14.8,30.4,28.8,27.6,25.4,34.2,24.7,16.8,10.1,28.8,32.8,26.8,6.8,24.9,20.9,51.1,36.5,42.4,18.6,29,29.5,28.1,41.8,30.1,17.1,21.7,28.8,16.6,26.2,26.4,30.6,18.7,29,4.9,24.4,46.2,47.9,0.6,17.3,34.3,24.8,18.4,8.4,22.5,12.6,11.5,35.3,16,20.6,22.3,29.1,20.6,43.3,13.3,3.1,24.8,52.4,34,15.3,47.9,50,36.4,16.3,23.7,17,29.5,40,10.1,44.9,26.7,61.5,40.4,16.5,9.7,45.9,31.8,64.9,19.9,38.2,35.6,23.7,26,15.7,24.5,21.5,15,10.3,25.2,24.5,20.8,12.9,13.4,15.4,8.8,25.5,21.1,3.8,11.1,23.7,18.8,4.8,56.3,6.9,19.4,47.2,20.1,21.9,20.9,22.2,45.4,17.4,21,19.1,2.6,17.2,29.3,37.4,21.8,33.6,29.1,29.6,28.6,38.7,28.7,28.6,30.4,28.8,27.6,28.8,29,30.1,30.6,39.3,16,29.6,10.4,17.8,27.8,46.1,56.8,27.9,9.9,45.5,54.4,17.2,47.1,34.3,25.8,2.1,21.2,22.9,37.9,127.2,40,20.7,20.6,20.1,32,37.3,24.2,7.3,55.7,7.3,36.4,13.3,16.5,17.7,31.8,50,204.2,146.1,11.8,6.7,61.7,42.7,55.9,42.8,35.4,43.8,41.9,51.6,10.3,65,79.5,35,10.1,8.5,30.4,54.9,37.2,10.8,32.5,326.4,581.7,28.6,8.3,32.9,24.2,32.7,17.2,1.7,42.1,40.2,13,21.3,37.5,78.1,42.4
ENSG00000147113,DIPK2B,"CXorf36, DIA1R, FLJ14103",Divergent protein kinase domain 2B,Q9H7Y0,X,45148373-45200901,"Disease related genes, Predicted secreted proteins",,,"Autism, Autism spectrum disorder",Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enriched,Detected in some,4,Adipocytes: 96.3,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,57,HUVEC TERT2: 81.7,Not detected,Not detected,,,Low region specificity,Detected in all,,,HPA002806,Uncertain,,,,Secreted - unknown location,NA,NA,,940000,,,HPA002806: AB_1078595,unprognostic (2.12e-1),unprognostic (1.32e-2),unprognostic (8.51e-3),unprognostic (2.05e-1),unprognostic (4.65e-2),unprognostic (4.07e-3),unprognostic (7.30e-2),unprognostic (1.61e-1),unprognostic (1.50e-1),unprognostic (3.39e-1),unprognostic (6.06e-2),unprognostic (1.32e-1),unprognostic (1.75e-3),unprognostic (3.79e-3),unprognostic (1.98e-1),unprognostic (8.47e-2),unprognostic (3.11e-2),38.8,5.4,14.4,6.1,13.9,0.8,37.3,10.9,14,19.7,7.4,8.2,2.6,20.6,7,6.5,18.2,8.8,18.9,10.8,11,6.7,1.4,14.2,5.7,13.9,13.6,8.8,6.9,3.5,4.7,3.4,40.9,13.6,11.4,3.8,1.4,6.9,7.2,16.7,7.1,7.8,20.9,11.6,3.1,6.3,1.5,14.6,2.8,18.6,16.8,3.4,14.4,14,14.9,0.1,0.1,0.1,0.1,0,0,0.1,0,0.1,0,0,0.2,0.1,0.1,0,0,0,0,0.1,0.1,0,0.1,0.1,0.1,0.3,0,0,0.2,0.1,0,0.1,0,0,0.1,81.7,0.1,0,0.5,0,0.1,0,0.3,0.1,1.4,0.5,0.1,0.1,0.1,0.1,0.1,0.3,0,0,0,0.3,0.1,0.1,0.1,0.5,0.1,0.1,0,0,0.3,0.1,0.1,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,14.4,13.9,10.9,14,10.8,11,13.9,13.6,8.8,13.6,11.6,14.6,14.9,96.3,0,0,0,0,0,0,0,0,0,0,0,4.3,0,0,0,0,0.1,0.1,0,0,0,0,0,0,23.3,0,0,0,0,0.1,1,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0.3,0,0,0,0
ENSG00000176978,DPP7,"DPP2, DPPII",Dipeptidyl peptidase 7,Q9UHL4,9,137110546-137115177,"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins",,"Aminopeptidase, Hydrolase, Protease, Serine protease",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Cell type enhanced,Detected in all,,Late spermatids: 997.8,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in all,,,Low lineage specificity,Detected in all,,,Cell line enhanced,Detected in many,,RPMI-8226: 232.0;THP-1: 218.1,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA021282, CAB025541, HPA059381",Enhanced,,Supported,"Golgi apparatus,Vesicles",Secreted - unknown location,NA,NA,,1600000,"Golgi apparatus, Vesicles",,"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999",unprognostic (1.15e-1),unprognostic (5.54e-2),prognostic unfavorable (6.07e-6),unprognostic (6.78e-3),unprognostic (1.25e-1),unprognostic (8.33e-2),unprognostic (7.49e-2),unprognostic (6.10e-2),unprognostic (2.28e-2),unprognostic (5.71e-3),prognostic favorable (8.31e-5),unprognostic (7.99e-2),unprognostic (1.46e-2),unprognostic (2.56e-2),unprognostic (1.72e-1),unprognostic (2.15e-1),unprognostic (1.02e-1),56.8,99.6,37.9,28.2,36.8,46.2,57.3,38,65.4,43.5,69.4,56,28.6,46.7,16.9,46.3,54.1,31.5,106.7,36.8,49.5,58.8,70.6,57.8,42,46.2,40.5,33.4,38,83.5,54.8,113.1,27,38.3,81.8,7.4,8.1,93.1,46.6,53.2,54.3,52.2,13,40.1,79.6,70,75.9,39.9,20,84.4,21.6,14.6,59.8,48.4,39.8,28,43.1,3.5,3.6,51.1,40.5,5.7,42.2,66.2,26.6,17.4,41,22.2,56.2,44.4,27.2,1.2,60.3,30.7,8.2,1.3,54.8,2.1,26.4,63.6,1.3,113.5,69.1,135.5,50,31.7,11.6,24.1,38.3,35.1,65.8,57.5,41.2,18,76.4,35.7,65.7,14.8,99.9,42.8,52.8,0.5,232,43.3,30.5,67.7,46.7,47.8,122.6,118.9,0.8,43.5,218.1,44.1,67.4,23.5,43.4,29.5,51.7,31.8,14.9,80.9,41.1,31.1,40.2,194.8,59.2,148.8,176.2,151.8,86.6,131.4,127.9,190.6,83.4,117.1,106.2,12,95,110.6,276.6,173.6,204.1,37.9,36.8,38,65.4,36.8,49.5,46.2,40.5,33.4,38.3,40.1,39.9,39.8,80.5,54.5,80.9,54.9,96.8,67,103.2,109.2,59.7,74.5,90.3,82.2,66.5,94.4,76.8,53.3,35.5,55.2,129.2,28.2,37.2,121,288.7,35.9,40.7,58.2,88.1,35.9,31.4,68.1,115.3,97.2,33.6,47.3,74.3,178.7,64.6,77.1,315.7,121.1,27.9,32.3,107.8,171.7,106.2,997.8,155.4,150.1,167.2,9.4,165.5,123.9,122.6,16.6,26.4,58.2,54.3,169.2,190.2,108.5,97.3,84.9,75.4,83.6,52.6,57.4,58.4,106.2,46.2,47.3,64.9,51.4,115.4,19,43.1,90.4
ENSG00000158813,EDA,"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED",Ectodysplasin A,Q92838,X,69616067-70039472,"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins",Differentiation,Developmental protein,"Disease variant, Ectodermal dysplasia",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Microglial cells: 84.3;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 45.9,Low cancer specificity,Detected in many,,,Low region specificity,Detected in all,,,Immune cell enhanced,Detected in some,,intermediate monocyte: 1.2;MAIT T-cell: 1.3,Group enriched,Detected in many,5,monocytes: 1.2;T-cells: 1.3,Cell line enhanced,Detected in many,,EFO-21: 5.2;Hep G2: 17.9;OE19: 5.1;RPMI-8226: 6.0,Low region specificity,Detected in all,,,Low region specificity,Detected in some,,,"HPA037972, HPA037973",,,Supported,"Vesicles,Lipid droplets",Secreted - unknown location,NA,NA,,,Vesicles,Lipid droplets,"HPA037972: AB_2675761, HPA037973: AB_2675762",unprognostic (3.76e-2),unprognostic (8.29e-2),unprognostic (1.59e-1),unprognostic (3.59e-3),unprognostic (7.85e-2),unprognostic (1.25e-4),unprognostic (4.33e-4),unprognostic (5.03e-2),unprognostic (1.53e-1),unprognostic (1.12e-1),unprognostic (1.02e-2),unprognostic (2.01e-1),prognostic favorable (1.04e-9),unprognostic (8.63e-4),unprognostic (7.64e-2),unprognostic (9.85e-2),unprognostic (2.79e-1),3.9,8.6,2.4,0.7,2.9,0.1,2.8,2.2,2.4,4.7,4.6,2.5,0.5,3,3.2,1.5,3.8,2,8,2,2.4,3.7,2.1,3.3,0.8,2.8,2.7,2,5,4.3,9.7,1.3,1.8,2.9,3.4,1.1,0.3,2.2,2.3,1.7,4.2,1.1,2.1,2.3,1.4,3.9,1.2,2.6,1.2,6,2.1,0.6,2.3,3.9,4.5,0,0.6,0.3,2.8,0.5,0,0.2,0,0.1,0,0,1.3,0.1,0.3,5.2,0.2,0.2,0.5,3.8,1.4,0,0,4.5,0,0,17.9,1,0,1.1,1.8,1.3,0,0.9,0,0.5,3.5,0,4.9,0,1.2,0,0,2.8,5.1,0.3,0,1.2,6,0.1,0,1.5,0,0.1,0.3,0.1,2,0.3,0.1,0.5,1.7,2.2,2.3,0,0,0.2,0.1,0.1,0,0,0,0,0,0,1.2,1.3,0,0.6,0.2,0,0,0.3,0,0,0.2,0.8,0,0,0.1,2.4,2.9,2.2,2.4,2,2.4,2.8,2.7,2,2.9,2.3,2.6,4.5,3.3,3.2,0.5,21.2,0.3,3.8,2.6,2,6.8,0.2,0.9,1.5,12.1,0,1.1,5.5,0,0.2,0.1,1,0,1.3,21.3,4.6,1.2,2.2,1.8,0,17.9,1.3,0.2,6,5.6,12.2,0,0.5,11,1.2,4.1,0,9.6,0.6,0,4.8,1.2,9.2,4.7,2.8,1.8,84.3,0.1,1.3,0,30.2,45.9,1.1,0.1,2.2,0.2,2.3,0.4,3.1,1.3,0.1,6.6,10.7,5.4,1.7,3.5,3.2,4.1,0,2.1,0.4,0.9,1.5
ENSG00000241404,EGFL8,"C6orf8, NG3",EGF like domain multiple 8,Q99944,6,32164595-32168281,"Metabolic proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Alveolar cells type 1: 6.4;Granulosa cells: 10.4,Low cancer specificity,Detected in many,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,Hep G2: 3.2;SK-MEL-30: 3.4,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,HPA061173,Uncertain,,Approved,"Nuclear speckles,Vesicles",Secreted - unknown location,NA,NA,,,Vesicles,Nuclear speckles,HPA061173: AB_2684443,unprognostic (7.13e-2),unprognostic (1.86e-1),unprognostic (6.79e-3),unprognostic (3.64e-1),unprognostic (1.30e-1),unprognostic (7.60e-4),unprognostic (3.42e-2),unprognostic (2.49e-1),unprognostic (6.42e-3),unprognostic (1.97e-1),unprognostic (7.60e-3),unprognostic (8.11e-3),unprognostic (1.07e-4),unprognostic (1.11e-1),unprognostic (6.79e-2),unprognostic (1.21e-1),unprognostic (3.29e-2),13.2,7.3,3.1,0.5,2.8,1.1,13.7,3,5.7,22.6,6,16.3,0.6,10.1,0.8,12.4,16.5,3.1,12.4,3.1,3.2,12.5,7.4,9.5,0.3,3.1,3.2,2.5,31.4,5.1,0.4,8.3,3,2.9,17,0.5,0,8,1.5,3.8,12.9,8.9,0.3,3.2,8,10.3,4.4,3.2,0.6,8.7,2.5,0.2,13.6,17.4,3.1,0.2,0.1,0.4,1.1,0.1,0,0.1,0,0,0,0,0.6,0,0,0.3,0,0,1.1,0.4,0,0,0,0.5,0,0.3,3.2,0,0,0.3,0,0.4,0.2,0.1,0,0.2,0.7,0.5,0,0,0.6,1,1,0,0.2,0,0.3,0,0,0,0.2,0.1,0.6,0,0,3.4,0,1,0.7,0,0.3,0.6,0,0,0,0,0,0,0.6,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.1,2.8,3,5.7,3.1,3.2,3.1,3.2,2.5,2.9,3.2,3.2,3.1,1.2,6.4,4.1,0,0.3,1.5,0.6,0.3,4.6,1.5,0.5,0.3,0.1,0,1.6,1.8,2.1,0.8,0.6,0.2,0,0.4,0.1,1,1.9,1.7,0,1.7,0,0.2,0.4,1.5,4.6,1.3,0,10.4,3.3,0.3,0.2,0,0,1.1,0,0.6,1.6,0.2,3.7,0.7,0,0,0,0.9,3.1,0,0,0.3,0.2,1.2,2.1,0.7,0.4,0.1,1.6,1.5,0,2,1.5,0.5,0.4,4,2.3,0.8,0.9,1.5,1.3,0.5
ENSG00000164318,EGFLAM,"AGRINL, AGRNL, FLJ39155, PIKA","EGF like, fibronectin type III and laminin G domains",Q63HQ2,5,38258409-38465480,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,tongue: 122.2,Cell type enhanced,Detected in many,,Cone photoreceptor cells: 120.9;Early spermatids: 50.7;Late spermatids: 49.1;Leydig cells: 155.4;Sertoli cells: 85.5;Smooth muscle cells: 70.9,Cancer enhanced,Detected in all,,testis cancer: 6.8,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,EFO-21: 10.2;HBEC3-KT: 12.6;hTERT-HME1: 16.4;HUVEC TERT2: 16.1;LHCN-M2: 37.0;U-2 OS: 15.6,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA066577,Approved,,,,Secreted - unknown location,NA,NA,,,,,HPA066577: ,unprognostic (2.05e-1),unprognostic (4.81e-2),unprognostic (1.01e-1),unprognostic (1.38e-3),unprognostic (1.08e-2),unprognostic (3.63e-3),unprognostic (6.31e-2),unprognostic (2.83e-1),unprognostic (2.08e-2),unprognostic (1.71e-3),unprognostic (1.12e-1),unprognostic (5.80e-2),prognostic unfavorable (4.47e-5),unprognostic (7.02e-6),unprognostic (2.60e-1),unprognostic (9.90e-2),unprognostic (1.04e-2),39.6,20,2,2.8,2.3,0.2,47.5,1.9,2.3,15,3.2,5.3,1.9,5.7,6.9,4,8.3,4.9,16.4,1.4,5.8,6.9,4.7,2.9,14.3,2.8,4.2,1.6,23.9,3.2,4,5.8,52.1,3.5,14.3,3.2,67.3,6.9,20.8,72.7,5.9,4.7,6.7,1.4,9.9,3.4,15.2,3,20.6,9.1,122.2,9.1,7.7,13.1,2.4,3.2,0,6.5,0.2,0.8,0.2,0,2.9,0,0.5,0.1,0,0,0.1,10.2,0.1,0.1,0,0,12.6,0,0,1.6,0,6.1,0,2.8,0,0.1,5.4,0,0.1,16.4,0,16.1,0,0,0,37,0,0,0,0.1,0,0,0,0,0.5,0,0,1.3,3.9,0,3.7,0.1,1.3,0,0.2,0,0.1,15.6,0.6,0.2,0,0.2,0.1,0.1,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,2.3,1.9,2.3,1.4,5.8,2.8,4.2,1.6,3.5,1.4,3,2.4,11.4,0,0,0.3,0,2.7,0.3,0,0,1.3,2.4,9.8,2.6,0,0,0,120.9,0.3,0.4,0,3.9,0.5,50.7,0.2,3.2,5.4,0,0,0.6,1,0.5,17.8,0,0.3,0,1.6,1.4,0,0.7,0,0.9,0,0,0,4.2,49.1,155.4,0.6,5.4,1.9,0,3.4,0,1,0.1,1.3,0,30.9,0,0.2,0,6.5,0,33.1,85.5,22,70.9,9.8,3.3,0.3,2,0.5,0.4,23.5,0,0.3
ENSG00000149218,ENDOD1,KIAA0830,Endonuclease domain containing 1,O94919,11,95089846-95132645,"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins",,"Endonuclease, Hydrolase, Nuclease",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Cell type enhanced,Detected in many,,Distal enterocytes: 99.5;Granulosa cells: 93.4;Oligodendrocytes: 122.9,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in all,,,Cell line enhanced,Detected in many,,ASC diff: 194.4,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA008932, HPA010517",Enhanced,,Approved,Nuclear membrane,Secreted - unknown location,NA,NA,,5200000,Nuclear membrane,,"HPA008932: AB_2262252, HPA010517: AB_1852351",unprognostic (8.81e-3),unprognostic (1.92e-2),unprognostic (2.22e-2),unprognostic (1.43e-1),unprognostic (6.34e-2),unprognostic (2.78e-2),unprognostic (4.43e-2),unprognostic (2.23e-1),unprognostic (1.41e-1),unprognostic (3.65e-1),prognostic unfavorable (8.86e-4),unprognostic (2.84e-1),prognostic favorable (6.64e-7),unprognostic (5.92e-2),unprognostic (2.35e-1),unprognostic (5.62e-3),prognostic unfavorable (3.27e-4),19.2,17.4,33.4,10.8,53.9,5.9,16.8,46.5,44.2,21.5,16.6,35,10.9,17.7,15.2,24.9,18.6,16,13.2,30.8,47.3,24.5,6,14,10.3,53,51.9,26.7,14.8,5.7,36.5,15,16,54.6,47.9,39,3.5,17.2,28.6,52.8,29.7,19.6,21,45,32.8,10.4,10.4,48.1,4.1,16.4,35.1,8.9,13.7,23.6,79.8,3.7,5.8,7,4.3,194.4,61.9,29.3,27.2,6,7.2,7.4,28.3,48.8,26.4,32.7,21.7,16,36,6.9,37.3,2.8,21.3,5.2,57.4,2.6,12.1,21.3,10.7,71,56.3,47.6,4.1,13.3,48.5,24.9,24.8,11.8,16.7,26.8,9.9,4.5,0.4,1.6,41.2,18.2,19.5,0,11.1,21,30.6,3.7,2.9,11.5,11.4,21.2,9.6,11.6,2.9,17.9,38.6,11.3,26.1,11.7,13.8,11,2.2,11.7,5.6,87.8,1.2,0.8,0.6,3.6,2.2,3.4,4.6,2.3,3.1,1.9,4.7,1.9,2.3,0.4,2.2,3.9,0.8,1.5,4.2,33.4,53.9,46.5,44.2,30.8,47.3,53,51.9,26.7,54.6,45,48.1,79.8,34.1,9.6,19.4,22.9,15.6,8,18.9,14.9,7.4,2.4,8.4,15.9,10.9,20,16.2,11,0,3.6,9.9,99.5,1.9,5.5,2.7,7.1,13.8,32.4,16.2,29.9,24.9,8.9,7.8,16.9,10.2,22.9,14.5,93.4,43.2,3.9,3.1,0,30.2,22.2,8.2,3.4,4.9,4.4,10.2,15.6,28.4,16.9,4.3,2.2,23.7,19.1,122.9,7.9,44.5,15.1,3.3,17.7,26.9,9.2,5.8,0.8,39.5,15.9,34.5,0.4,2.5,27.8,12.5,12.4,8.8,18.5,21,8.8
ENSG00000197594,ENPP1,"M6S1, NPPS, PC-1, PCA1, PDNP1",Ectonucleotide pyrophosphatase/phosphodiesterase 1,P22413,6,131808016-131895155,"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins",Biomineralization,Hydrolase,"Diabetes mellitus, Disease variant, Obesity",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,placenta: 44.4,Cell type enhanced,Detected in many,,Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0,Low cancer specificity,Detected in all,,,Low region specificity,Detected in some,,,Immune cell enhanced,Detected in single,,NK-cell: 1.6,Low lineage specificity,Detected in single,,,Cell line enhanced,Detected in many,,ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"CAB032904, HPA062066",Enhanced,,,,Secreted - unknown location,NA,NA,,4400000,,,"CAB032904: AB_2099635, HPA062066: AB_2684674",unprognostic (1.47e-1),unprognostic (1.23e-1),unprognostic (2.15e-1),unprognostic (1.60e-3),unprognostic (2.40e-1),unprognostic (1.11e-1),unprognostic (2.00e-1),unprognostic (1.60e-2),unprognostic (7.22e-3),unprognostic (8.96e-2),unprognostic (1.95e-1),unprognostic (3.00e-1),unprognostic (2.61e-2),unprognostic (1.41e-1),unprognostic (1.96e-1),unprognostic (1.84e-1),unprognostic (3.28e-3),6.8,3.1,0.5,1.4,0.6,0.1,7.2,0.7,0.6,6.6,0.8,2.3,1.8,22.2,7.4,2.3,6.9,1.2,1.4,0.4,0.9,4.2,32.2,0.8,1.4,1.1,1.3,0.3,8.3,28.8,28.1,11,44.4,0.9,3.4,2,0.5,4.2,5.8,2.7,1.4,1.3,10.3,0.9,1.9,1.8,1.6,0.8,2.2,20.3,3.3,0.9,2.7,4.9,0.8,0,1.3,1.2,0.1,34.1,5.3,0,9.2,9.4,3.5,9.5,4.1,1.1,0,0.8,5.9,7.2,0,1.3,0.2,14.8,0.3,1.8,0,1.1,12,1,0,4.2,8.8,0.4,9.6,0.4,4.1,4.3,0.7,0,1.8,21.1,2.6,0,0,7.9,1.6,1.3,0,10.2,0.3,0.2,0.4,3.4,0,0.2,1.3,4.2,5.7,3.9,0,2.9,27.6,1,1.9,9.1,3.4,0,0,12.6,0,3.5,0.6,0,0.1,0.1,0,0.5,0.1,0.1,0.1,0.7,0.2,0,0,0.3,1.6,0.1,0.1,0,0,0.5,0.6,0.7,0.6,0.4,0.9,1.1,1.3,0.3,0.9,0.9,0.8,0.8,2.6,0,1.7,0.3,1.5,1.5,9.9,0,0.6,4.5,28.7,19.9,6.4,5.7,0.1,1.8,0,3,1.2,16.7,5.9,0.3,4.8,3.9,80.2,4.1,0,8,3.5,10.6,2.1,56.9,6.1,3.2,0,9.4,3.3,111.6,4.6,1.7,10.5,12.7,0,2.9,5.9,6.7,25.1,3.9,1.8,12.2,0.2,3.6,0,21.6,1.6,5.2,3.9,70,0.4,2.3,6.7,25.2,0.1,0.5,13.1,12.6,18.8,4.1,2.2,0.1,1.3,6.2,2.6,1.9,2.5,1.7
ENSG00000154269,ENPP3,"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3",Ectonucleotide pyrophosphatase/phosphodiesterase 3,O14638,6,131628442-131747418,"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins",,Hydrolase,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,cervix: 32.4;intestine: 44.9,Group enriched,Detected in many,5,Endometrial ciliated cells: 160.0;Glandular and luminal cells: 387.2,Cancer enriched,Detected in many,8,renal cancer: 49.6,Not detected,Not detected,,,Immune cell enriched,Detected in single,86,basophil: 30.6,Lineage enriched,Detected in single,86,granulocytes: 30.6,Group enriched,Detected in some,18,HEL: 4.4;Hep G2: 14.6;HMC-1: 6.2,Low region specificity,Detected in some,,,Region enriched,Detected in single,4,spinal cord: 2.6,HPA043772,Enhanced,,,,Secreted - unknown location,NA,NA,,1100000,,,HPA043772: AB_10795616,unprognostic (2.74e-1),unprognostic (1.99e-2),unprognostic (1.84e-1),unprognostic (5.41e-3),unprognostic (6.07e-2),unprognostic (4.86e-5),unprognostic (1.13e-1),unprognostic (7.20e-3),unprognostic (1.17e-1),unprognostic (1.13e-1),unprognostic (2.21e-3),unprognostic (2.34e-1),prognostic unfavorable (1.96e-4),unprognostic (2.80e-2),unprognostic (7.85e-2),unprognostic (2.29e-1),unprognostic (1.31e-3),1.2,6.3,0.4,1.1,0.3,0.1,6.7,0.9,0.5,32.4,0.2,9.3,16.3,3.8,1.2,0.5,2.3,1.3,0.1,0.3,0.4,10.1,5,1,0.5,0.4,0.5,0.3,0.5,0.1,0.3,0.1,0.1,0.6,2.4,8.5,0.3,18.2,15.8,0.1,0.6,44.9,0.8,0.4,0.3,0.5,0.8,0.4,9.7,0.3,0.2,0.4,0.4,0.7,0.3,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0.4,0.1,4.4,0,14.6,0,0.1,6.2,0,0,0,0,0,0,0.1,0.1,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0.1,0,0,0,0.1,0,0,0,0,0.1,0,0,0,0.2,0,0.1,0.1,0,0,30.6,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0.4,0.3,0.9,0.5,0.3,0.4,0.4,0.5,0.3,0.6,0.4,0.4,0.3,0.4,0,1.1,5.2,0.2,0,2.6,0.7,1.2,0.2,1,0.6,0.3,0,2.5,0,0,0,0.2,9.2,1.9,0,1.6,160,46.3,1.4,0,2.1,2.1,0,0.1,0.5,0,387.2,36,0.1,0.7,1.7,0.1,0,4.1,1.5,0,0.6,1.1,0.4,1.2,1.5,1.8,2.8,0,0.1,1,3.5,0.9,0,1.9,0.7,0.3,2.7,53.3,9.1,5.4,0.1,0,0.2,1,2.5,0.8,0,0.6,0.1,2.2,0.1,4.9,1.1
ENSG00000065361,ERBB3,"HER3, LCCS2",Erb-b2 receptor tyrosine kinase 3,P21860,12,56076799-56103505,"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins",,"Kinase, Receptor, Transferase, Tyrosine-protein kinase","Cancer-related genes, Disease variant",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Distal enterocytes: 254.3;Oligodendrocytes: 187.0;Paneth cells: 184.6;Proximal enterocytes: 240.2,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Group enriched,Detected in some,4,basophil: 2.4;neutrophil: 1.0,Lineage enriched,Detected in single,6,granulocytes: 2.4,Cell line enhanced,Detected in many,,Hep G2: 116.4;OE19: 119.1;RT4: 89.7;SK-BR-3: 106.5;SK-MEL-30: 149.5;T-47d: 122.2;WM-115: 153.4,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"CAB025331, HPA045396, HPA070524",Approved,,Supported,"Plasma membrane,Actin filaments",Secreted - unknown location,NA,NA,,450000,Plasma membrane,Actin filaments,"CAB025331: , HPA045396: AB_2679312, HPA070524: ",unprognostic (2.97e-1),unprognostic (2.71e-2),unprognostic (1.91e-1),unprognostic (8.97e-2),unprognostic (1.63e-1),unprognostic (1.07e-3),unprognostic (2.31e-3),unprognostic (2.66e-2),unprognostic (9.89e-2),unprognostic (4.30e-2),unprognostic (4.76e-3),unprognostic (5.77e-2),unprognostic (1.06e-2),unprognostic (4.56e-2),unprognostic (1.57e-1),unprognostic (6.72e-3),unprognostic (2.07e-2),2.2,2.7,38.7,8.1,70.9,0.9,57.1,50.2,61.6,16.2,18.5,63.5,89.3,5.6,12.4,82.6,12.2,30.9,6.1,43.2,51.6,36.5,99.4,29.6,0.6,75.4,61.9,33.8,1.6,57.4,24,2.4,13.1,76.8,38.1,64.7,1.3,83.8,18.4,2.4,75.7,83.2,3.8,45.3,0.6,75.4,2.3,58.8,1,9.4,1.7,12.6,22,44.6,113,39.8,2.1,3.2,1.4,0.2,0.1,63.2,3.9,7.2,4.5,4.1,20.4,70.4,0.2,0.8,1,0.6,32.2,5,7.7,2.3,0.7,3,0.1,1.1,116.4,0.1,0.1,0.5,1.3,9.3,0.7,0.3,0.7,0.1,0.8,2.6,1,0.4,71.6,0.4,1.3,10.4,119.1,1.9,0.4,7.4,2.1,7.9,89.7,3.3,1.3,2.6,106.5,149.5,9.1,122.2,0.7,0.3,0.5,4,1.9,0.5,0.9,0.6,0.6,0.4,0.3,153.4,2.4,0.1,0.3,0.2,0.1,0.1,0.1,0.2,0.1,0.1,0.2,0.2,0.4,1,0.4,0.2,0.2,0.3,0.1,38.7,70.9,50.2,61.6,43.2,51.6,75.4,61.9,33.8,76.8,45.3,58.8,113,0.8,118.6,81,1,1.5,18.2,15.3,21.6,19.4,1.5,106.4,47.8,1.9,171.6,74.6,35,2.1,52.6,2,254.3,1.9,60.1,1.3,36.1,10.9,2.7,93.1,2.7,0.7,88.1,84.6,4.5,96.4,95.9,1.3,0.7,5,112,6.1,0,2,145.2,40.7,1.9,3.7,0.5,1.5,1.5,55.2,1,1.7,7.7,0,49.8,187,94.8,184.6,0,0.3,103.3,240.2,30,54.8,1.1,6.6,4.5,3.4,9.5,13.4,87.7,36.9,100.6,2.5,0.1,136.9,135.4
ENSG00000189320,FAM180A,"HWKM1940, UNQ1940",Family with sequence similarity 180 member A,Q6UWF9,7,135728348-135748813,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,gallbladder: 16.2;heart muscle: 16.1,Cell type enhanced,Detected in some,,Basal keratinocytes: 7.5;Cardiomyocytes: 6.6;Fibroblasts: 19.7;Hepatic stellate cells: 4.6;Langerhans cells: 9.5;Melanocytes: 7.2;Suprabasal keratinocytes: 4.8,Low cancer specificity,Detected in many,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,4,U-2197: 259.7,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA021224,Uncertain,,Approved,Nucleoplasm,Secreted - unknown location,NA,NA,,,Nucleoplasm,,HPA021224: AB_1851352,unprognostic (3.85e-2),unprognostic (9.13e-2),unprognostic (1.42e-1),unprognostic (2.57e-1),unprognostic (2.54e-1),unprognostic (2.33e-2),unprognostic (6.85e-2),unprognostic (1.27e-1),unprognostic (5.05e-2),unprognostic (1.97e-3),unprognostic (5.62e-2),unprognostic (7.55e-2),unprognostic (8.88e-4),unprognostic (3.14e-3),unprognostic (1.82e-1),unprognostic (4.35e-4),unprognostic (6.62e-4),3.1,2.8,0,0.5,0.1,0.1,3.5,0.1,0.3,2.6,3.7,1.8,0.9,4.7,0.4,4.1,2,16.2,16.1,0.3,0,4.2,10.3,2.5,0.1,0,0,0,7.9,1.3,0.2,0.1,0.3,0,0.6,2,0,1.2,0.2,0.3,3.1,1.3,4.7,0,0.6,1,0.4,0,0.2,2.7,1.4,0.6,4.4,1.3,0.1,0,0.1,0,0,27.8,28.4,0,14.9,56.2,0.3,0.2,0,0,0,0,57.8,0,0,0,0,1.2,0,0,0,0,0,2.2,0,0,2.6,0,35.6,4.6,0,0,0,0,0,4.1,0,0,0,0,0,0,0,0,0.1,0,0.1,0,0.1,0.1,0.9,0,0,0,0,0.6,57.1,0,259.7,0,0,0.1,0,1.9,0,0.2,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0.3,0.3,0,0,0,0,0,0,0,0.1,0.4,0,0,0,0,7.5,0,0,0,0,0.1,0.8,6.6,0,0.6,0,0,0,0,0,0,0,0.1,0,1.1,0.8,0,0,0.3,0,0,19.7,0,0,0,0,4.6,0,0,0,0.1,0,0,0,9.5,0,2.8,0.1,7.2,2.8,0,0,0,0,0.1,0.1,0,4.1,0,0.1,0,0,0,0,0,2.5,1.8,0,0,0.1,4.8,0.7,0.2,0,0,0
ENSG00000066468,FGFR2,"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25",Fibroblast growth factor receptor 2,P21802,10,121478332-121598458,"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins",Apoptosis,"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase","Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,brain: 302.9;choroid plexus: 202.1,Group enriched,Detected in many,5,Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Group enriched,Detected in some,24,basophil: 13.2;eosinophil: 3.8,Lineage enriched,Detected in single,58,granulocytes: 13.2,Cell line enhanced,Detected in many,,AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"CAB010886, HPA035305",Uncertain,,Supported,"Nucleoplasm,Vesicles,Cell Junctions",Secreted - unknown location,NA,NA,,1200000,Cell Junctions,"Nucleoplasm, Vesicles","CAB010886: AB_259379, HPA035305: AB_10672862",unprognostic (5.53e-2),prognostic favorable (8.79e-4),unprognostic (1.08e-1),unprognostic (5.23e-2),unprognostic (1.73e-1),prognostic favorable (9.32e-4),unprognostic (1.53e-1),unprognostic (4.96e-3),unprognostic (1.74e-1),unprognostic (1.56e-1),unprognostic (1.07e-1),unprognostic (3.74e-2),unprognostic (1.01e-1),unprognostic (6.11e-2),unprognostic (2.54e-1),unprognostic (6.93e-2),unprognostic (2.25e-1),3.8,21.5,142.4,8.3,204.7,0.3,23.1,204.2,179,19.3,202.1,36.9,10.4,55.1,15.4,25.4,29.8,31.6,3.1,136,152.3,26.6,41.4,31.2,2.9,260.1,216.9,117.2,18.1,31.3,61.4,6.9,15.8,225.9,27.7,21.4,1.3,59.6,55.1,0.5,110.2,12.3,43.9,227.3,0.9,22.7,7.6,175.6,10.1,55.1,0.2,9.2,16.7,27.7,302.9,7.2,0.4,30.2,189,0.1,0,60.9,0.4,0,0,0,49.6,1.1,0.1,12.5,2.8,0.1,55.6,63.7,13,0,0.1,12.7,0,0.2,1.2,1.5,0.2,11.7,0.1,26.2,0,0.6,0,0,0.3,0.2,0.2,0,11.7,0.2,0.1,57.8,8.7,0,0.1,0,7.5,18,15.8,0.5,0.5,0.4,33.4,0,36.6,49.3,0,0.1,0.3,8.5,0.2,0.7,0.1,0.1,0,0.3,0,0.5,13.2,0,3.8,0,0,0,0,0.2,0,0,0.1,0,0,0.3,0,0,0,0,0,142.4,204.7,204.2,179,136,152.3,260.1,216.9,117.2,225.9,227.3,175.6,302.9,1.4,19.2,36,228.2,0.6,40.1,34.3,18.4,58.6,0.2,8.7,25.4,9.1,213.1,38.4,36.8,0,16.5,0.3,7.3,0,7.4,4.1,28.1,4.4,1,2.4,2.7,14.8,0.2,3,9,13.3,53.1,0,0.1,1.8,5,2.3,0,31.2,40.8,10.2,0.6,4.4,9.6,1.2,1.1,5.4,10.3,0.6,2,1,6,562.5,0.7,3,6,0.1,15,1.8,13.6,15.3,0.2,0,1.6,2.6,0.7,9.9,18.7,27.7,4,1.5,0.4,3.8,31.4
ENSG00000068078,FGFR3,"ACH, CD333, CEK2, JTK4",Fibroblast growth factor receptor 3,P22607,4,1793293-1808872,"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins",Apoptosis,"Kinase, Receptor, Transferase, Tyrosine-protein kinase","Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,brain: 159.4;esophagus: 140.8;skin 1: 273.6,Cell type enhanced,Detected in many,,Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"CAB004231, HPA067204",Enhanced,,Supported,Endoplasmic reticulum,Secreted - unknown location,NA,NA,,2500000,Endoplasmic reticulum,,"CAB004231: AB_627596, HPA067204: AB_2685804",unprognostic (1.34e-1),unprognostic (5.29e-3),unprognostic (1.49e-1),prognostic unfavorable (3.77e-4),unprognostic (5.90e-2),unprognostic (1.24e-3),unprognostic (7.22e-2),unprognostic (2.54e-1),unprognostic (1.99e-1),unprognostic (2.17e-1),unprognostic (1.38e-1),unprognostic (2.88e-2),unprognostic (1.30e-1),unprognostic (9.11e-3),unprognostic (1.98e-1),unprognostic (4.74e-2),unprognostic (1.97e-1),1.3,1.6,117.2,1.5,123.2,1.4,5.6,118.7,104.8,12.4,37.3,8,19.7,1.5,2.8,140.8,2.3,7.9,4.5,102.2,102.9,26.9,41,7.5,0.4,159.4,121.6,83.7,0.5,77,0.2,16.2,9.4,157.4,13.9,5.2,0.2,20.3,15.1,1.4,273.6,14.8,0.4,97.4,4,7.8,17.7,126.4,1.7,1.5,0.9,11.2,23.3,61.4,78.2,0,3.8,19.5,5.6,0,0.3,22.1,2.4,0.3,0.8,0.4,48.2,1,0,17.8,0.7,0.7,34.9,5.5,0.3,0.3,0.2,19.3,14.2,3.9,80.6,0.1,0,0.6,0,10.9,0.2,0.1,0.1,0.1,2.3,16.7,0.1,0,23.9,0.8,0.5,36.1,19.5,0.1,1.2,1,0.3,2.8,64.1,5.7,1.6,1.9,4,0,22.2,20.4,2.5,1,0,2.1,0.5,1.6,0.1,0,0,0.2,1.7,1.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,117.2,123.2,118.7,104.8,102.2,102.9,159.4,121.6,83.7,157.4,97.4,126.4,78.2,2.2,0,32.5,410.4,1.1,103.8,4.1,29.8,23.9,0,4.8,1.5,3.1,91.5,37.6,14.7,0,0.5,1.6,36.1,0,5,7.9,3,1.7,3.4,4.2,0,0.5,0.7,12,3.2,3.6,4,0,0.1,16.1,30.4,0.6,0,1.3,20.7,4.1,1.2,6.5,1.3,0.6,0.6,12.4,14,0.6,0.1,0,34.2,2.2,0.4,18,0.4,0,4.2,21.2,9.9,9.8,0.6,0,0.7,2.9,0.4,25.9,55,88.7,0.8,0.7,0.1,17,12.8
ENSG00000144649,GASK1A,"C3orf41, DKFZP434B172, FAM198A",Golgi associated kinase 1A,Q9UFP1,3,42979267-43060211,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in some,,Cytotrophoblasts: 1.4;Extravillous trophoblasts: 2.6;Fibroblasts: 1.8;Hofbauer cells: 3.9;Syncytiotrophoblasts: 2.7,Cancer enhanced,Detected in many,,glioma: 5.1,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,AN3-CA: 3.1;RPMI-8226: 3.4;SK-BR-3: 2.6;T-47d: 6.7,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA047726,Approved,,Supported,Vesicles,Secreted - unknown location,NA,NA,,600000,Vesicles,,HPA047726: AB_10960554,unprognostic (2.16e-3),unprognostic (2.19e-1),unprognostic (1.04e-1),unprognostic (2.93e-2),unprognostic (7.48e-2),unprognostic (2.18e-2),unprognostic (1.65e-2),unprognostic (5.79e-2),unprognostic (2.69e-1),unprognostic (6.21e-2),unprognostic (2.02e-1),unprognostic (1.50e-1),unprognostic (1.57e-4),unprognostic (4.45e-2),unprognostic (2.09e-2),unprognostic (3.49e-2),unprognostic (3.81e-1),5.6,2.2,4.9,2.5,5.7,0,4.2,6.6,4.8,9.1,4.5,3,0.7,9.9,2.2,1.8,11.4,5.4,1.1,4,5.6,1,13.2,3.1,0.8,7.6,6.4,2.9,6.8,2,0.1,3.1,2,7.3,2.6,1,4,2.6,2.2,1.4,1.7,2.1,6,5.7,0.9,3.5,2.9,8.7,0.6,2.2,0.8,0.3,3.2,4,5.2,0,0,0,3.1,0.1,0,1.1,0.2,0.3,0,0,0.1,0.9,0,1,0,1.6,0,0.3,0,0,0,1.9,0.7,0,0,0.6,0.4,1.2,0.8,0,0.4,0.7,0,0,0.5,0,0,0,0,0.8,0,1.9,0,0,0,0,3.4,0,0.5,0.1,0.3,0,2.6,0,0.1,6.7,0.9,0,0.4,0.6,1.4,0,0.2,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,4.9,5.7,6.6,4.8,4,5.6,7.6,6.4,2.9,7.3,5.7,8.7,5.2,0.5,0,0,0,0.1,0,0,0,0,0,0,0,0.7,0,0,0,0,1.4,0,0,0,0,0,0,0,0,0,0,0,0,2.6,1.8,0,0,0,0,0,0,3.9,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,2.7,0,0,0,0
ENSG00000145990,GFOD1,"ADG-90, C6orf114, FLJ20330",Glucose-fructose oxidoreductase domain containing 1,Q9NXC2,6,13357830-13487662,"Predicted intracellular proteins, Predicted secreted proteins",,Oxidoreductase,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,brain: 27.3,Cell type enhanced,Detected in many,,Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Group enriched,Detected in some,5,eosinophil: 15.5;NK-cell: 13.1,Group enriched,Detected in many,5,granulocytes: 15.5;NK-cells: 13.1,Cell line enhanced,Detected in many,,HEL: 30.5;HMC-1: 46.3,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA029096,Uncertain,,Approved,"Nucleoplasm,Plasma membrane,Cytosol",Secreted - unknown location,No,No,,,"Nucleoplasm, Cytosol",Plasma membrane,HPA029096: AB_10602320,unprognostic (5.00e-2),unprognostic (1.34e-2),unprognostic (1.08e-1),prognostic unfavorable (2.29e-5),unprognostic (8.49e-2),unprognostic (1.95e-3),unprognostic (1.36e-2),unprognostic (2.81e-1),unprognostic (2.34e-2),unprognostic (3.11e-2),unprognostic (6.49e-2),unprognostic (1.15e-1),prognostic unfavorable (6.72e-5),unprognostic (9.79e-2),unprognostic (1.61e-1),unprognostic (3.56e-1),unprognostic (4.66e-3),10.6,2,11.9,2.8,22.1,12.8,9.7,11.9,27.3,4,1.9,5.7,1.8,3.7,0.8,8.7,4.4,4.4,16.7,24.9,7.5,1.8,7.3,9.8,4.4,5.8,4.2,19.1,1.5,1.5,1.7,3.6,4,9.2,4,2.9,2.1,3.6,1.4,12.1,5.3,6.6,5,0.6,8.9,8,0.6,3.8,3,2.7,9.8,4.2,6.2,5.8,18,12.5,1.3,1,2.1,1.7,1.8,1.3,1,0.5,0.7,0.4,0.4,0.9,16.8,16.6,1.2,1,10.9,3.4,5.4,0.7,1.2,6,30.5,7.2,6.6,2.4,9,46.3,0.9,4.1,1.6,4.5,2.6,9.5,4.5,0.9,1.5,1.3,4.1,2,5.2,1.8,4.3,3.3,6.9,2.1,8.8,0.6,2.4,5.5,1,4,0.7,4,2.1,0.9,0.9,12.2,1.6,3.2,3.5,5.6,13.4,8.3,19.8,1.4,5.3,0.4,0.2,0.4,15.5,1.5,0.9,0.2,2.7,0.2,0.7,0.2,1.9,0.1,0.5,0.3,13.1,0.9,0.1,0.1,1,11.9,22.1,11.9,27.3,24.9,7.5,5.8,4.2,19.1,9.2,0.6,3.8,18,100.9,0,1.8,33,14.3,20.3,4.9,14.5,19.9,43.8,7.4,3.7,108.2,10,14.4,0,0,1.5,46.1,18.2,0,5.3,0.1,3.8,1,49,8.4,31.2,133.2,3.1,34.7,9.1,2,8,4.5,0.2,51.4,19.5,2.5,1.7,106.2,11.2,8.2,15.7,31.3,0.3,2.5,21.4,12.4,42.2,4.7,2.1,142.2,58.8,56.6,30.5,31.7,1.2,14.5,3.1,10.6,0.3,13.6,2.7,13.1,19.9,17.5,0,3.3,34.6,22.4,0.7,23.4,1,4.4,4.7
ENSG00000163521,GLB1L,MGC10771,Galactosidase beta 1 like,Q6UWU2,2,219236598-219245478,"Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins",,"Glycosidase, Hydrolase",,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,testis: 52.8,Cell type enhanced,Detected in many,,Early spermatids: 41.5;Spermatocytes: 117.4,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in all,,,Cell line enhanced,Detected in many,,HHSteC: 19.7,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA043058,Enhanced,,,,Secreted - unknown location,NA,NA,,,,,HPA043058: AB_10806375,unprognostic (4.30e-2),unprognostic (6.93e-2),unprognostic (2.68e-2),unprognostic (2.08e-3),unprognostic (4.35e-2),unprognostic (1.51e-1),unprognostic (1.67e-3),unprognostic (3.32e-2),unprognostic (4.77e-1),unprognostic (2.39e-1),unprognostic (8.48e-3),unprognostic (3.27e-1),unprognostic (3.62e-1),unprognostic (1.28e-1),unprognostic (9.23e-3),unprognostic (1.33e-1),unprognostic (8.50e-2),4.5,4.9,4.2,4.1,3.1,4.5,5.3,3.1,2.8,5.3,12.1,3.1,3.1,6,11.5,2.5,23.3,9.1,2.2,2.6,7.1,13.7,3.2,5.4,3,4.8,5.4,2.2,7.2,3.1,14.5,6.8,8.6,4.7,5.6,3.7,8,4.5,4.8,0.9,4.7,4.2,5.9,4.8,4.9,2.9,52.8,3.2,3.4,8.5,1,3.4,6,2.2,4.9,2.8,4.8,7.4,5.9,8,9.8,3.7,4.6,9.7,5.7,5.3,1.9,7.7,0.9,4.1,4.1,4.3,1.5,1.9,4.6,4.5,2.6,3.6,2.9,6.9,4.5,19.7,1.1,4.4,11.4,2.9,5.4,3.3,13.5,5.3,4.3,1.8,5.3,5.4,4,2.5,2.7,1.3,1,1.3,2.5,4.1,4,11.5,1.6,4.7,4.2,3.9,5.3,4.3,4.9,8.4,2.6,4.1,4.7,5.8,2.8,2.6,5,1.7,1.5,8.8,1.2,12.3,1.9,5.1,0.3,0.7,6.4,0.4,0.4,0.5,0.7,2.1,1,1.1,0.7,2.1,1,5.4,0.9,0.2,1.7,4.2,3.1,3.1,2.8,2.6,7.1,4.8,5.4,2.2,4.7,4.8,3.2,4.9,3.2,3.2,5.1,3.3,1.3,1.8,2.6,3.6,0.6,4.7,4.9,5.6,1.9,1.5,6.3,3.7,12.5,3.4,1.9,1.1,3.9,3.8,41.5,15.7,3.9,4.2,4.9,1.3,0.9,1.8,2.2,8.4,1.1,2.2,0,2.7,8.6,1.3,14.5,3.3,1.1,3.2,2,5.6,2.4,25.6,10.8,4.4,8.8,1.9,2.7,5,3.1,1,0.5,2.1,3.3,6.4,1.8,2.7,6.5,16.5,23.9,10.2,6.6,3.8,2.2,117.4,9.7,1.8,1.7,1.4,2,7,2.4,1.7
ENSG00000182327,GLTPD2,,Glycolipid transfer protein domain containing 2,A6NH11,17,4788964-4790589,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,6,liver: 74.4,Group enriched,Detected in some,5,Hepatocytes: 83.7;Proximal tubular cells: 135.8,Cancer enriched,Detected in many,5,liver cancer: 25.5,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4,BEWO: 3.4;CACO-2: 9.2;Hep G2: 13.7;MCF7: 4.1,Not detected,Not detected,,,Low region specificity,Detected in all,,,"HPA058295, HPA065267",Uncertain,,Approved,Vesicles,Secreted - unknown location,NA,NA,,150000,Vesicles,,"HPA058295: AB_2683671, HPA065267: AB_2685451",unprognostic (4.00e-1),unprognostic (1.93e-1),unprognostic (1.95e-3),unprognostic (1.70e-1),unprognostic (3.03e-2),unprognostic (1.79e-4),unprognostic (1.40e-1),unprognostic (1.45e-2),unprognostic (4.16e-3),unprognostic (2.33e-2),unprognostic (5.62e-4),unprognostic (7.80e-2),unprognostic (2.62e-1),unprognostic (4.25e-1),unprognostic (4.79e-1),unprognostic (1.71e-4),unprognostic (7.59e-3),0.5,0.5,1.1,0.5,1.1,1.5,0.3,1.7,2.6,0.4,0,0.5,10.1,0.5,0,0.8,0.4,0.3,0.2,1,1.6,11.7,74.4,0.4,0.1,3.2,1.4,1.3,0.3,0.7,0.2,0.8,0.1,1.6,0.4,0,0.3,1,0,1.3,1.7,6.2,0,0.3,1.2,1.1,0.1,1.2,0,0.2,0,0,0.5,0.5,1.2,0.5,1.8,0.1,1.5,0,0,3.4,0.4,0,0,0,9.2,0.6,0.8,0.9,0,0.3,1.7,0,0,0,1.7,1.2,0.1,0.7,13.7,0.1,0.2,1.4,0,0,0,0,0.1,0,0.9,0.5,0.4,0,4.1,0.1,0.1,0.2,0.6,0.7,0.7,0.5,0.2,0,0.7,1.1,0.7,1.6,0.3,0.4,0,1,0.1,1.7,0.5,0.7,0.4,0.3,0.1,0.5,0.1,0.2,0.5,0.6,0,0,0,0,0.1,0,0,0,0,0.1,0,0,0,0,0,0.6,0,0,0,1.1,1.1,1.7,2.6,1,1.6,3.2,1.4,1.3,1.6,0.3,1.2,1.2,0,0,0,0,0,0.1,0.5,0.1,0,0,0.1,0.3,0.2,1.5,0.5,0,0,0,0.1,0.4,17.6,0.1,0,0.3,0.1,0,0,0,0.2,0,0.6,0.2,0,0.2,0,0,2.2,83.7,0.1,0,0.2,0.6,0,1.3,0.4,0.2,0.6,1.3,0,0,0.6,0,0,0,0,0.2,1.2,0,0.6,0.3,21.1,135.8,0.3,0,0,0,0,0.6,0.9,0,0.1,0.3,0.3,0.1,0.3,0.4
ENSG00000132297,HHLA1,PLA2L,HERV-H LTR-associating 1,C9JL84,8,132061486-132111159,Predicted secreted proteins,,,,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Evidence at transcript level,Not detected,Not detected,,,Cell type enriched,Detected in some,5,Alveolar cells type 2: 19.8,Not detected,Not detected,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,NTERA-2: 1.1,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,Secreted - unknown location,NA,NA,,,,,,,,,,,unprognostic (5.15e-2),,,,,,,,unprognostic (1.19e-1),unprognostic (2.15e-1),,,0,0,0,0,0.1,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.1,0,0,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.1,0,0.1,0,0.2,0,0,0,0.2,0.2,0,0,19.8,0,0,0,0,0,0,0,0,0,0.7,0,2.5,0,0,0,0.1,0,1.9,0,0.4,0.1,0,0.3,0,0,0.9,0,0,0.6,0,0.2,3.8,0,0,0,0,0,1.2,0,0,0,0,0.6,0,0.4,0,0,0,0,0,1.5,0.1,0,0,0,0.1,0,0,0.1,1.5,0,0,0,0,0.1,0.2,0,0,0,0.1,0,0.1,0
ENSG00000204869,IGFL4,,IGF like family member 4,Q6B9Z1,19,46039748-46077118,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Group enriched,Detected in some,6,retina: 19.7;skin 1: 7.0,Cell type enhanced,Detected in some,,Bipolar cells: 6.2;Cone photoreceptor cells: 14.6;Excitatory neurons: 9.5;Inhibitory neurons: 10.1;Rod photoreceptor cells: 42.1,Low cancer specificity,Detected in some,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,A549: 3.9;HaCaT: 3.5;OE19: 6.1,,,,,,,,,HPA047655,Approved,,Approved,Cytosol,Secreted - unknown location,NA,NA,,,Cytosol,,HPA047655: AB_2680113,unprognostic (1.22e-2),unprognostic (3.37e-2),unprognostic (2.57e-1),unprognostic (7.96e-2),unprognostic (5.48e-2),unprognostic (1.03e-1),unprognostic (2.39e-1),unprognostic (8.25e-2),unprognostic (1.63e-1),unprognostic (1.62e-1),unprognostic (6.33e-3),unprognostic (1.09e-2),unprognostic (3.59e-4),unprognostic (4.30e-2),unprognostic (1.12e-1),unprognostic (3.38e-1),unprognostic (2.85e-1),0,0.3,0.9,0.1,1.3,0.1,0.1,1.1,2.2,0,0,0.1,0.4,0.4,1.3,1,0.2,0.5,1,1.4,0.3,0.1,0.1,0.3,0.4,0.4,0.5,1.5,0.9,0,0.5,1.6,0.1,1.2,0.4,0.2,19.7,0.5,0,0.3,7,0.3,0,0,0.2,0.3,0.4,0.2,0,0.8,0,0,0.3,0,2,0,3.9,0.1,0.2,0,0.8,0.3,0,0,0,0,0.9,0.1,0.5,0,0.1,0.5,3.5,0,0,0,0.4,0.6,0,0.6,1,0,0.1,0.1,0,0,0,0,0.3,0,0.3,0.1,0.4,0,0.4,0,0.3,0.2,6.1,0.2,0,1.7,0.9,0,0.2,0.2,0.3,0,0.1,0.9,0.4,0.2,0.7,0.4,0.3,0.7,0.2,0.2,0.4,0.3,0.1,0.1,0.6,1.1,0.1,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0.1,0,0,0.9,1.3,1.1,2.2,1.4,0.3,0.4,0.5,1.5,1.2,0,0.2,2,0,0,0,2.6,0,1,0,0.8,0,6.2,0.1,0,0,0,0,0,14.6,0,0,0,0,0,0.1,0,0,0,0,0,9.5,0,0,0,0,0,0,0.1,0,0,0,1.7,10.1,0,0,0,0.3,0.2,0,0,0,0,0,3.7,0,3.5,3.1,0,0,0,0,0,0,0,0,42.1,0,0,0.1,0.8,2.5,0,1.1,0,0,0,0,0
ENSG00000152580,IGSF10,"CMF608, FLJ25972",Immunoglobulin superfamily member 10,Q6WRI0,3,151425384-151458709,"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins","Differentiation, Osteogenesis",Developmental protein,Disease variant,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,ovary: 17.9,Cell type enhanced,Detected in many,,Early spermatids: 170.5;Horizontal cells: 60.6;Late spermatids: 34.1;Microglial cells: 61.8;Syncytiotrophoblasts: 30.9,Low cancer specificity,Detected in some,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,5,HeLa: 44.1;HL-60: 23.3;REH: 17.2;RPMI-8226: 55.1,Low region specificity,Detected in many,,,Low region specificity,Detected in single,,,"HPA012655, HPA012921",Uncertain,,Approved,Vesicles,Secreted - unknown location,NA,NA,,540000,Vesicles,,"HPA012655: , HPA012921: AB_1851526",unprognostic (1.78e-3),unprognostic (2.48e-2),unprognostic (1.71e-1),unprognostic (3.47e-7),unprognostic (1.68e-1),unprognostic (2.12e-1),unprognostic (9.82e-2),unprognostic (8.84e-4),unprognostic (9.38e-3),unprognostic (1.96e-1),unprognostic (5.70e-2),unprognostic (2.04e-1),unprognostic (7.52e-4),unprognostic (6.01e-2),unprognostic (8.93e-2),unprognostic (4.59e-3),unprognostic (7.57e-4),3.9,4,1.5,1,0.8,0.6,6.1,0.4,1.2,0.4,2.7,1.3,0.5,1.4,1.6,3,4.4,9.8,3.9,3,1.4,0.2,0.3,8.7,1.4,0.2,0.6,0.6,17.9,0.7,1.3,1.7,0.7,0.4,0.1,1.3,0.2,5.2,0.2,0.1,1.9,1.2,1.6,0.3,0.9,0.7,0.9,2.5,1.4,1.5,0.5,2.6,2.2,0.3,0.7,0,0.1,0.3,0,1.3,0.1,0,0,0,0,0,0,0.1,0,0,1.7,0.1,0,0.4,0,0,0.3,0.3,7.5,44.1,0,1.6,23.3,0.1,0.4,0,0,0,0.6,0,0.1,0.2,0.2,0,0,0,0,0.1,0,0,17.2,0.1,55.1,0.1,0.1,1,0,5.9,0,0,0.2,0,0.2,0,0.1,1.1,0,0,2.4,0,0,0.2,6.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,1.5,0.8,0.4,1.2,3,1.4,0.2,0.6,0.6,0.4,0.3,2.5,0.7,2,0,0.5,1,0.6,2.4,1.2,0.5,2.8,15.8,0.6,0.9,1.6,2.8,6.3,1.8,4.2,21.7,2.7,0.2,0,0.1,170.5,11.4,4,0.9,6,3.4,2.4,1.3,2.9,20.4,0.5,0.5,0,0,0,0.1,1.3,60.6,2.8,0.7,4.1,0.8,3.2,34.1,6.8,2.9,3.6,61.8,1.1,25.6,0,0.5,0.7,0.4,0.1,1.2,0.3,0.7,0,0.3,12.5,2.4,0,0.5,2.2,10.7,7.9,0.8,2.4,30.9,0.6,2.5,0.1,0.2
ENSG00000129009,ISLR,HsT17563,Immunoglobulin superfamily containing leucine rich repeat,O14498,15,74173710-74176872,Predicted secreted proteins,,,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,cervix: 204.0,Cell type enhanced,Detected in many,,Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0,Region enriched,Detected in all,5,olfactory bulb: 118.0,Region enriched,Detected in all,5,spinal cord: 124.7,"HPA040326, HPA050811",Approved,,Approved,"Golgi apparatus,Plasma membrane",Secreted - unknown location,NA,NA,,130000000,Plasma membrane,Golgi apparatus,"HPA040326: AB_2676928, HPA050811: AB_2681243",unprognostic (2.58e-1),unprognostic (1.36e-2),unprognostic (3.54e-2),unprognostic (3.06e-2),unprognostic (1.30e-1),unprognostic (1.76e-2),unprognostic (1.51e-1),unprognostic (1.21e-1),unprognostic (6.76e-3),unprognostic (1.16e-2),unprognostic (6.81e-2),unprognostic (8.93e-3),prognostic unfavorable (4.89e-8),unprognostic (1.64e-2),unprognostic (3.42e-2),unprognostic (2.28e-1),unprognostic (9.86e-3),78.5,17.7,3.9,5.6,8.2,0,67.5,1.1,11.9,204,9.7,57.2,5.7,182.9,19.1,17.2,79.4,38.9,49.3,3.9,11.9,20.8,8.2,38.1,10,4.5,3.1,3.5,172.3,10.2,2.1,44.9,10.3,3.2,51.8,5.3,0.3,33.9,23.1,18.7,40.1,31.6,26.6,1.5,33.3,32.8,15,3.5,3.4,63.9,19.9,5.3,64,112.8,5.2,0,1.5,0.1,0,62.7,33.5,0.2,10.2,0.1,0,0,0,4,0,0.6,148.1,0.1,0.1,0,0,0,0,0,0,0.2,0,0.7,0,0,25.5,0,0,0,0.1,0,0,0,0.5,0,0,0.1,0.2,0.2,0,0,0,0,47,0,0,0.5,5.8,0,0,0,0.6,0,0.1,0,0.3,0.4,7.6,0.1,0.1,1.1,0,0.3,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.9,8.2,1.1,11.9,3.9,11.9,4.5,3.1,3.5,3.2,1.5,3.5,5.2,10.3,0,1.3,0.7,0.1,11.7,0.1,0.2,0,0.1,4.8,3.9,3.9,1.5,0.7,0,0,1.3,0.8,0,0,0.2,2.4,7.2,193.5,14,0,0,1.9,0.2,1.4,154.5,2,4.2,0,0,7.5,0,3.8,0,0.2,0,0,0,16.2,6.1,214.9,2.6,12.4,34.7,0,0.2,0,0.5,0.7,0.8,0,159.9,0,0.1,0,0.1,1.5,0.5,26.3,7,49.8,0.7,0.7,1.3,8.8,1,2.6,7,0,0.2
ENSG00000198542,ITGBL1,"OSCP, TIED",Integrin subunit beta like 1,O95965,13,101452593-101720856,"Predicted intracellular proteins, Predicted secreted proteins, Transporters",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Group enriched,Detected in many,4,Fibroblasts: 76.1;Skeletal myocytes: 93.0,Cancer enhanced,Detected in many,,pancreatic cancer: 7.5,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,ASC diff: 208.3;ASC TERT1: 138.7;fHDF/TERT166: 345.3;LHCN-M2: 311.8,Low region specificity,Detected in many,,,Region enriched,Detected in many,12,spinal cord: 56.9,,,,,,Secreted - unknown location,NA,NA,,37000,,,,unprognostic (1.70e-1),unprognostic (2.12e-2),unprognostic (1.59e-2),unprognostic (1.55e-2),unprognostic (2.12e-4),unprognostic (1.45e-1),unprognostic (3.18e-1),unprognostic (2.54e-1),unprognostic (1.86e-1),unprognostic (8.84e-2),unprognostic (2.16e-2),unprognostic (9.50e-2),unprognostic (1.13e-5),unprognostic (1.44e-2),unprognostic (2.55e-1),unprognostic (1.68e-1),prognostic unfavorable (2.70e-4),10.7,9.2,1.8,0.7,1.7,0.1,18.2,2.7,4.3,24,8.1,1.4,0.5,2,0.5,9.8,5,38.7,14.7,1.9,7.9,2.8,7.8,25.7,1.4,3.9,2.2,0.9,5.3,8,5.6,10.4,33.6,4.1,4,2.5,0.1,11.8,4.4,4.5,11.1,0.5,4.1,3.8,4,7.2,2.5,2.3,0.9,8.5,15,4.4,18,10.1,7,4.2,0.3,0,0,208.3,138.7,0,65.8,67.7,29.3,18.7,0,2.4,0,0.3,345.3,13.9,70.9,0,24.1,46,0,0,21.3,0.6,0,21.7,0,0,59.3,1.5,16.8,46.6,55.3,76.8,0,1.5,0.7,311.8,0,0,0,0,0,24,0.1,0,0,0,2.7,0.1,0,0,0.1,0,0,0.1,0,8.8,24,33.2,27.3,0.1,8.3,0,0,50.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.8,1.7,2.7,4.3,1.9,7.9,3.9,2.2,0.9,4.1,3.8,2.3,7,1.9,3.2,0.5,5.5,0.1,4,0.1,1.3,0.6,1.8,4.2,19,0.5,0,0.1,0,0,0.7,0.1,0,0,0.5,4.5,0.5,7.7,1.2,0,0,3.6,0.2,0.8,76.1,5.6,1.1,0,0,8.6,0.5,0.7,5,6.7,0,0,0,4.7,2.1,0,0.8,5.4,13.1,0,0.5,0,2,5,1.1,0,8.2,0.6,0.2,0,0.1,0,0.7,0,93,4.8,11.6,8.4,0.7,2.4,0.8,0.4,1.2,0,0.2
ENSG00000187942,LDLRAD2,,Low density lipoprotein receptor class A domain containing 2,Q5SZI1,1,21812265-21825225,Predicted secreted proteins,,Receptor,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in some,,Adipocytes: 2.2;Granulosa cells: 4.9,Low cancer specificity,Detected in some,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,REH: 1.2;THP-1: 1.0;TIME: 2.2,Not detected,Not detected,,,Group enriched,Detected in some,20,basal ganglia: 4.0;midbrain: 5.9,HPA030478,Approved,,,,Secreted - unknown location,NA,NA,,,,,HPA030478: AB_10601541,unprognostic (4.16e-2),unprognostic (1.22e-1),unprognostic (4.13e-2),unprognostic (4.21e-2),unprognostic (1.78e-1),unprognostic (6.22e-3),unprognostic (1.35e-2),unprognostic (4.85e-2),unprognostic (7.52e-2),unprognostic (3.80e-2),unprognostic (5.34e-2),unprognostic (5.38e-2),unprognostic (1.04e-3),unprognostic (7.39e-3),unprognostic (3.14e-1),unprognostic (1.26e-1),unprognostic (6.94e-2),3.5,2.9,1,0.8,0.7,1,3,0.9,0.5,2.5,0.5,3.5,1.6,3.6,0,1.7,2.7,0.5,5.7,0.5,1.2,2.2,0.8,1.7,0.7,2,2.2,0,1.1,2.1,0,1.5,0.1,1.8,3.7,0.1,0,7.2,0,1.2,1.3,2.4,0.1,1.8,2.7,3.7,1.5,0.9,0,2.2,0,0.3,4,2.4,0.3,0.2,0.2,0.1,0.2,0,0,0.4,0.3,0,0,0,0.1,0.5,0,0.8,0,0,0.3,0,0,0,0,0,0.1,0.5,0.2,0,0,0,0.1,0,0,0,0.2,0.1,0,0.1,0,0,0,0,0.5,0.9,0.1,0.1,1.2,0.2,0,0,0.1,0,0.1,0.2,0,0,0.2,0,1,2.2,0.2,0.2,0.2,0,0,0,0.1,0,0,0.1,0.4,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0.1,0,0.5,0,0,1,0.7,0.9,0.5,0.5,1.2,2,2.2,0,1.8,1.8,0.9,0.3,2.2,0,0.6,0,0.6,0.5,0.1,0.4,0.6,0,0.1,0.1,0.7,0,0.2,1.8,0,0.2,0.3,0,0,0.2,1.7,0.3,1.2,1.6,0,1.3,0.2,0,0.6,1.3,0,0.9,0,4.9,0.7,0.2,0.3,0,0.1,0,0,0.3,0.2,0.4,0,0.3,0,1,0.5,0,0,0,0.2,0.3,0.1,0,1.3,0.5,0,0,0.8,0,0,1.2,0.7,0.6,1.2,0.1,0.4,0.3,0.4,0.4,0,0
ENSG00000204428,LY6G5C,"C6orf20, G5c, NG33",Lymphocyte antigen 6 family member G5C,Q5SRR4,6,31676684-31684040,"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,,testis: 1.7,Cell type enhanced,Detected in many,,Early spermatids: 21.4;Respiratory ciliated cells: 16.1;Spermatocytes: 15.9,Low cancer specificity,Detected in many,,,Region enhanced,Detected in single,,cerebral cortex: 1.1,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,HPA038690,Approved,,Approved,"Nucleoplasm,Cytosol",Secreted - unknown location,NA,NA,,,Nucleoplasm,Cytosol,HPA038690: AB_10673286,unprognostic (1.51e-2),unprognostic (7.26e-2),unprognostic (7.19e-2),prognostic favorable (1.07e-4),unprognostic (4.83e-1),unprognostic (6.91e-2),unprognostic (1.33e-1),unprognostic (1.57e-2),unprognostic (4.27e-2),unprognostic (5.63e-2),unprognostic (3.74e-5),unprognostic (5.84e-2),unprognostic (3.78e-4),unprognostic (1.53e-1),unprognostic (2.07e-1),unprognostic (5.88e-2),unprognostic (1.39e-2),0.2,0.2,0,0.6,0.4,0.3,0.2,0.2,1.1,0.2,0,0.2,0.1,0.1,0.1,0.1,0.5,0.5,0.3,0,0.1,0.3,0.3,0.5,0.3,0.1,0.1,0,0.2,0.6,0,0.9,0.1,0.3,0.4,0,0.6,0.2,0,0.8,0.1,0.3,0,0.1,0.6,0.3,1.7,0.1,0.1,0.3,0,0,0.2,0.2,0.2,0,0,0.1,0.6,0.8,0,0,0,0,0.1,0.2,0,0.7,0.4,0,0,0,0.1,0,0,0.2,0.8,0.4,0.3,0,0.1,0,0.1,0.3,0,0,0.2,0.4,0,0,0.2,0,0.4,0,0,0.7,0.1,0,0,0,0.2,0.1,0.2,0,0.1,0.1,0,0.2,0,0.1,0,0,0.5,0,0,0.3,0.5,0,0.1,0.1,0.1,0.6,0.4,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0.2,1.1,0,0.1,0.1,0.1,0,0.3,0.1,0.1,0.2,7.8,3.2,1.5,0.3,1.4,1.7,1.8,2,0,2.8,7.7,8,1.2,1.5,2.1,1.8,2.1,0.5,4.2,3.8,3.9,2.1,21.4,6.9,1.4,5.6,3.5,3,0.8,4.9,0.2,1.6,3.1,1.8,5.1,1.4,10.4,2.2,6.2,0,1.2,2,8.2,5.5,3.1,7.5,1.2,11.6,1.8,0,3.7,6,2.1,1,0.6,3.4,3.1,1.5,3.2,2.1,3,4.6,16.1,1.1,0,2.6,1.7,15.9,13.9,2,0.9,0.3,5.2,1.3,3.1,1.9
ENSG00000053328,METTL24,"C6orf186, dJ71D21.2",Methyltransferase like 24,Q5JXM2,6,110245928-110358272,Predicted secreted proteins,,"Methyltransferase, Transferase",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in many,,smooth muscle: 14.3,Group enriched,Detected in some,4,Astrocytes: 30.0;Excitatory neurons: 23.8;Inhibitory neurons: 28.7;Late spermatids: 8.6;Oligodendrocyte precursor cells: 31.7,Low cancer specificity,Detected in many,,,Low region specificity,Detected in all,,,Immune cell enriched,Detected in single,4,MAIT T-cell: 3.5,Lineage enriched,Detected in single,29,T-cells: 3.5,Cell line enhanced,Detected in some,,HHSteC: 1.0;SCLC-21H: 1.6;SuSa: 1.3,Low region specificity,Detected in some,,,Low region specificity,Detected in all,,,"HPA037441, HPA037442",Uncertain,,,,Secreted - unknown location,NA,NA,,,,,"HPA037441: AB_10670933, HPA037442: AB_10696931",unprognostic (6.62e-2),unprognostic (1.15e-1),unprognostic (9.31e-3),unprognostic (5.02e-2),unprognostic (5.21e-3),unprognostic (1.46e-1),unprognostic (6.12e-2),unprognostic (2.06e-1),unprognostic (3.98e-1),unprognostic (1.42e-1),unprognostic (8.45e-2),unprognostic (5.96e-2),unprognostic (1.54e-4),unprognostic (4.08e-2),unprognostic (1.23e-2),unprognostic (1.63e-2),unprognostic (4.78e-3),1.8,1.6,1.5,1.6,2.1,0,1.7,2,2,3.9,6.8,4.4,1.5,7.6,2.2,4.1,6,5.8,3,1.7,1.9,3.9,0.9,1.6,0.1,1.6,2.1,1.3,5.7,1.3,2.5,2.1,0.4,1.6,5,4.3,1.4,0.4,7.2,0,0.5,2.1,14.3,1.7,0.7,2.5,2.2,1.6,1,1.3,1.1,0.6,4.7,1.6,1.5,0,0,0.9,0,0,0,0,0.3,0.3,0,0,0,0,0,0,0.9,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0,0.2,0,0,0,0,0,0,0,1.6,0.9,0,0,0,1.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,3.5,0,0,0.7,0,0,0,0,0,0.1,0,0,0,0,1.5,2.1,2,2,1.7,1.9,1.6,2.1,1.3,1.6,1.7,1.6,1.5,0,0,0,30,0.3,0.1,0,0,0,0.5,0,0,0.3,0,0,0,0,0,0.1,0,0,0,4.9,0.4,1.5,0.1,0,0,23.8,0,0,0.8,0,0.4,0,0.5,0,0,0,1.7,28.7,0,0,0,0,8.6,0,0,0,3.7,0,0.6,0,31.7,5.4,0,0,0.4,0,0,0,0.6,0,0.2,0,0,0.3,2.1,0,1,0,0,0.3,0.1,0,0
ENSG00000270394,MTRNR2L13,,MT-RNR2 like 13,S4R3P1,4,116298876-116300320,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in some,,brain: 2.4;choroid plexus: 1.3;skeletal muscle: 1.5,Cell type enriched,Detected in some,20,Cardiomyocytes: 176.3,Not detected,Not detected,,,Low region specificity,Detected in all,,,Immune cell enhanced,Detected in single,,neutrophil: 1.5,Lineage enriched,Detected in single,9,granulocytes: 1.5,Group enriched,Detected in some,6,HeLa: 4.3;Hep G2: 1.8,,,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,,,,,unprognostic (6.40e-2),,,,,unprognostic (2.88e-1),,,unprognostic (2.49e-1),unprognostic (1.99e-1),,,,0.2,0.6,1.4,0,1.4,0.1,0,1.4,2.4,0,1.3,0.3,0.1,0.1,0,0.1,0,0.1,0.9,1.4,1.4,0.6,0.3,0.1,0,1.4,1.4,1.4,0,0.1,0.1,0,0,1.4,0,0.2,0,0.1,0,1.5,0.1,0.2,0,1.4,0,0.1,0.1,1.4,0,0,1,0,0,0,1.5,0.1,0.4,0,0.4,0,0,0.1,0.3,0,0,0,0,0.2,0.1,0,0,0,0,0,0,0,0.2,0.1,0,4.3,1.8,0,0,0.1,0.1,0,0,0,0.1,0,0,0,0,0,0.2,0,0.1,0,0.1,0,0,0,0.1,0.1,0.5,0,0.1,0.1,0,0.2,0,0.1,0.1,0,0,0,0.1,0,0,0,0,0,0,0,0.5,0.1,0.3,0,0,0,0.1,0,0,0,0.1,0,0,1.5,0.1,0,0,0,0.1,1.4,1.4,1.4,2.4,1.4,1.4,1.4,1.4,1.4,1.4,1.4,1.4,1.5,0,0,0,0,0,0.1,8.4,0,0,0,0,0,176.3,0,0,0,0,0,0,0,0,0,0,0,0,3.4,0,0,0,0,0,4.3,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,4.6,0,3.8,0,0,0,0.8,4,0,0,0,0,0,0.6,0,0,3.7
ENSG00000256222,MTRNR2L3,,MT-RNR2 like 3,P0CJ70,20,57358447-57359498,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Group enriched,Detected in some,5,brain: 3.3;skeletal muscle: 1.0,Cell type enriched,Detected in some,49,Cardiomyocytes: 3203.4,Not detected,Not detected,,,Region enriched,Detected in single,6,cerebral cortex: 3.3,Immune cell enhanced,Detected in single,,neutrophil: 1.1,Lineage enriched,Detected in single,5,granulocytes: 1.1,Cell line enhanced,Detected in single,,HeLa: 1.1,,,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (1.55e-4),unprognostic (2.65e-1),unprognostic (2.59e-1),unprognostic (8.34e-2),unprognostic (2.64e-1),unprognostic (1.80e-2),unprognostic (9.44e-6),unprognostic (2.56e-1),unprognostic (6.68e-2),unprognostic (5.35e-3),unprognostic (1.52e-3),unprognostic (7.52e-2),unprognostic (5.36e-2),unprognostic (4.37e-2),unprognostic (2.44e-1),unprognostic (1.18e-1),unprognostic (2.94e-3),0,0.1,0.2,0,0.3,0.2,0,0.5,3.3,0,0.4,0.1,0,0,0,0,0,0,0.2,0.4,0.3,0.2,0.2,0,0,0.2,0.3,0.2,0,0,0,0,0,0.4,0,0.1,0.1,0,0,1,0,0,0,0.2,0,0.1,0.1,0.3,0,0,0.4,0,0,0,0.5,0.1,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,1.1,0.3,0,0,0.1,0,0.1,0,0,0.2,0,0.1,0,0,0,0.1,0,0.1,0,0,0,0.1,0,0,0,0,0.1,0,0,0,0.2,0,0,0.2,0,0.1,0,0,0,0,0,0,0,0,0,0.3,0.2,0.4,0.1,0,0.1,0.1,0.1,0.1,0.1,0.2,0.2,0.1,1.1,0,0.1,0,0.1,0.1,0.2,0.3,0.5,3.3,0.4,0.3,0.2,0.3,0.2,0.4,0.2,0.3,0.5,0.7,0,0,0,1,3.2,32.3,0.3,0,0,2.4,1.3,3203.4,1.5,0.1,0,0,0.4,0.2,0,1.9,0,0.1,0.3,0.3,58.4,0,2.7,0,0,0.4,64.9,0,0.7,0,0.2,2.2,2.6,0.7,0,0,0,0,3.9,12,0.5,1.5,1.8,7.2,0,0.9,0,0,0,0,0,0,0.4,0.7,17.7,0,10.6,0.1,0,0,9.2,60.8,0.3,0.7,0,3.1,0.5,1.2,0.1,0,18.1
ENSG00000249860,MTRNR2L5,,MT-RNR2 like 5,P0CJ72,10,55599042-55600728,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.6,Cell type enriched,Detected in some,18,Cardiomyocytes: 27.7,Not detected,Not detected,,,Low region specificity,Detected in many,,,Group enriched,Detected in some,4,basophil: 1.2;neutrophil: 1.2,Lineage enriched,Detected in single,5,granulocytes: 1.2,Not detected,Not detected,,,,,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,,,,,,,,,,unprognostic (2.11e-2),,,,unprognostic (1.20e-1),,,,0,0.1,1.2,0.1,0.9,0.3,0,0.4,1.2,0,0.2,0,0.2,0.1,0,0.1,0,0,0.2,1.2,1.6,0.1,0.1,0,0.2,1.1,1,1,0,0.2,0,0,0,0.9,0,0,0.1,0.2,0,0.7,0.2,0.1,0,0.4,0.2,0.1,0,1.6,0,0.1,0.1,0,0,0,1.1,0,0.1,0,0.1,0,0,0.3,0.1,0,0,0,0.1,0.1,0.2,0.1,0,0,0.2,0,0,0,0.1,0,0,0.4,0.4,0,0.2,0,0,0,0,0,0,0,0,0.1,0.4,0,0.1,0,0.2,0.1,0,0.1,0.1,0,0.6,0,0.1,0,0,0.1,0.1,0,0.1,0.1,0.1,0.1,0,0,0.1,0,0.3,0.2,0.1,0,0.1,0.1,1.2,0.2,0.3,0.1,0,0,0.1,0.1,0,0,0.2,0,0.1,1.2,0.2,0.1,0.1,0,0.1,1.2,0.9,0.4,1.2,1.2,1.6,1.1,1,1,0.9,0.4,1.6,1.1,0,0,0,0,0,0.6,0.2,0,0,0,0,0,27.7,0,0,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0.8,0,0,0,0,0,0,0,0,0.1,0,0,0,1.1,0,0,0,0,0,0,0,0,1.5,0,0,0,0,0,0,0,0.2,0,0,0,0,0.8,0,0,0,0.1,0,0.1,0,0,0.1
ENSG00000256892,MTRNR2L7,,MT-RNR2 like 7,P0CJ74,10,37601440-37602974,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,4,brain: 1.7,Cell type enriched,Detected in some,26,Cardiomyocytes: 188.3,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,,,,,,,,,,unprognostic (2.28e-1),,,,unprognostic (5.87e-2),,,,0,0.1,0.4,0,0.4,0.1,0,0.4,1.7,0,0.4,0,0,0,0,0,0,0,0.2,0.4,0.4,0.1,0.1,0,0,0.4,0.4,0.3,0,0,0,0,0,0.4,0,0.1,0.1,0,0,0.3,0.1,0,0,0.4,0,0,0,0.4,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.1,0,0,0,0,0,0,0,0,0,0.1,0.6,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.2,0,0.1,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0.4,0.4,0.4,1.7,0.4,0.4,0.4,0.4,0.3,0.4,0.4,0.4,0.5,0,0,0,0,0,0.1,0.5,0.1,0,0,0,0,188.3,0,0.1,0,0,0,0,0,0,0,0,0,0,3.8,0,0,0,0,0,4.4,0,0,0,0,0,0,0,0,0,0,2,0,0.4,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0.7,0,0,0,0.6,7.1,0,0,0,0,0,0,0.1,0,0.4
ENSG00000188038,NRN1L,"MRCC2446, UNQ2446",Neuritin 1 like,Q496H8,16,67884885-67888855,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in some,,Alveolar cells type 1: 3.2;Alveolar cells type 2: 12.0;Astrocytes: 2.9;Bipolar cells: 2.0;Oligodendrocytes: 1.9,Not detected,Not detected,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in single,,,Low lineage specificity,Detected in single,,,Cell line enriched,Detected in some,5,BEWO: 38.1,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA041761,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA041761: AB_10961155,,,,,,,,,,unprognostic (2.79e-2),,,,unprognostic (3.32e-1),unprognostic (1.19e-1),unprognostic (3.99e-2),unprognostic (4.85e-1),1.6,1.4,4.4,0.9,5.8,3.8,1.7,6.2,8.3,2.4,8.1,1.3,1,1.3,0.4,1.1,2.9,0.7,1.9,4.2,5.6,1.8,2.4,1.9,2.1,5.1,4.8,4.2,4.7,1.3,0.7,6.3,0.6,5.3,2.7,0.6,5.5,1.7,0.8,2.1,3.2,1.7,0.5,3.8,2.5,1.2,1.8,4.6,1.1,2.5,0.7,0.6,2,2.1,6.1,0.1,0.5,0.7,0.9,0.3,1.1,38.1,0.4,0.1,0.4,0.3,0,0.6,0.5,0.7,0.1,0,0.4,0.1,0.3,0.3,0.3,0.9,0.4,1.5,2,0.6,0.2,1.4,0.5,1.2,0.1,0,0.4,0.1,1.4,0.9,0.7,0.1,1.6,0.5,4.3,7.1,0,0.5,1.5,0,0.7,0.3,0.4,1.1,0.4,0.5,0.5,0.5,6.8,1,1.4,0.6,0.3,0.3,0,0.1,0.1,0.4,0.9,0.1,0.4,0.2,0,0.5,0,1,0.3,0.6,0.5,0.6,0.3,0.1,0.2,0.5,0.3,0.6,0.3,0.4,0.1,0.4,0.3,4.4,5.8,6.2,8.3,4.2,5.6,5.1,4.8,4.2,5.3,3.8,4.6,6.1,0.1,3.2,12,2.9,0.1,0.3,0,0,0,2,0.2,0,0,0,0,0,0,0.4,0.1,0.3,0,0.1,0,0.1,0.1,0.1,0,0,0.7,0,0.5,0,0,0.1,0,0.3,0,0.2,0.1,0,0.8,0.1,0,0,0,0,0,0,0,0,0,0,0,1,1.9,0,0.2,0,0,0,0.3,0,0,0.1,0,0,0,0,0,0,0.1,0,0.2,0.1,0.2,0.1
ENSG00000111696,NT5DC3,"FLJ11266, TU12B1-TY",5'-nucleotidase domain containing 3,Q86UY8,12,103770453-103841234,"Metabolic proteins, Predicted secreted proteins",,Hydrolase,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,intestine: 57.6,Cell type enhanced,Detected in many,,Enteroendocrine cells: 41.2;Excitatory neurons: 36.6;Oligodendrocyte precursor cells: 29.1,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Low immune cell specificity,Detected in some,,,Low lineage specificity,Detected in many,,,Cell line enhanced,Detected in many,,hTERT-HME1: 22.7,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA041634,,,Approved,"Mitochondria,Cytosol",Secreted - unknown location,NA,NA,,,Mitochondria,Cytosol,HPA041634: AB_10795597,unprognostic (2.61e-2),unprognostic (1.16e-1),unprognostic (7.30e-2),unprognostic (2.72e-1),unprognostic (8.45e-2),unprognostic (1.04e-1),prognostic unfavorable (4.31e-4),unprognostic (1.57e-1),unprognostic (2.19e-1),unprognostic (2.45e-2),unprognostic (5.43e-2),unprognostic (2.95e-1),prognostic unfavorable (5.72e-6),unprognostic (8.60e-3),unprognostic (7.42e-2),unprognostic (2.14e-1),prognostic unfavorable (8.11e-4),2.7,4.1,14.5,1.9,12.7,17.7,3.3,0.3,11.8,8.9,0,57.6,1,23.3,5,5.2,3.7,1.4,1.9,21.4,6.8,2,5,2.8,1.3,1.9,2.7,12,2.9,3.5,0.8,4.5,1.5,2.1,7.6,7.8,2.4,4.1,5.5,7.8,2.4,4.7,6.9,0.3,1.6,6.7,3.2,6.6,0.6,1.9,3.3,1.3,21.8,5.7,9.2,3.6,6.5,3.6,4.2,5.1,4,6.8,5.9,3.5,4.1,2.6,4.4,0.9,6.1,1.1,7,4.5,4.1,5.2,11.7,5.9,4.5,4.2,7.6,2.5,5.2,2.8,4.1,1.9,3.5,2.5,5.3,22.7,8.3,2.4,3,12.2,3,9.2,3.3,3.6,6.6,4.5,5.2,6.9,4.9,6.3,2.3,6.5,2.4,4.9,2,4.9,5.4,7.1,3.3,3.1,3.8,3.2,4,4.8,5.5,11.9,2.7,3.5,4.4,3.8,6.2,6,0.4,0.5,0,0.6,0.6,1.2,1.3,0.9,0.5,1.5,1.4,0.7,0.6,0.9,0.6,0.4,1.9,0.2,0.3,14.5,12.7,0.3,11.8,21.4,6.8,1.9,2.7,12,2.1,0.3,6.6,9.2,1.4,0,2.3,3.9,2.7,4.5,21.9,3,21.6,2,5.6,7.4,3.8,2.8,2.1,1.8,0,5.2,2.7,5.8,0,2.1,12.1,14,11.9,1.7,41.2,1.3,36.6,2,4.7,3.8,7.7,19.4,0,3.7,0.7,5.3,1.8,10.1,24.4,11.4,10.2,4.1,6.5,10.5,5,2.8,0,6.5,2.9,0.8,1,29.1,2.7,2.7,2.2,8.2,2.7,13,1.1,2.1,6.9,5,0,5.6,5.7,0.4,3.1,9,4.4,4.1,2.5,4.1,9.2,9.8
ENSG00000184232,OAF,MGC52117,Out at first homolog,Q86UD1,11,120211032-120230334,"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in all,4,liver: 399.9,Cell type enhanced,Detected in many,,Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Group enriched,Detected in some,5,classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4,Group enriched,Detected in many,14,dendritic cells: 2.4;monocytes: 3.3,Cell line enhanced,Detected in many,,EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA047412,Uncertain,,Approved,Nucleoplasm,Secreted - unknown location,NA,NA,,69000000,Nucleoplasm,,HPA047412: AB_10960631,unprognostic (1.59e-1),unprognostic (2.10e-2),unprognostic (1.40e-1),unprognostic (2.80e-1),unprognostic (5.69e-2),prognostic unfavorable (5.71e-5),unprognostic (2.11e-1),unprognostic (3.98e-3),unprognostic (5.09e-2),unprognostic (3.90e-2),unprognostic (3.28e-2),unprognostic (1.52e-2),unprognostic (1.07e-2),unprognostic (1.12e-2),unprognostic (7.15e-2),unprognostic (2.13e-1),unprognostic (1.95e-1),55,92.3,37,18.2,49.4,10.8,43,29.5,57.6,66.8,34.6,49.1,48.1,54.7,16.1,23,55.1,34.8,50.7,42,41.6,51.3,399.9,19.3,5.9,39.3,31.4,36.9,61.5,74.7,6.7,27.6,8.1,34.5,33.8,36.8,30.9,54.4,13.8,13.3,12,57.8,29.4,29,54.9,33.8,3.8,32.5,4.7,26.2,12.3,3.7,43,40.7,37.9,24.9,7.5,30.9,14.4,47.8,53.4,1.7,47.7,53.8,20.5,30,7.5,37.3,0,115.5,35.6,33.7,25.7,8.9,13.2,8.2,18.7,21.1,21.1,4.7,190.1,42.4,46.7,7.9,66.8,7.9,19.8,54.8,39.9,59.7,12.7,14,22.7,5,9.4,0.3,139.9,11.6,7.3,40.8,11.8,0.9,23.7,31.8,13.4,1.5,10,14,15.2,40.2,8.6,4.8,74.7,32.7,39.3,14.7,40.8,4.6,0.8,0.7,0.4,30.3,76.2,14.1,0,3.3,0,0.1,1.6,0,0,0,0,2.4,0,0,0.2,0.1,0,0.3,0.5,0.1,0.8,37,49.4,29.5,57.6,42,41.6,39.3,31.4,36.9,34.5,29,32.5,37.9,19.4,0,0.6,102.2,3.7,9.4,33.6,7.3,12.5,3.2,6,7,5.5,34.3,3.5,71.7,2.1,2.1,1.1,135.9,27.4,14.8,0.2,4.7,70.9,40,22.8,12.8,0.6,28.7,5.5,135.9,11.7,12.2,1.3,2.6,12.5,218.8,6,0,2.3,56.5,4.1,11.5,20.9,1.1,16.8,11,16,23.4,10.2,279.4,0,5.5,11,28.2,56.5,4.5,14.5,31.3,111.1,79.3,0.4,10.6,52.6,8.6,40.8,0.7,6.9,11.3,10.2,6.2,3.1,149,45.8,192.5
ENSG00000183801,OLFML1,UNQ564,Olfactomedin like 1,Q6UWY5,11,7485388-7511377,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,ovary: 49.1,Cell type enhanced,Detected in some,,Fibroblasts: 52.3;Leydig cells: 39.7;Peritubular cells: 39.5;Sertoli cells: 26.3;Smooth muscle cells: 16.3,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4,BEWO: 31.2;U-2197: 20.7,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA058824,Approved,,,,Secreted - unknown location,NA,NA,,260000,,,HPA058824: ,unprognostic (3.05e-1),unprognostic (5.35e-2),unprognostic (1.52e-1),unprognostic (3.80e-2),unprognostic (5.32e-1),unprognostic (1.82e-3),unprognostic (1.36e-1),unprognostic (1.16e-1),unprognostic (7.33e-2),unprognostic (1.37e-2),unprognostic (2.30e-1),unprognostic (1.05e-2),prognostic unfavorable (4.28e-8),unprognostic (3.13e-3),unprognostic (2.00e-2),unprognostic (3.34e-2),unprognostic (8.72e-3),18.1,6.3,1.5,5.3,1.9,0.4,12.6,2.2,1.9,27.4,7.1,8.5,5.1,19.2,21.5,8.2,17.7,24,14.4,1.9,1.8,6.5,10.8,19,9.4,2.1,1.5,1.1,49.1,2.9,2.3,3.1,7.4,2.1,14.2,10.3,0.2,5.7,18.5,5.2,8.3,7.2,18.2,1.3,14.8,5.5,4.1,1.7,3.3,8.3,12.2,5.6,15,17.9,2.1,0,0,0.4,0,1.9,1.9,31.2,0.3,0,0,0.1,0.4,0.1,0,0,0.7,0,0.1,0,0,0.1,0,0.2,0,0.6,0.2,0.1,0.1,0.1,4.7,0,0,0,0,0,0,0,0.3,0,0,0,0.1,0.1,0,0,0.1,0.1,0,0,0.2,0,0.4,0,0,0,6.4,0,0,0.1,0.2,0.1,20.7,0,0.1,0,0,0.1,0,0,0,0.1,0.2,0,0.2,0,0.4,0,0,0,0.6,0.1,0.1,0.2,0,0.8,0.1,0,0,1.5,1.9,2.2,1.9,1.9,1.8,2.1,1.5,1.1,2.1,1.3,1.7,2.1,6.1,0,0,1,0.4,5.2,0,0,1.2,0.1,0.2,0.3,1,0,0.6,0,0,0.6,0.1,0,0,0,0.1,0.3,13.3,2.9,0,0,0.1,0,2,52.3,0,0.4,0,0,5,0.9,0.6,0,0.1,0,0,0,6.1,0.7,39.7,0.4,7.2,2.8,0,0,0,0.5,1.4,0.1,0,39.5,0.2,0.1,0,0.3,0,0,26.3,9.4,16.3,0.3,0.1,0.2,3.7,0.3,0.7,5,0,0.1
ENSG00000185585,OLFML2A,FLJ00237,Olfactomedin like 2A,Q68BL7,9,124777133-124814885,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Adipocytes: 40.1;Endothelial cells: 21.2;Fibroblasts: 29.0;Skeletal myocytes: 63.0;Smooth muscle cells: 36.4,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,ASC TERT1: 160.0;GAMG: 34.0;HeLa: 39.8;hTERT-RPE1: 38.0;WM-115: 64.1,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,"HPA021180, HPA022254",Approved,,Approved,"Nucleoplasm,Cytosol",Secreted - unknown location,NA,NA,,240000,"Nucleoplasm, Cytosol",,"HPA021180: AB_1854790, HPA022254: AB_1854791",unprognostic (1.12e-1),unprognostic (3.07e-2),unprognostic (3.16e-1),unprognostic (2.45e-1),unprognostic (4.01e-2),unprognostic (1.27e-1),unprognostic (1.15e-1),unprognostic (3.00e-1),unprognostic (1.26e-3),unprognostic (7.53e-2),unprognostic (2.49e-2),unprognostic (1.52e-1),prognostic unfavorable (3.73e-5),unprognostic (5.72e-3),unprognostic (3.30e-2),unprognostic (7.91e-2),unprognostic (1.05e-2),11.7,2.9,3,2.7,2.5,0.3,11.2,2.3,4.1,24.9,5.2,22.7,3.3,25.5,2.8,8.2,6.4,4.8,16.5,2.2,2.6,4.3,0.7,10.6,2.4,3.1,2.2,1.4,12.1,4.8,4.6,2.8,7.1,2.6,7.4,6.2,2.2,7,12.3,10.9,16.2,7,16.1,2,33.1,5.5,1.1,2.8,3.1,19.3,10.1,3.7,17.8,14.7,2.4,0.8,14.6,1.2,0.4,16.8,160,0.1,1.8,8.2,3.5,3.5,0.2,2.2,0,3.4,0.1,34,25.5,0.4,0.8,4,0,0.1,0,39.8,0.1,0.9,0,0.1,11.3,2.7,10.2,1.4,38,0,0,0,0.2,1.8,0.4,0,0.3,3.4,0,0.9,0,9.5,0,0,1.2,0,0.1,2.9,0.2,4.3,28.6,3.9,0.5,0.1,5.2,4.6,5.5,0.7,1.9,0,0.1,15.2,0.8,64.1,0.5,0.1,0,0,0,0,0.1,0,0,0.1,0.2,0,0.1,0.5,0.1,0,0.1,0,0.1,3,2.5,2.3,4.1,2.2,2.6,3.1,2.2,1.4,2.6,2,2.8,2.4,40.1,0,1.3,0.7,0.4,12,5.9,17.5,6.2,0.6,2.9,8.3,13.8,1.5,5.5,0,2.1,0.3,0.5,0,0,0.1,0.7,0.2,1.5,21.2,0,0,0.4,0.6,0.3,29,0.5,0.2,0,0.9,3.6,0.1,0.1,0,0.6,0,4.1,1.5,7.9,1.4,2.8,0.9,10.6,8.4,0.1,0.3,0,0,0.1,0,0,1.5,0.1,4,0,0.1,11.5,4,13.1,63,36.4,0.4,0.7,4.5,8.4,0,0.6,4.2,0,3.5
ENSG00000162745,OLFML2B,DKFZP586L151,Olfactomedin like 2B,Q68BL8,1,161983192-162023869,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,gallbladder: 48.7,Cell type enhanced,Detected in many,,Early spermatids: 122.5;Hofbauer cells: 38.4;Skeletal myocytes: 175.5;Smooth muscle cells: 57.2,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Group enriched,Detected in some,10,intermediate monocyte: 6.7;non-classical monocyte: 5.5,Lineage enriched,Detected in single,11,monocytes: 6.7,Cell line enhanced,Detected in many,,ASC TERT1: 39.7;HSkMC: 113.3;RH-30: 88.5,Group enriched,Detected in all,4,hippocampal formation: 41.0;white matter: 11.9,Low region specificity,Detected in all,,,"HPA054136, HPA062739",Approved,,Approved,Cytosol,Secreted - unknown location,NA,NA,,12000,Cytosol,,"HPA054136: AB_2682397, HPA062739: AB_2684858",unprognostic (2.97e-2),unprognostic (1.79e-1),unprognostic (8.91e-2),unprognostic (1.05e-1),unprognostic (6.01e-2),unprognostic (1.22e-2),prognostic unfavorable (4.67e-4),unprognostic (5.97e-3),unprognostic (7.32e-2),unprognostic (7.68e-3),unprognostic (1.16e-1),unprognostic (2.21e-1),prognostic unfavorable (1.01e-12),unprognostic (1.64e-3),unprognostic (2.11e-2),unprognostic (4.53e-3),unprognostic (1.97e-2),22.5,6.9,3.5,19.4,6.8,0.4,14.9,2.4,5.2,17,6.7,13.2,2.1,16.4,5.1,4,11.5,48.7,5.5,5.7,8.5,3,0.8,15.4,14.1,4.3,3.7,3.9,4.2,1.4,3.6,2.8,41,3.4,5.3,2.9,0.2,10.5,6.9,10.3,8.3,5.6,22.2,2.9,10.3,3.3,16,8.3,3.8,21,6.5,11.3,17,7.4,7,0.1,0.4,6.6,2.2,21,39.7,0,2.3,10.6,4.3,11.8,0,0.2,0,0.3,25.7,4.3,0,0.6,0.1,2.5,0,0.8,0.5,0.2,0,0.3,0.1,0.8,113.3,0,5.3,0,2.1,0.7,0,0,1,19.3,0.1,0.1,0.2,2.1,0,1,0.2,88.5,8.9,1.6,0.1,0.8,0.3,9.1,0,0.6,19.6,0,0.1,0.1,2.7,0.7,4,3.6,0,0.1,0,25.1,2.7,1.3,0,0.4,0,0,6.7,0,0,0,0,0.6,0,0,0,0.2,0,5.5,0,0,0.2,3.5,6.8,2.4,5.2,5.7,8.5,4.3,3.7,3.9,3.4,2.9,8.3,7,4.1,0,0.6,0,0.2,3.3,0.1,0.1,0,0.1,0.4,1,3,1.5,0.7,1.8,0,0.3,0.1,0,0,0,122.5,1.2,24.9,1.7,0,0.4,2.8,0,0.3,21.9,0,0.7,1.3,1.1,1.1,0.2,38.4,0,0.9,0.1,0,31.1,9,12.9,20.8,16.6,1.8,8.4,0.9,0.8,0,0,2.9,0,0,29.3,0.1,0.1,0,0.1,0.1,0.1,6.6,175.5,57.2,8.8,1.7,0.1,2.3,0.3,0.6,16.4,0,0
ENSG00000285231,OOSP3,,Oocyte secreted protein family member 3,A0A2R8YFM6,11,59878809-59896481,Predicted secreted proteins,,,,Evidence at transcript level,No human protein/transcript evidence,No human protein/transcript evidence,Evidence at transcript level,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Not detected,Not detected,,,Immune cell enriched,Detected in single,33,basophil: 5.5,Lineage enriched,Detected in single,55,granulocytes: 5.5,Not detected,Not detected,,,,,,,Low region specificity,Detected in all,,,,,,,,Secreted - unknown location,NA,NA,,,,,,,,,,,,,,,,,,,,,,,0,0,0,0.1,0.1,0.1,0,0,0.2,0,0,0,0.1,0,0,0,0,0,0,0.1,0,0.1,0,0,0,0.2,0,0,0,0,0,,0,0.1,0,0,0,0.1,0,0.1,0,0,0,0,0,0,0.4,0.1,0,0,0,0,0,,0.3,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.3,0.1,0,0,0.1,0.3,0,0.1,0,0,0,0.2,0,0,0,0.2,0,0,0,0,0,0,0,0.5,0,0,0.1,0,0,0.1,0,0,0,0,0.1,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0,5.5,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.2,0.1,0,0.2,0,0,0.1,0,0.1,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000285010,OOSP4A,,Oocyte secreted protein family member 4A,A0A2R8YFL7,11,59964033-59970146,Predicted secreted proteins,,,,Evidence at transcript level,No human protein/transcript evidence,No human protein/transcript evidence,Evidence at transcript level,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Not detected,Not detected,,,Immune cell enriched,Detected in single,12,basophil: 4.1,Lineage enriched,Detected in single,12,granulocytes: 4.1,Group enriched,Detected in some,5,HEL: 1.0;K-562: 2.6,,,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,,,,,,,,,,,,,,,,,,0,0,0.2,0,0.1,0,0,0.1,0.3,0,0.1,0,0,0,0,0,0,0,0,0.2,0.1,0.1,0,0,0,0.1,0.1,0.2,0,0,0,,0,0.1,0,0,0,0,0,0,0,0,0,0.1,0,0,0.1,0.2,0,0,0,0,0,,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0.1,0,0,0,0,0,0,0,2.6,0,0,0,0,0.3,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0,4.1,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0.1,0.1,0.3,0.2,0.1,0.1,0.1,0.2,0.1,0.1,0.2,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000255393,OOSP4B,,Oocyte secreted protein family member 4B,A0A2R8Y4Y8,11,59978020-60031077,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,No human protein/transcript evidence,No human protein/transcript evidence,Evidence at transcript level,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,,,,,,,,,,,,,,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000149090,PAMR1,"DKFZP586H2123, RAMP",Peptidase domain containing associated with muscle regeneration 1,Q6UXH9,11,35431823-35530300,"Enzymes, Predicted intracellular proteins, Predicted secreted proteins",,Serine protease homolog,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enriched,Detected in many,7,Astrocytes: 380.3,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,ASC diff: 86.9;ASC TERT1: 354.7;BJ hTERT+: 357.7;fHDF/TERT166: 86.7;HSkMC: 123.1;U-87 MG: 82.6,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,,,,,,Secreted - unknown location,NA,NA,,5600000,,,,unprognostic (3.38e-1),unprognostic (1.07e-2),unprognostic (1.67e-1),unprognostic (1.00e-3),unprognostic (6.50e-3),unprognostic (1.01e-1),unprognostic (2.07e-2),unprognostic (6.92e-2),unprognostic (3.32e-2),unprognostic (4.07e-2),unprognostic (1.91e-2),unprognostic (1.36e-2),prognostic unfavorable (5.08e-5),prognostic unfavorable (6.29e-4),unprognostic (2.08e-1),unprognostic (9.98e-2),unprognostic (8.25e-2),20.4,15,24.4,0.6,24.6,0,15.6,24,23.6,60.4,14.2,13.5,4.5,58.8,18.5,10.1,22.8,20.5,18.8,22.5,25.1,4.1,12.7,6,1.3,36.8,30.1,19.7,3.4,5.3,1.7,6.5,56.4,30.2,21.4,6.6,0.9,5.7,18.1,2.7,20,10,15,44.1,5.8,5.4,0.2,30.8,2.8,7,9.1,1.8,28.3,41.6,37.5,0,0,0.1,0,86.9,354.7,0.1,42.8,357.7,4.9,8.3,32.7,0,0,0,86.7,0.1,0.1,0,0,3.3,0,0.8,0,0,0,50.1,0,0,123.1,1.8,9.7,1.3,0.1,0,0,0,0.1,0.3,0.1,0,0.1,0.7,0,0.2,0,0.2,0.2,0,8.4,0.1,0,0,0,0,14.3,2,0,0,0,1.1,0.1,0,0,0.1,0,82.6,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.4,24.6,24,23.6,22.5,25.1,36.8,30.1,19.7,30.2,44.1,30.8,37.5,2.5,0,0,380.3,0,19.1,1.4,14.8,1.2,0.1,0.7,19.7,1.3,0,2.4,1.8,0,2.2,0,0,0,1.4,0.1,4.5,26.2,1.1,0,0,13.1,0,1.4,50.2,1.1,0.8,0,0.6,0,0,2,0,8.2,0.2,0,0,5.5,0.1,0.3,0.5,1.8,28.1,0.6,0,0,9.5,1.4,0.1,0,0,0,0.4,0.2,0,1.8,0.2,0,1.6,5.8,0,0.2,0.1,9.2,3.4,0.6,0.2,0,0.2
ENSG00000100767,PAPLN,MGC50452,"Papilin, proteoglycan like sulfated glycoprotein",O95428,14,73237497-73274640,"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins",,"Protease inhibitor, Serine protease inhibitor",,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Astrocytes: 119.8;Endometrial stromal cells: 37.9;Leydig cells: 34.5;Peritubular cells: 44.0,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Group enriched,Detected in some,5,neutrophil: 2.5;plasmacytoid DC: 5.4,Group enriched,Detected in many,7,dendritic cells: 5.4;granulocytes: 2.5,Cell line enhanced,Detected in many,,HHSteC: 16.1;HSkMC: 30.6;hTCEpi: 11.4,Not detected,Not detected,,,Low region specificity,Detected in some,,,"HPA048682, HPA053453",Uncertain,,Approved,Nucleoplasm,Secreted - unknown location,NA,NA,,76000000,Nucleoplasm,,"HPA048682: AB_2680492, HPA053453: AB_2682155",unprognostic (1.97e-3),unprognostic (3.27e-2),unprognostic (1.88e-1),unprognostic (3.56e-3),unprognostic (7.42e-2),unprognostic (7.91e-3),unprognostic (2.01e-2),unprognostic (2.46e-3),unprognostic (9.13e-3),unprognostic (3.69e-2),unprognostic (1.41e-1),unprognostic (4.87e-2),unprognostic (1.89e-2),unprognostic (2.14e-2),unprognostic (3.05e-3),unprognostic (2.69e-2),unprognostic (5.58e-2),13.6,6.6,16.6,8.5,16.5,2.3,10.8,13,19.3,24.6,15.9,11.1,3,20.6,15,7.1,23.2,5.6,6,14.8,30.3,41.9,3.3,13.6,15.4,17.2,13.4,14.5,17,4,0.4,16.5,4,17,13.7,4.5,9.6,7.5,7.6,2.1,15.4,18,6.4,12.5,29.3,11.4,6.5,13.8,5.1,25,1.8,13.7,5.2,9.2,13.4,2.7,2.6,1,0.4,1.9,2.3,5.8,0.5,0,0.1,0.2,3.4,0.8,0.5,2.7,0,0.1,4.3,2.7,2,0.3,3,3.9,1.2,4.7,0.3,16.1,0.4,2.1,30.6,11.4,0.5,1.7,0.2,0.6,2.5,0.8,0.3,0,1.4,0.3,3,0.6,0.3,0.8,0.4,0.3,2.8,2.3,0.6,0.3,0.5,6.2,7,1.3,7.9,0.2,4.8,0.5,0.7,2.3,0.2,0.3,1.3,0.1,0.3,1.4,1.4,0.6,0.8,0.5,0.3,0.2,0.3,0.1,0.4,0.1,0.2,0.1,0.5,0.2,0.2,2.5,0.3,0.2,5.4,0.3,0.1,16.6,16.5,13,19.3,14.8,30.3,17.2,13.4,14.5,17,12.5,13.8,13.4,0.4,0,2.6,119.8,0.3,2,0.7,5.1,0.6,1.2,1.8,1.4,1.9,7.2,4.8,5.5,8.4,0.5,5.7,0.4,0,4,0.3,11.8,37.9,3.4,0,0,0.3,0,1.1,8.3,0.5,16.1,0,0.2,3.3,0.1,1.2,0,0.9,0.4,2,0.3,1.6,1.7,34.5,1.8,1.8,10.3,1.6,15.7,0,3,0.3,0.4,0,44,0.2,1.4,0.2,10.2,3.7,3,6.6,1.4,1.8,0.6,0.1,0.8,3,0.4,0.7,0.1,1,0.4
ENSG00000204970,PCDHA1,,Protocadherin alpha 1,Q9Y5I3,5,140786136-141012347,"Predicted membrane proteins, Predicted secreted proteins",Cell adhesion,,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in some,,brain: 1.9;pituitary gland: 1.0;testis: 1.0,Cell type enhanced,Detected in some,,Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;Hepatic stellate cells: 1.4;Sertoli cells: 6.6;Spermatogonia: 1.0,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,7,T-47d: 9.1,Low region specificity,Detected in many,,,,,,,HPA035969,Enhanced,,Approved,Plasma membrane,Secreted - unknown location,NA,NA,,,Plasma membrane,,HPA035969: AB_10673492,unprognostic (2.76e-5),unprognostic (1.19e-1),unprognostic (3.74e-2),unprognostic (1.09e-4),unprognostic (7.38e-2),unprognostic (2.86e-2),unprognostic (2.26e-3),unprognostic (1.25e-2),unprognostic (1.91e-2),unprognostic (1.81e-1),unprognostic (9.01e-5),unprognostic (2.46e-2),unprognostic (1.91e-1),unprognostic (7.57e-2),unprognostic (1.11e-1),unprognostic (1.77e-3),unprognostic (1.29e-1),0,0.2,0.3,0,0.8,0,0.1,1.5,1,0,0,0.1,0.1,0,0,0,0,0,0,0.7,0.5,0.1,0,0,0,1.6,0.8,0.5,0,0.1,0,1,0,1.1,0,0,0.4,0,0,0,0,0.1,0,0.8,0,0,1,0.5,0,0,0,0,0,0,1.9,0,0.4,0.2,0.3,0,0,0,0,0,0,0,0.1,0,0,0.2,0,0.9,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0.1,0,0.1,0,0.2,0.3,0,0,0,0,0,0,0,0.9,0.6,0,0.1,1.1,0.1,9.1,0.3,0,1,0.6,0.4,0,0,0,0,0.2,0.1,1.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0.8,1.5,1,0.7,0.5,1.6,0.8,0.5,1.1,0.8,0.5,1.9,0,3.2,2.2,0,0,0,0,0,0,0,0.1,0,0.1,0,0,0,0,0,0,0.1,0,0,0.4,0,0.1,0,0,0,0,0.4,0,0.2,0,0,0,0,1.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,6.6,0,0.1,0.6,1,0,0,0,0,0,0,0
ENSG00000250120,PCDHA10,"CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10",Protocadherin alpha 10,Q9Y5I2,5,140855883-141012347,"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins",Cell adhesion,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,brain: 6.3;pancreas: 4.2,Cell type enhanced,Detected in some,,Bipolar cells: 7.3;Cone photoreceptor cells: 8.4;Horizontal cells: 8.4,Low cancer specificity,Detected in single,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,4,EFO-21: 16.2,Low region specificity,Detected in all,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (4.24e-2),unprognostic (1.33e-1),unprognostic (1.73e-1),unprognostic (4.70e-2),unprognostic (4.19e-1),unprognostic (2.36e-1),unprognostic (6.46e-2),unprognostic (8.24e-2),unprognostic (8.10e-2),unprognostic (5.28e-2),unprognostic (2.65e-1),unprognostic (6.14e-3),unprognostic (1.93e-2),unprognostic (3.57e-3),unprognostic (5.21e-2),unprognostic (3.03e-1),unprognostic (1.10e-1),0.8,0.5,1.4,0.3,1.8,0.1,0.7,6.3,2.4,0.9,0,0.2,0.3,1.8,2,0,1,1.2,0.1,1.6,1.2,1.5,0,0.8,0.2,2.1,1.3,1.3,1.1,4.2,0.7,1.5,0,2.1,0.4,0.1,2.4,0.5,0.2,0.1,0.1,0.7,1.6,1.5,0.1,0.3,1.4,1.2,0,2.1,0.1,0,0.2,0.1,2.9,0,0.2,0.5,3.9,0,0,0.2,0.1,0,0,0,0,0.1,0,16.2,0.2,0.2,0,0,0.4,0,0,0.3,0,0.3,0,0,0,0.1,0.1,0.3,0,0,0,0.2,0.1,0,0.1,0,0.1,0,0,0.7,0.1,0.2,0,0,0,0,0.3,1.2,0.8,0,0.1,0,2.4,0.3,0,0,0.3,0.4,0.1,0,0,0,0,0.2,0,0.2,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,1.4,1.8,6.3,2.4,1.6,1.2,2.1,1.3,1.3,2.1,1.5,1.2,2.9,0.9,0,1.5,0,0,0,0.3,0,0,7.3,1.2,1.4,0.6,1.5,0.1,0,8.4,0,0,0.2,0,0.2,3.2,0.6,2.7,0.6,1.8,0,0,0.9,0,0.6,0,0.5,0,0.3,0.4,0,0,8.4,0,0,2,0,0,0.5,0,0,0,0,0,1.9,1,0,0,1.1,0,0,0,0.2,0,0.4,0,3.2,0,2.5,2.3,2.2,0.3,0,0,0,0.2,0.3,0.1,0.3
ENSG00000197646,PDCD1LG2,"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2",Programmed cell death 1 ligand 2,Q9BQ51,9,5510531-5571282,"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins","Adaptive immunity, Immunity",Receptor,Cancer-related genes,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,lymphoid tissue: 15.3,Cell type enhanced,Detected in many,,Extravillous trophoblasts: 17.9;Langerhans cells: 13.1;Microglial cells: 12.2;monocytes: 26.4,Low cancer specificity,Detected in many,,,Low region specificity,Detected in some,,,Low immune cell specificity,Detected in some,,,Low lineage specificity,Detected in many,,,Cell line enhanced,Detected in many,,BJ: 71.4;BJ hTERT+: 111.6;HDLM-2: 88.1;TIME: 49.7,Not detected,Not detected,,,Low region specificity,Detected in all,,,HPA013411,Approved,,Uncertain,Cytosol,Secreted - unknown location,NA,NA,,31000000,Cytosol,,HPA013411: AB_1855102,unprognostic (3.93e-2),unprognostic (1.90e-1),unprognostic (3.51e-3),unprognostic (6.68e-3),unprognostic (7.66e-2),unprognostic (6.77e-2),unprognostic (5.72e-2),unprognostic (2.91e-1),unprognostic (1.68e-1),unprognostic (4.37e-3),unprognostic (5.79e-2),unprognostic (5.29e-2),prognostic unfavorable (1.15e-4),unprognostic (5.00e-2),unprognostic (4.66e-2),unprognostic (2.01e-1),unprognostic (7.51e-3),4.5,0.8,0.6,7,0.7,0.3,4.4,0.5,1,2.5,0.8,1.7,0.7,2.2,1.3,2,2.4,3.4,2.7,0.5,1.4,1.2,4.2,7.1,10.5,0.9,0.8,0.3,1.6,0.6,0.4,0.2,4.8,1.2,1,2.1,0,1.3,1.4,1.5,1.3,1.5,3.1,0.8,15.3,1.4,0.6,0.7,5.1,1,2.2,6.2,4.3,2.2,1.4,6,0,0,0,4.7,5.4,0.1,71.4,111.6,33.7,40.4,0,0.3,0,0.2,29.2,4.8,0.5,0.1,9.7,33.3,88.1,0,0,0,0,26.5,0,0,5,0.1,15.8,18.5,9.7,22.4,0,0,8.5,41,0,0,0,0,0,0,0,42,0.7,0,0,0,0,1.6,0.1,0,0.2,0,0.1,49.7,24,1.4,11.8,20.1,1.2,0.1,0.1,13.6,0,3,1.5,0.3,0,0.5,1.4,0.6,0.2,0.7,0.3,0.3,0.1,0,0.3,0.7,0,0.1,0,1.1,0.3,0.6,0.7,0.5,1,0.5,1.4,0.9,0.8,0.3,1.2,0.8,0.7,1.4,6.1,6.4,0.5,1.6,0.4,1,0.1,0.7,1.8,0,0.2,1.5,0.1,0,0.7,0,0,0.6,0.4,0,0,0.1,0,0,0.4,2.2,0,0,1.6,0.2,17.9,6.7,0.5,0,3.8,0.2,6.8,0,2.9,0,1.4,0,0,5.3,13.1,0,5.9,2.5,1.8,12.2,26.4,0,0,1,2.4,3.7,0,2.2,1.5,0.1,0,0,0,0,0,2.2,3.1,0,0,0.3,1,0.8,1.1,0.1,0,0.1
ENSG00000104213,PDGFRL,PRLTS,Platelet derived growth factor receptor like,Q15198,8,17576433-17644071,"Disease related genes, Predicted secreted proteins",,,Disease variant,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7,Cancer enhanced,Detected in all,,thyroid cancer: 22.9,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in many,5,AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA052801,,,Approved,"Nucleoplasm,Nucleoli,Golgi apparatus",Secreted - unknown location,NA,NA,,,Golgi apparatus,"Nucleoplasm, Nucleoli",HPA052801: AB_2681956,unprognostic (1.25e-1),unprognostic (1.73e-1),unprognostic (5.10e-2),unprognostic (1.59e-2),unprognostic (7.39e-3),unprognostic (1.31e-1),unprognostic (1.32e-1),unprognostic (6.54e-2),unprognostic (3.86e-1),unprognostic (7.46e-2),unprognostic (1.63e-1),unprognostic (6.72e-2),prognostic unfavorable (0.00e+0),unprognostic (1.58e-3),unprognostic (1.26e-1),unprognostic (4.47e-3),unprognostic (6.00e-3),34.4,4.2,2.5,3.9,3.4,0.2,52.4,2.8,3,28,2.1,6.8,0.9,15.9,10.4,3,23.5,13.5,9.4,2.3,6.7,1.3,0.7,4.7,1.2,2.7,2.6,2.1,43.3,6.9,9.1,7.5,9.1,2.6,5.5,3.2,0.6,13.2,6.8,18.6,10.2,2.7,26.3,2.4,0.8,6.2,6.5,2.7,3.8,33.3,38.3,2,6.5,12.1,3.3,0,17.7,1,189.4,5.6,2.5,13.8,4.6,159.1,7.5,31.3,1,0.2,0,0.9,2.5,24.7,0,11.6,0.9,3.7,0.2,14.5,0,5.3,4.1,14.6,0,0,86.9,0.1,9.2,0.1,0,13,1.6,0,2.4,1.1,12.5,0.2,0.4,9.9,0.7,3.6,0,0.2,0.4,1,11.4,0.6,1.2,1.4,1.7,3.3,11.4,0.6,0,2.6,0.2,6.9,0.2,0,0,0,0,0,0,0.9,0,0.3,0,0,0,0,0,0,0,0.1,0,0,0,0.2,0,0,0,0,0,2.5,3.4,2.8,3,2.3,6.7,2.7,2.6,2.1,2.6,2.4,2.7,3.3,15.5,0,3.6,2.3,0.3,13.3,0.5,4.3,0.6,0.6,2.9,3.3,4.5,1.5,2.8,0,0,14.9,0.7,0.4,0,4.1,36,2.4,5.4,4.1,1.2,0,1.1,7.1,19.9,186.2,0.5,4.7,0,0.3,1.4,0.2,3.5,0,3.5,1.3,2,0,14.6,6.7,74.6,1.6,10.6,1.9,1.6,1.4,0,3,1.3,3.1,0.1,70.7,0.2,1.9,0.4,0.1,0.2,0.4,0,8,10.7,0.8,1.9,0.6,9.9,9.7,1.7,1.5,0.4,0.5
ENSG00000187980,PLA2G2C,UBXN10-AS1,Phospholipase A2 group IIC,Q5R387,1,20161253-20186518,"Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins",,,,Evidence at transcript level,No human protein/transcript evidence,No human protein/transcript evidence,Evidence at transcript level,Not detected,Not detected,,,Group enriched,Detected in some,4,Early spermatids: 2.9;Late spermatids: 9.8,Not detected,Not detected,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,HL-60: 1.6;U-698: 2.0;U-937: 1.7,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (3.02e-3),unprognostic (2.75e-2),unprognostic (5.76e-2),unprognostic (3.00e-4),unprognostic (9.44e-3),unprognostic (6.55e-3),unprognostic (1.32e-1),unprognostic (1.32e-1),unprognostic (3.92e-1),unprognostic (1.80e-1),unprognostic (1.46e-1),unprognostic (1.22e-2),unprognostic (4.84e-2),unprognostic (1.67e-1),unprognostic (2.56e-1),unprognostic (2.65e-2),unprognostic (8.16e-2),0.1,0,0.3,0.1,0.2,0.4,0,0.6,0.5,0.1,0.3,0.8,0.2,0.4,0.2,0.7,0.1,0.1,0.1,0.5,0.3,0,0,0.1,0.2,0.2,0.2,0.4,0.2,0,0.1,0,0.1,0.4,0.4,0.3,0.2,0.1,0.2,0.2,0.3,0.2,0.2,0.3,0.1,0.2,0.4,0.2,0.1,0.1,0.1,0.1,0.1,0,0.9,0.1,0,0.1,0.2,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0,0,0,0,0,0,0.1,0,0,1.6,0.2,0,0,0,0,0,0,0.4,0.2,0.1,0,0,0.2,0.9,0.1,0,0,0.1,0,0.1,0,0.1,0.1,0,0.1,0.4,0,0.1,0.1,0,0,0.2,0,0.1,0,0.1,0,2,0.1,1.7,0,0.5,0.3,0,0.4,0.1,0.8,0.1,0.3,0.4,0.5,0.1,0.2,0.1,0.6,0.3,0,0.2,0,0.1,0.3,0.2,0.6,0.5,0.5,0.3,0.2,0.2,0.4,0.4,0.3,0.2,0.9,0,0,0,0,0,0,0,0,0,0,0.1,0.5,0.3,0,0,0,0,0,0,0,0,0,2.9,0.1,0.1,0,0,0,0.1,0,0,0.1,0,0.2,1.3,0.1,0,0,1.1,0,0.1,0.2,0,0.6,0,9.8,0.3,0.2,0,0,0.6,0,0,0,0,0,0,0,0.1,0,0,0.1,0,0,0,0,0.1,0.2,0.2,0,0,0,0.3,0,0,0
ENSG00000188784,PLA2G2E,,Phospholipase A2 group IIE,Q9NZK7,1,19920009-19923617,"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins","Inflammatory response, Lipid metabolism, Phospholipid metabolism",Hydrolase,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,8,lymphoid tissue: 2.5,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,HPA064085,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA064085: AB_2685188,,,,,,,,,,,,,,unprognostic (9.56e-2),,unprognostic (3.71e-2),,0,0,0.1,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0.2,0.1,0,0,0,0,0,0,0,0,0,2.5,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.2,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0.3,0.1,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000189129,PLAC9,,Placenta associated 9,Q5JTB6,10,80131682-80145359,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Fibroblasts: 926.5;Leydig cells: 873.5;Peritubular cells: 659.7;Sertoli cells: 295.9;Smooth muscle cells: 446.6,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Immune cell enhanced,Detected in single,,eosinophil: 1.0,Lineage enriched,Detected in single,6,granulocytes: 1.0,Cell line enhanced,Detected in many,,ASC diff: 98.5;ASC TERT1: 85.3;BEWO: 32.1;HSkMC: 28.7,Low region specificity,Detected in all,,,Region enriched,Detected in all,4,spinal cord: 37.9,HPA043469,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA043469: AB_10795770,unprognostic (1.72e-1),unprognostic (4.22e-2),unprognostic (5.01e-3),unprognostic (1.78e-2),unprognostic (2.76e-1),unprognostic (3.93e-1),unprognostic (5.57e-3),unprognostic (5.88e-3),unprognostic (8.45e-2),prognostic unfavorable (6.60e-4),unprognostic (1.30e-2),unprognostic (1.09e-1),unprognostic (4.23e-3),unprognostic (4.36e-2),unprognostic (1.01e-1),unprognostic (2.14e-1),unprognostic (2.82e-3),99.5,18.6,9,6.7,8.2,1.3,86.5,9.5,14.9,66.2,43.4,21.4,4,27.1,5.1,21.6,30.6,9.1,97.1,13.2,5.2,13.8,6.4,56.6,2.8,5.8,5.9,7.8,11.6,5.8,4.1,4.9,12.6,7.2,36.2,4.6,0.6,20.3,7.7,17,43.8,19.9,6.5,5.2,5,21.6,15,5.4,2.2,45,19.4,2,54.5,76.4,7.6,0.2,0,0.8,0,98.5,85.3,32.1,10.3,8.7,0.9,1.2,0,0.7,0,0.2,6,0.1,0.8,0.1,0,0,0.8,0.3,0,0.5,0,16.4,0,2.3,28.7,0,2.1,1.2,10.6,3.4,0.4,0,0.4,0,0.3,0.1,0.6,1.9,0.4,1.5,0,0.1,1.5,0,0.6,0,1.8,0,1.2,0.7,0.2,0.1,0.2,3.6,6.6,3.6,21,0.2,0.7,0.9,0.1,1.9,0.3,0,0,0,1,0,0,0.1,0,0,0.1,0,0,0,0,0.5,0,0,0.1,0.1,0,9,8.2,9.5,14.9,13.2,5.2,5.8,5.9,7.8,7.2,5.2,5.4,7.6,246.2,3.2,1.8,0,1.6,126.4,0.7,1.1,8,0.4,7.4,14,24.4,0,0.3,0,0,7,3.6,0.1,0,0.3,4.6,3.1,75.7,102.5,1.8,0,0.5,0.2,17.7,926.5,5.6,4.4,1.3,0.1,115.6,0.3,14.1,0,0.5,0,0,0,191.3,26.7,873.5,7.9,136.9,7.5,0,50.2,0,0,0.2,0.7,0,659.7,2.1,1,0,0.2,0.9,1.7,295.9,89.7,446.6,2.6,2.9,4.6,126.3,11.5,14.1,1.1,0,1.8
ENSG00000203837,PNLIPRP3,,Pancreatic lipase related protein 3,Q17RR3,10,116427847-116477957,"Enzymes, Metabolic proteins, Predicted secreted proteins","Lipid degradation, Lipid metabolism",Hydrolase,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in some,,breast: 9.1;skin 1: 14.3,Cell type enhanced,Detected in some,,Basal keratinocytes: 1.1;Early spermatids: 1.5;Late spermatids: 1.9;Melanocytes: 1.8,Cancer enhanced,Detected in some,,head and neck cancer: 4.8,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,18,hTCEpi: 320.3,,,,,Not detected,Not detected,,,"HPA046202, HPA052009",Uncertain,,,,Secreted - unknown location,NA,NA,,,,,"HPA046202: AB_10959739, HPA052009: AB_2681692",,,,,unprognostic (2.62e-4),unprognostic (1.60e-1),,,unprognostic (6.97e-2),,,,,,,,,1.3,0.1,0,0,0,0,9.1,0,0,0.4,0,0.1,0,0,0,2.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0.9,0,0,14.3,0,0,0,0,0.3,0.1,0,0,0,0,0,0.3,3,0,0,0,0,0,2.1,0,0,0,0,0,0,0,0,0,0,0,0.9,0.5,0,1.5,0,0,0,0,0,0,0,0,0,0,320.3,0,4.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,17.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.1,0,0.9,0,0,0,0,0.2,0,0.4,0,0,0,0,0,0,0,1.5,0,0,0,0,0,0.4,0.6,0,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,1.9,0,0,1.8,0,0,0,0,0,0.1,0.2,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0.1,0,0.4,0,0,0,0,0
ENSG00000132000,PODNL1,"FLJ23447, SLRR5B",Podocan like 1,Q6PEZ8,19,13931187-13953392,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Basal respiratory cells: 13.4;Bipolar cells: 38.7;Leydig cells: 18.3;Peritubular cells: 38.0,Low cancer specificity,Detected in many,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,fHDF/TERT166: 6.6;HSkMC: 11.6;hTERT-RPE1: 18.8;SiHa: 9.7;U-2 OS: 6.7,Not detected,Not detected,,,Region enriched,Detected in some,11,spinal cord: 18.9,HPA042807,Approved,,,,Secreted - unknown location,NA,NA,,,,,HPA042807: AB_10795514,unprognostic (1.24e-1),unprognostic (4.94e-2),unprognostic (8.08e-3),unprognostic (2.13e-1),prognostic unfavorable (5.61e-8),unprognostic (1.78e-1),unprognostic (1.86e-2),unprognostic (3.68e-1),unprognostic (2.02e-1),unprognostic (3.08e-3),unprognostic (4.37e-2),unprognostic (1.01e-1),unprognostic (0.00e+0),unprognostic (3.94e-3),unprognostic (1.79e-1),unprognostic (4.99e-2),prognostic unfavorable (4.49e-4),1.8,0.7,2.1,0.9,1.7,0.5,5,2.2,1.6,4.8,0.9,2.2,0.4,1.5,0.3,8.3,2.1,1.4,4.2,1.1,3.5,1.6,0.5,5.1,0.2,4.4,4.1,0.9,3.3,1.5,0.1,5.1,3.7,2.8,8,0.3,2,5.3,0.9,1.6,11.5,2.3,0.5,2.6,1,1.7,7.3,3.2,0,3.1,1.3,0.2,2.7,12.1,3.2,0.3,0.4,0.4,0.2,0.6,1.5,0.1,4.1,2.4,0.8,1.6,0.3,0.4,0.2,0.3,6.6,0.2,1.6,0.1,0.1,0.4,1.5,0.6,0.8,0.4,0,5.1,0.2,0.5,11.6,0.7,1.1,0.1,18.8,0,0.1,0.4,0.3,1.6,2.7,0.2,0.2,0.1,0.3,0.4,0.1,0.1,0,0.3,0,0.7,0.4,9.7,0.1,0.3,0.4,0.1,0.5,0.7,2,6.7,0.5,0.2,0.3,0,0.1,0.8,0.9,0.2,0,0.1,0,0,0.1,0,0,0,0,0.3,0,0,0,0.1,0.1,0,0,0,0,2.1,1.7,2.2,1.6,1.1,3.5,4.4,4.1,0.9,2.8,2.6,3.2,3.2,1.4,0,0.5,2.3,0,1.3,0.9,13.4,0,38.7,2.1,8,1.6,0,1.4,0,2.1,0.4,0.2,1.8,0,0.2,1.7,0.5,6.1,0.9,0,2.7,0.5,0,0.2,4.7,0,0.4,0,0.5,0.7,0.1,9.8,1.7,0.7,1.1,0,1.2,1.7,2.1,18.3,0.9,1.8,1.9,0,1.8,0,1.5,0.3,0.6,9,38,0,0.5,0.6,0.1,1.4,4.6,0,0.6,1,1,0.7,2.6,4.3,0.8,0.2,0.1,1.4,1.6
ENSG00000164099,PRSS12,"BSSP-3, MRT1",Serine protease 12,P56730,4,118280038-118353003,"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins",,"Hydrolase, Protease, Serine protease",Mental retardation,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1,Low cancer specificity,Detected in many,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,HPA035054,Uncertain,,Approved,"Nucleoplasm,Actin filaments",Secreted - unknown location,NA,NA,,,Actin filaments,Nucleoplasm,HPA035054: AB_10603990,unprognostic (4.30e-2),unprognostic (1.04e-2),unprognostic (2.55e-1),unprognostic (4.41e-2),prognostic favorable (2.66e-4),prognostic favorable (1.03e-4),unprognostic (4.21e-1),unprognostic (3.48e-2),unprognostic (7.83e-2),unprognostic (6.38e-2),unprognostic (1.09e-1),unprognostic (1.27e-1),unprognostic (2.41e-2),unprognostic (1.29e-1),unprognostic (1.85e-1),unprognostic (9.55e-2),unprognostic (1.09e-1),0.6,0.5,1.4,1.6,0.9,0.1,2.3,0.7,1.4,14.5,11.6,6.8,2.7,1.9,0.7,3.3,10.6,9.9,0,2.8,0.6,0.8,0.6,7.6,0.1,0.5,1.8,0.5,1.7,7.7,0.1,0.6,10.7,0.5,1.4,6.4,0.3,2.5,2,0.2,6,4.8,1.3,0.5,0,9.3,10.1,0.8,1,0.2,1.3,5.8,3.9,12.7,0.6,5.2,0.2,1.8,0,0.2,13.3,0.1,46,41.5,9.7,16.1,0.1,18.7,0,0.2,70.2,4.9,0.8,31.1,9.5,12.7,0.2,7.2,0,3.6,0,1.4,0,0.2,4.1,17.5,3.4,9.9,31.2,0.1,0.6,0,0,8,0.3,0.5,9.6,2.2,36.4,2.9,0,38.7,0,0,7,5.1,215.4,0,0.2,3,30.9,0,100.6,0,19.2,2.8,12.2,9.1,1,0.1,0,1,3.3,11.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4,0.9,0.7,1.4,2.8,0.6,0.5,1.8,0.5,0.5,0.5,0.8,0.6,0.3,6.4,4.6,0.7,0.2,8.4,0.8,16.4,2.2,0.6,0.8,0.8,1.4,10,34.3,1.8,0,48,0,26.8,0,0.4,9.9,19.7,16.8,0.9,5.3,0,10.5,10.2,4.5,7.1,17.9,2.6,7,3.3,0,0.4,3.8,0,14.3,2.7,10.2,0,4.2,18.3,0,0.4,5.4,7.5,0,0,0,0.5,0.2,8.1,12.8,0,0.2,0.4,9.4,0.6,76.1,0.2,0,0.6,4.9,10.1,13.3,3.6,4.3,11.9,0.7,21.8,5.3,4.7
ENSG00000189099,PRSS48,ESSPL,Serine protease 48,Q7RTY5,4,151277171-151291453,"Enzymes, Predicted membrane proteins, Predicted secreted proteins",,"Hydrolase, Protease, Serine protease",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in some,4,choroid plexus: 15.1,Group enriched,Detected in some,4,Excitatory neurons: 2.2;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 3.7;Sertoli cells: 6.6;Spermatocytes: 3.1;Spermatogonia: 4.0,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in all,,,HPA053801,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA053801: AB_2682267,,,unprognostic (9.68e-2),,unprognostic (1.35e-2),,,unprognostic (2.15e-1),,unprognostic (2.18e-2),,,,unprognostic (3.76e-2),unprognostic (4.10e-2),,,0,0,1.5,0,1.5,0,0,2.4,1.1,0,15.1,0,0,0,0,0,0,0,0,0.8,1.6,0,0,0,0,2.7,2.1,0.3,0,0,0,0,0,3.4,0,0,0.1,0,0,0,0.3,0,0,0.6,0,0,0.7,1.3,0,0,0,0,0,0,2.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.2,0,0,0,0,0.1,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.5,1.5,2.4,1.1,0.8,1.6,2.7,2.1,0.3,3.4,0.6,1.3,2.6,0,0,0,0.3,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.2,0.1,0,0,0,2.2,0,0,0.2,0,0.3,0,0.1,0,0,0,0,1.1,0,0,0,0,0,0,0,0,0,0,0.3,0,8.5,3.7,0,0,0,0,0,0,0,0,0.2,6.6,0.1,0,3.1,4,0,0,0,0,0,0,0
ENSG00000052344,PRSS8,,Serine protease 8,Q16651,16,31131433-31135727,"Enzymes, Predicted membrane proteins, Predicted secreted proteins",,"Hydrolase, Protease, Serine protease",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,salivary gland: 247.5,Cell type enhanced,Detected in many,,Distal enterocytes: 403.5;Extravillous trophoblasts: 648.4;Paneth cells: 262.6;Proximal enterocytes: 358.0;Syncytiotrophoblasts: 450.7,Low cancer specificity,Detected in many,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,BEWO: 243.7;CACO-2: 165.9;CAPAN-2: 111.9;hTCEpi: 157.8;OE19: 79.6;SK-BR-3: 186.3,Region enriched,Detected in single,8,hippocampal formation: 1.4,Low region specificity,Detected in single,,,HPA030436,Uncertain,,,,Secreted - unknown location,NA,NA,,4400000,,,HPA030436: AB_10602291,unprognostic (1.88e-1),unprognostic (2.97e-1),unprognostic (9.34e-2),unprognostic (4.08e-1),unprognostic (6.83e-2),unprognostic (5.07e-3),unprognostic (5.78e-2),unprognostic (2.05e-1),unprognostic (2.26e-1),unprognostic (4.51e-2),unprognostic (8.74e-3),unprognostic (1.58e-1),prognostic favorable (2.05e-10),unprognostic (1.89e-2),unprognostic (1.20e-1),unprognostic (1.31e-1),unprognostic (3.63e-3),0.8,0.4,0.4,15.1,0.3,0.2,25.7,2,0.7,31.3,5.3,128.3,157.2,10,114,137.3,15.6,48.1,0.4,0.7,0.2,82,28.2,54.5,0.3,0.4,0.4,0.2,0.6,140.6,56.5,8.5,51.4,0.7,49.4,73.3,0,247.5,8.6,0.3,115.5,153,3.6,0.2,0.2,157.5,0.5,0.2,15.5,51.2,0,11.9,5,56.5,0.4,63.4,0.2,0.1,0.2,0,0,243.7,0,0,0,0,165.9,111.9,0,1.3,0,0,73.5,0.1,69.7,0,0.3,0.4,0.1,0.3,6.5,0,0,0.3,0,157.8,0,2.4,0,0,0.1,1.9,0.1,0,68.1,0.6,1.4,20.5,79.6,0.1,0.5,0,1.2,7.5,13.1,0.9,0.7,0,186.3,0.1,18.8,42.8,0.8,0,0.1,1.9,0.6,0.4,0.3,0.5,0.1,0.1,0.2,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0.3,2,0.7,0.7,0.2,0.4,0.4,0.2,0.7,0.2,0.2,0.4,0.4,99.3,60.1,0,1,37.9,82.7,108.9,76.2,0.5,74.4,39.2,0.3,62.9,107.4,42.3,0,168.8,0.8,403.5,29.4,192.4,0,35.2,11.4,2.6,9.6,2.7,0.1,224.4,648.4,3.5,82.6,109.5,7,0,0,18.2,22.8,0,0.2,132.1,87.5,0.3,2.7,0,0.6,1.9,3.6,0,4.2,0.3,0,0,0,240.7,262.6,0,0.1,66,358,28.6,21.2,0.1,0,0.1,4.7,0,0.2,81.9,54,450.7,2.2,0,150.8,91
ENSG00000178597,PSAPL1,,Prosaposin like 1,Q6NUJ1,4,7430285-7434930,Predicted secreted proteins,"Lipid metabolism, Sphingolipid metabolism",,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Group enriched,Detected in some,13,skin 1: 93.8;stomach 1: 38.9,Cell type enriched,Detected in some,13,Gastric mucus-secreting cells: 41.8,Group enriched,Detected in some,5,head and neck cancer: 0.7;melanoma: 2.5;pancreatic cancer: 2.0;stomach cancer: 3.0;urothelial cancer: 1.0,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4,CACO-2: 16.6;OE19: 32.2;RPMI-8226: 24.7,Not detected,Not detected,,,Not detected,Not detected,,,"HPA038013, HPA038482",Approved,,Enhanced,Cytosol,Secreted - unknown location,NA,NA,,31000,Cytosol,,"HPA038013: AB_10673652, HPA038482: AB_2676037",,unprognostic (2.64e-2),,,,unprognostic (2.40e-1),,unprognostic (9.33e-2),unprognostic (2.40e-1),unprognostic (2.61e-1),unprognostic (7.90e-3),unprognostic (2.52e-1),,unprognostic (2.08e-2),unprognostic (2.75e-1),,unprognostic (2.63e-3),0.2,0,0,0,0.2,0,5,0,0.2,0,0,0,0,0,0,0.1,0,0,0,0.2,0,0,0,0.1,0,0.2,0.1,0,0,0,0,0,0,0.6,0,0,0,0,0,0.2,93.8,0,0,0,0,38.9,3.5,0.1,0.2,0,0,3.1,0,0.2,0.7,0,0.6,0,0,0,0,0.2,0,0,0,0,16.6,0,0,0,0,0,4.4,0,0.1,0,0,0,0,0,0,0,0,2.4,0,5.5,0,0,0,0,0,0,0,0,0,0,0,0,32.2,0,0,0,24.7,0,0,0,0,0,1.5,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0.2,0.2,0,0.2,0.1,0,0.6,0,0.1,0.7,0,0,0,0.3,0.2,0.1,0,1.8,0,0,0,0,0.3,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.2,41.8,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,3.1,0,0,0,0,0
ENSG00000105426,PTPRS,,Protein tyrosine phosphatase receptor type S,Q13332,19,5158495-5340803,"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins",Cell adhesion,"Heparin-binding, Hydrolase, Protein phosphatase, Receptor",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Excitatory neurons: 76.8;Inhibitory neurons: 104.2;Melanocytes: 80.0;Oligodendrocytes: 90.2,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Immune cell enriched,Detected in single,89,plasmacytoid DC: 12.5,Lineage enriched,Detected in single,89,dendritic cells: 12.5,Cell line enhanced,Detected in many,,AN3-CA: 121.8;HaCaT: 124.6,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA054747,,,Approved,"Plasma membrane,Cytosol",Secreted - unknown location,NA,NA,,150000000,"Plasma membrane, Cytosol",,HPA054747: AB_2682591,unprognostic (8.14e-2),unprognostic (4.59e-3),unprognostic (2.57e-2),unprognostic (9.20e-2),unprognostic (2.15e-1),unprognostic (6.96e-3),unprognostic (6.85e-2),unprognostic (2.36e-1),unprognostic (3.12e-3),unprognostic (1.86e-1),prognostic favorable (1.07e-4),unprognostic (1.25e-1),prognostic unfavorable (1.70e-4),unprognostic (2.80e-1),unprognostic (1.45e-1),unprognostic (4.05e-1),unprognostic (3.46e-2),55.2,21.3,30.4,5.1,21,1.5,36.5,1,20.8,38,0,20.5,2.6,30.7,2.2,16.7,41.5,13.8,26.1,28.8,6.7,11.2,6.1,27.1,5.6,14,13.8,21.7,36.1,32.7,9.8,29.3,2.3,22.7,30.8,1.6,5.8,18.7,14.8,14.5,19.9,13.7,8.6,0.6,9.1,23.4,10,24,4.2,29.6,7.5,4.4,32.3,32.1,30.8,11.3,64,56.2,121.8,25.3,20.5,7.4,19.4,22.5,22.8,18.5,0.7,6.2,0.2,44.5,32.2,18,124.6,15.1,0.2,10,1.5,24.3,0,27.2,40.5,11.7,0,14.1,21.8,5.4,4.8,0.9,29.4,0.6,7.9,18.5,0.2,9.1,48,5.2,12.3,31.7,0.4,27,0,12.4,0,4.7,22.5,43.1,58.9,18.3,3.4,34.6,10.7,22,4.8,2.8,20.2,34.3,46.9,23.6,6.2,0.1,36.9,10.5,0,44.6,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,12.5,0,0,30.4,21,1,20.8,28.8,6.7,14,13.8,21.7,22.7,0.6,24,30.8,1.1,6.4,1.1,53.8,3.2,60.9,42.4,16.1,22.2,49.6,3.3,5.5,14.1,27.1,4.9,12.9,2.1,0.7,56.4,0.1,9.8,1.4,3.4,5.4,11.4,9.7,3,0,76.8,0.9,32.2,51.2,5.1,5.3,0,4,25.4,20.2,1.7,11.8,104.2,0,10.2,0.3,20,5.4,46.6,3.4,80,15.9,0.8,46.6,0,71.9,90.2,0.5,0,36.1,6.3,35,0,2.9,1.7,10.1,13.1,46.4,22.6,7.4,14.8,16.8,36.7,1,2,2.7,0.4,30
ENSG00000251692,PTX4,C16orf38,Pentraxin 4,Q96A99,16,1485886-1488981,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.8,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,7,HL-60: 21.2;NB-4: 15.7,Region enhanced,Detected in single,,hypothalamus: 1.0,Low region specificity,Detected in all,,,HPA073694,Supported,,,,Secreted - unknown location,NA,NA,,,,,HPA073694: AB_2732237,unprognostic (1.04e-1),unprognostic (2.66e-1),unprognostic (1.54e-2),unprognostic (1.55e-2),unprognostic (1.12e-1),unprognostic (1.84e-4),unprognostic (3.98e-2),unprognostic (5.66e-2),unprognostic (1.10e-1),unprognostic (3.09e-1),unprognostic (1.39e-2),unprognostic (3.54e-1),unprognostic (1.52e-4),unprognostic (2.23e-3),unprognostic (4.53e-1),unprognostic (1.71e-1),unprognostic (1.03e-1),0,0.2,0.5,0,0.2,0.7,0,0.7,0.3,0,0.1,0,0.1,0,0,0,0.1,0,0,0.2,0.7,0,0,0,0,1,1.2,0,0,0,0,0,0,1.8,0.1,0,0,0,0,0.1,0,0,0,0,0.1,0,0.5,1.1,0,0,0,0,0,0,0.2,0,0,0,0.1,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,21.2,0.1,0,0,0.2,0,0,0.1,0,0,0,0,0.3,0,15.7,0.1,0,0.1,0.8,0,0,0,0,0.4,0,0.2,0.1,0,0,0,0,0.1,0,0,0.3,0,0,0,0,0,2.8,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0.5,0.2,0.7,0.3,0.2,0.7,1,1.2,0,1.8,0,1.1,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000073008,PVR,"CD155, HVED, Necl-5, NECL5, PVS, Tage4",PVR cell adhesion molecule,P15151,19,44643798-44666162,"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins","Cell adhesion, Host-virus interaction","Host cell receptor for virus entry, Receptor",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Cell type enhanced,Detected in many,,Pancreatic endocrine cells: 69.6,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Group enriched,Detected in some,4,classical monocyte: 4.5;intermediate monocyte: 4.5;myeloid DC: 3.8;non-classical monocyte: 5.5,Group enriched,Detected in many,4,dendritic cells: 3.8;monocytes: 5.5,Cell line enhanced,Detected in many,,TIME: 175.3,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA012568, HPA064739",Approved,,Supported,"Nucleoplasm,Vesicles,Plasma membrane",Secreted - unknown location,NA,NA,,720000000,"Nucleoplasm, Vesicles, Plasma membrane",,"HPA012568: AB_1846248, HPA064739: ",unprognostic (2.90e-3),prognostic unfavorable (1.29e-4),unprognostic (3.36e-1),unprognostic (2.34e-1),unprognostic (7.89e-2),unprognostic (2.45e-3),unprognostic (3.06e-2),prognostic unfavorable (9.30e-4),unprognostic (9.05e-3),unprognostic (1.69e-1),unprognostic (2.09e-3),unprognostic (2.64e-3),unprognostic (1.69e-1),unprognostic (4.97e-1),unprognostic (1.27e-1),unprognostic (1.04e-3),prognostic unfavorable (2.75e-4),11.2,17.6,9.4,7.1,9.3,5.2,9.6,8.5,10.2,8.6,9,9.9,12.6,14.1,5.3,8.5,11.9,6.3,24.7,9.3,13.5,12.4,31,19.6,2.8,9.8,9.1,9.5,12.6,14.1,10.4,17.4,12.6,11.1,9.8,8.9,5.4,10,6.5,19.1,7.1,11.1,10.6,7.1,4.6,12.4,5.8,13.4,2.5,10.7,6.2,2.9,9.2,8.5,10.4,58.8,52.1,5.6,25,8.6,9.7,7.4,96.7,38.8,40.7,45.8,31.9,28.2,0.1,50.6,43.7,60.2,44.4,24.3,51.1,31.7,7.8,27.1,8.8,40.3,23.3,43.7,4.1,22.2,10.6,28,40.9,82.5,49.7,50.7,6.6,4.3,0.5,23.4,7.8,4.2,5.8,12.5,30.1,31.7,0.1,23.2,5,111.8,25.5,21.2,22.9,66.3,54.3,14.7,7.2,22.8,12.5,175.3,39,52.8,33.7,78.2,0.3,6.3,0.2,35.3,23.4,24.6,0.2,4.5,0,0.1,4.5,0,0,0,0.2,3.8,0,0.2,0.1,1.1,0.7,5.5,0.5,0,1.7,9.4,9.3,8.5,10.2,9.3,13.5,9.8,9.1,9.5,11.1,7.1,13.4,10.4,11.1,16,25.2,2.3,1.6,3.6,16,6.9,4,5.7,4.7,3.4,14.4,14.3,12.2,1.8,2.1,2.9,0.2,18.5,3.9,37.9,10.5,5.4,6.3,20.4,13.1,2.1,11.4,35.3,34.8,7.7,13.7,11.6,1.3,6.5,7.9,41.1,8.4,1.7,13.7,11.3,2,8.9,7.5,14.3,5.6,6.8,1.8,5.6,17.2,1.8,2.1,6,4.6,69.6,18,15.8,0.2,14.4,10.8,5.7,2.8,3.4,0,23.8,10.4,10.4,1.5,5.8,5.5,1,0.9,10.8,12.7,7.4
ENSG00000101074,R3HDML,dJ881L22.3,R3H domain containing like,Q9H3Y0,20,44337043-44351238,Predicted secreted proteins,,Protease inhibitor,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,5,intestine: 2.4,Cell type enriched,Detected in single,5,Microglial cells: 1.0,Cancer enriched,Detected in single,5,colorectal cancer: 1.5,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,CACO-2: 1.0;OE19: 1.0,Not detected,Not detected,,,Low region specificity,Detected in many,,,HPA070264,Enhanced,,,,Secreted - unknown location,NA,NA,,,,,HPA070264: AB_2686244,unprognostic (1.89e-1),,unprognostic (2.23e-1),,,,unprognostic (9.86e-2),unprognostic (9.12e-2),unprognostic (6.06e-3),,unprognostic (2.64e-1),,,unprognostic (6.32e-2),unprognostic (4.95e-3),,,0,0,0.3,0.3,0.1,0.1,0,0.1,0.2,0,0,0.7,2.2,0,0,0,0.3,0,0,0.2,0.2,0.2,0.1,0.1,0,0.2,0.1,0,0.1,0,0,0,0,0.2,0,0,0.1,0,0,0,0.1,2.4,0,0,0,0.4,0.4,0.5,0,0,0,0,0,0,0.3,0,0,0.4,0,0,0,0,0,0,0,0,1,0.2,0.1,0,0,0,0,0,0,0,0.1,0.1,0,0.4,0.1,0,0,0.1,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,1,0,0,0,0,0,0,0,0.1,0,0,0.1,0,0,0,0,0.1,0.7,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0.1,0.1,0.2,0.2,0.2,0.2,0.1,0,0.2,0,0.5,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0.1,0.2,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,1,0,0,0,0,0.1,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0
ENSG00000203722,RAET1G,ULBP5,Retinoic acid early transcript 1G,Q6H3X3,6,149916878-149923121,"Predicted membrane proteins, Predicted secreted proteins","Host-virus interaction, Immunity",,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,,adrenal gland: 8.5;esophagus: 15.2,Cell type enhanced,Detected in some,,Basal respiratory cells: 42.9;Club cells: 14.8;Ionocytes: 12.2;Respiratory ciliated cells: 23.3;Squamous epithelial cells: 8.9;Urothelial cells: 8.1,Group enriched,Detected in many,4,cervical cancer: 4.5;head and neck cancer: 4.7;lung cancer: 1.2;thyroid cancer: 1.5;urothelial cancer: 4.2,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,HeLa: 29.5;hTCEpi: 22.6;SiHa: 11.9;U-87 MG: 9.3,,,,,,,,,"HPA062673, HPA066741",,,Supported,"Vesicles,Plasma membrane",Secreted - unknown location,NA,NA,,,"Vesicles, Plasma membrane",,"HPA062673: , HPA066741: ",unprognostic (4.46e-3),unprognostic (4.92e-2),unprognostic (1.95e-1),unprognostic (1.21e-1),unprognostic (2.87e-3),unprognostic (1.49e-1),unprognostic (4.61e-3),prognostic unfavorable (5.35e-4),unprognostic (3.05e-1),unprognostic (1.57e-1),unprognostic (1.43e-1),unprognostic (1.38e-2),unprognostic (1.33e-1),unprognostic (1.49e-2),unprognostic (2.48e-1),unprognostic (8.85e-2),unprognostic (9.11e-2),1.5,8.5,0.6,0.4,0.6,0,0.6,0.1,0.7,2.3,0,0.2,0.1,0.3,0.7,15.2,0.6,0.7,0.4,0.5,0.3,0.5,0.1,0.5,0.1,1,0.6,0.4,0.7,0.1,0.2,0.3,0.1,0.6,0.7,0.1,0.1,3.7,1,0.2,2.7,0.2,0.6,0.1,0.1,0.4,0.3,0.6,0,0.5,0.1,1.1,1.8,6.1,0.3,1,1.4,0,1.7,2.3,1.7,0,0.8,3,1.3,1.9,0,1.5,0,0.6,1.7,1.4,2.7,0.9,5.3,1.1,0.3,1.6,0.5,29.5,0,0.7,0,0,3.3,22.6,3.5,1.7,1.5,0.3,0.7,0.3,0.2,0.6,1.3,0,0,0,0.3,2.3,0,0,0,1,3.2,0.3,0.3,11.9,0.5,0,0.1,0.4,0.4,1.6,0.6,0.5,1.6,0.8,0,0,0,9.3,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.6,0.6,0.1,0.7,0.5,0.3,1,0.6,0.4,0.6,0.1,0.6,0.3,1.4,0,0,0,0,3.1,5.1,42.9,2.8,0,0.4,0.4,0.1,1.5,14.8,0,0,0,0.2,0.1,0,0.2,0.1,0.4,0.1,1.3,0,0,0,1.3,0,1.9,0,0.1,0,0,0.7,0,0.1,0,0,0,12.2,0,0.7,0.1,0.9,0,3.6,0,0,0.8,0,0,0,1.2,0,0,0,0.4,0,0,23.3,0,0,0.2,1.1,0,0.3,8.9,1.7,0.1,0.3,0.5,0,8.1
ENSG00000182175,RGMA,RGM,Repulsive guidance molecule BMP co-receptor a,Q96B86,15,93035273-93089204,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,skeletal muscle: 200.7,Cell type enhanced,Detected in many,,Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3,Cancer enriched,Detected in many,6,glioma: 26.0,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"CAB012343, HPA039880, HPA044222",Approved,,Approved,"Nucleoplasm,Cytosol",Secreted - unknown location,NA,NA,,2000000,Nucleoplasm,Cytosol,"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861",unprognostic (3.21e-2),unprognostic (1.59e-1),unprognostic (8.85e-2),unprognostic (3.96e-3),unprognostic (5.73e-2),unprognostic (4.72e-3),unprognostic (2.53e-2),prognostic favorable (2.78e-4),unprognostic (2.19e-2),unprognostic (1.12e-1),unprognostic (2.11e-1),unprognostic (6.25e-2),unprognostic (3.59e-4),unprognostic (8.11e-2),unprognostic (2.92e-2),unprognostic (1.73e-1),unprognostic (7.98e-5),25.6,3.2,56,22.8,56.1,0.4,30.5,69.6,59.5,56.3,0.4,62.2,9.9,51.3,2.9,57.9,40.2,7.8,22.5,51.6,55.1,3.7,0.6,4.7,2.5,116.8,94.1,21.7,38.8,11.5,0.8,6.9,1.3,77.6,12.9,6.3,1,24.4,6.4,200.7,16.5,43.3,61.2,76.4,1.3,74.2,33.7,100.7,2.6,10.1,45.4,3.4,10.1,29.5,62.9,2.1,0.3,50,0.8,10.3,5.7,14.6,0.3,0,0,0,0.6,0.6,0.1,0.2,0.4,0,3.4,8.4,0.2,0,0,9.2,0.1,0.3,0,0,0.1,0.2,6.1,0.2,0,0,0.3,0,0.9,0,0.1,0,1,15.5,0.2,22.2,0.1,0,13.1,11.4,0.1,0,0.5,5.1,3,0.5,0.2,0,2.6,4,2.7,0,0.1,10.4,0.3,0.1,0.1,0,0.2,0.2,0.2,1.3,0.1,0,0,0,0.1,0,0,0,0,0,0.1,0,0,0.2,0,0,0,0,0,56,56.1,69.6,59.5,51.6,55.1,116.8,94.1,21.7,77.6,76.4,100.7,62.9,4.2,0,1.5,143.3,0.5,5.5,20.4,10.2,40.5,1.9,7.5,4.4,4.4,0,3.9,0,2.1,4.4,0.5,0.3,0,6.5,1.2,0.6,10.9,2.7,0,0.4,16.8,0.7,1.2,40.5,1.5,2.3,0,0.6,1.8,0.3,2.1,0,2.8,0,12.2,2.5,2.3,6.4,119,1.6,3.6,9.4,0.6,4.5,0,11.1,1.6,0.4,0,116.9,0.1,61.3,0,0.1,1.3,1.2,13.1,69.3,20.3,0.9,43.8,58.3,2.8,2.5,1.4,0.1,0.1,29.2
ENSG00000182545,RNASE10,"RAH1, RNASE9",Ribonuclease A family member 10 (inactive),Q5GAN6,14,20505537-20511169,"Predicted intracellular proteins, Predicted secreted proteins","Cell adhesion, Fertilization",,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,brain: 5.1,Not detected,Not detected,,,Group enriched,Detected in some,5,head and neck cancer: 2.0;testis cancer: 1.8,Low region specificity,Detected in all,,,Immune cell enhanced,Detected in single,,basophil: 1.1,Low lineage specificity,Detected in single,,,Cell line enhanced,Detected in many,,SiHa: 7.2;U-2 OS: 10.8,Not detected,Not detected,,,Low region specificity,Detected in all,,,HPA052593,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA052593: AB_2681878,unprognostic (2.48e-3),unprognostic (2.22e-1),unprognostic (2.46e-2),unprognostic (1.17e-1),unprognostic (1.74e-1),unprognostic (5.91e-3),unprognostic (5.03e-3),unprognostic (5.58e-3),unprognostic (4.20e-2),unprognostic (3.04e-1),unprognostic (1.98e-3),unprognostic (1.11e-1),unprognostic (7.88e-4),unprognostic (1.58e-1),unprognostic (3.62e-1),unprognostic (8.76e-2),unprognostic (2.58e-1),2.1,1.8,3,1.6,3.1,1.1,0.4,2.5,4.2,0.5,2.8,0.7,1.6,2,1.1,1.1,1.1,0.6,0.4,3.1,2.4,0.9,0.8,1.6,0.8,3.6,2.9,2.4,1.1,0.4,0.4,0.5,0.8,3.2,1.2,0.4,0.5,0.9,0.7,2,2.5,1.7,0.5,1.7,1.3,1.1,1.9,3.5,0.5,0.7,0.2,0.4,0.7,0.5,5.1,4.4,2,0.9,1.9,0.2,0.4,2.8,0.2,0.4,0.1,0.3,0.9,1.2,0.5,1.3,0.5,0.6,2.3,0,0.3,0.1,1.7,0.7,0,1.5,0.6,0.5,0.1,2,0.7,1.5,0.1,2.3,0.4,1,0.7,1,2.3,0,1.2,0.7,1.1,0.5,0.6,0.2,3.3,0.3,2.6,0.7,1.8,1.1,1.4,7.2,1.7,0.9,0.9,1.6,0.7,0.4,0.7,10.8,0.9,0.8,2.2,0.9,0.2,0.8,0.6,0.9,1.1,0.1,0,0.1,0.1,0.1,0.2,0,0,0,0.1,0,0.1,0.4,0.1,0.3,0.3,0,0,3,3.1,2.5,4.2,3.1,2.4,3.6,2.9,2.4,3.2,1.7,3.5,5.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0,0.1
ENSG00000176393,RNPEP,APB,Arginyl aminopeptidase,Q9H4A4,1,201982372-202006147,"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins",,"Aminopeptidase, Hydrolase, Metalloprotease, Protease",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Cell type enhanced,Detected in all,,Proximal enterocytes: 201.7,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in all,,,Group enriched,Detected in all,4,dendritic cells: 19.8;granulocytes: 22.9;monocytes: 29.9,Low cell line specificity,Detected in all,,,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA036074, HPA036075, HPA061487",Approved,,Approved,Golgi apparatus,Secreted - unknown location,NA,NA,,7800000,Golgi apparatus,,"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537",unprognostic (8.57e-2),unprognostic (3.43e-2),unprognostic (2.81e-1),unprognostic (5.45e-2),unprognostic (2.68e-1),unprognostic (1.74e-2),unprognostic (1.95e-2),unprognostic (2.87e-2),unprognostic (1.93e-3),unprognostic (1.80e-1),unprognostic (1.07e-1),unprognostic (1.28e-1),unprognostic (3.50e-3),unprognostic (1.91e-1),unprognostic (6.00e-2),unprognostic (1.97e-2),unprognostic (1.68e-1),25.4,31.4,7.3,23,7.4,25.5,26.1,7.9,8.6,25,14.3,54.1,69.1,25.9,39.4,54.3,40.9,22.5,14.7,7.9,10.3,26.1,32.6,30.8,22.2,9.1,8,6.1,23.6,34.4,25.6,13.4,27.7,8.7,26.2,57.5,4.3,38.6,27.8,19,37.3,58.6,28.3,9,33.7,28.8,18.1,9.4,21.9,33.5,12.8,26.7,23.5,29,10.2,66.2,71,40.8,62.7,65.1,61.3,102.1,49.5,95.6,60.9,67.6,51.8,83.1,14.3,61.8,87.8,38,117.4,52.5,97.2,42.4,39.1,67.6,35.5,32.5,48.7,55.1,92.3,121.3,55.9,97.9,54.1,62,74.7,110.6,34.8,82.5,21.6,62.1,61,12.8,40.2,58.4,105.4,34.4,48.3,57.5,101.6,128.7,61.2,46.9,39.9,122.2,155.9,52.1,78.9,116.6,52.4,79.9,28.9,38,28.7,61.3,45.3,39.6,12.9,27.8,77.3,58.1,22.9,14.9,22.1,3,25.9,4.1,2.5,3.2,3.4,19.8,4.6,2.8,3.2,11,2.9,29.9,7.2,5.4,4,7.3,7.4,7.9,8.6,7.9,10.3,9.1,8,6.1,8.7,9,9.4,10.2,26.7,9.6,21.5,8.5,19.7,28.8,40.5,31.2,40.5,15.5,32.8,33.1,12.2,38.6,26.7,25.8,10.4,116.6,21.4,136.6,19.6,71.1,5.4,35.9,17.7,26.1,44.9,19,12.7,51.2,91.1,26.1,45.3,21.5,15.2,23.2,27.1,51.4,103.7,11.8,11.1,71.9,14.2,81,39.4,4.9,25.4,72.9,24.9,15,86.7,12.6,17.5,5.5,8.1,47.8,83.4,23,23.6,25,201.7,65.8,39.1,8,26.3,11.4,28.2,22.7,9.5,53.6,21.6,87.6,17.7,33.2,86.6,34.8
ENSG00000189001,SBSN,"HLAR698, UNQ698",Suprabasin,Q6UWP8,19,35523367-35528351,"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,esophagus: 1064.7;skin 1: 2395.8;vagina: 762.7,Cell type enriched,Detected in some,11,Suprabasal keratinocytes: 1017.6,Cancer enhanced,Detected in many,,head and neck cancer: 355.2;melanoma: 153.1,Region enhanced,Detected in some,,basal ganglia: 3.7,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,ASC diff: 62.2;ASC TERT1: 107.5;HSkMC: 146.1;U-2197: 51.6;U-87 MG: 119.9,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,"HPA062568, HPA067734",Enhanced,,Approved,Vesicles,Secreted - unknown location,NA,NA,,89000000,Vesicles,,"HPA062568: AB_2684794, HPA067734: AB_2685894",unprognostic (1.10e-1),unprognostic (1.01e-1),unprognostic (2.02e-2),unprognostic (1.21e-1),unprognostic (1.73e-1),unprognostic (1.83e-2),unprognostic (1.23e-3),unprognostic (3.45e-3),unprognostic (2.56e-1),unprognostic (4.83e-4),unprognostic (4.31e-4),unprognostic (6.97e-2),unprognostic (9.08e-14),unprognostic (6.37e-2),unprognostic (6.51e-3),unprognostic (2.09e-1),unprognostic (1.36e-3),2.4,0.6,0.4,0.1,3.7,0.8,95.4,0.4,1.1,222.6,0.2,0.8,0,0.5,0,1064.7,0.2,0.3,1.3,0.5,0.6,0.4,1.7,0.9,0,0.8,0.4,0.5,0.7,1.6,0,0.9,0.3,0.6,0.6,0,0,354.6,0,13.2,2395.8,0.7,0.2,0.4,0.5,1.1,1,0.4,6.6,0.7,0,170.4,1.2,762.7,0.5,0.1,0.1,0,0.1,62.2,107.5,0.1,5.1,7.2,2.4,0.9,0,0.1,0.1,1.2,4.8,1.7,0.3,0,1.8,1,0.1,0.2,0,0.1,0,0.6,0,0.1,146.1,8.2,30,7.1,2.1,0,0,0.1,0.3,0,0.4,0,0.1,0.1,0.3,0,0,0.1,0.1,0,0,0,0,0.2,0.1,1.4,0.3,0.2,0,0.4,18.4,3.8,51.6,1.4,0.5,0.3,0,119.9,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,3.7,0.4,1.1,0.5,0.6,0.8,0.4,0.5,0.6,0.4,0.4,0.5,0,0,0,0,0,89.3,0.1,0.6,0,0,0.1,0.1,0,0,1.5,0,0,0,0.1,0,0,0,0.9,1.4,0.8,1.8,0,0,0.2,0.6,0.2,3.1,0,4.2,0,0,0,0,0.1,0,0.1,0,0,0,25.2,4,0,0.2,14.2,0,0,0,0,0,0,0.9,0,0,0,1.5,0,0,0.1,0,0,0.1,1,0.2,0.2,13.4,1017.6,0.3,0.7,0,0,0.4
ENSG00000188076,SCGB1C1,RYD5,Secretoglobin family 1C member 1,Q8TD33,11,193078-194575,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enhanced,Detected in some,,brain: 1.3;pancreas: 1.4;retina: 3.4;salivary gland: 1.1,Cell type enriched,Detected in single,5,Macrophages: 2.7,Cancer enhanced,Detected in single,,ovarian cancer: 0.6,Region enhanced,Detected in single,,pons: 1.3,Group enriched,Detected in some,32,basophil: 5.0;neutrophil: 1.3,Lineage enriched,Detected in single,50,granulocytes: 5.0,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,Secreted - unknown location,NA,NA,,,,,,,,,,,,,,,unprognostic (5.09e-3),,,,,,,,0,0.1,0.1,0.1,0.1,0.7,0.1,0.5,0.4,0,0,0,0,0,0,0.1,0,0,0,0.1,0,0.2,0,0,0,0,0,0,0,1.4,0,0,0,1.3,0,0,3.4,1.1,0,0,0,0,0,0,0.1,0,0.1,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0.2,0,0,0.3,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,1.3,0,0,0,0,3.3,0.1,0.1,0.5,0.4,0.1,0,0,0,0,1.3,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0.5,0,2.7,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0
ENSG00000169291,SHE,,Src homology 2 domain containing E,Q5VZ18,1,154469772-154502412,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6,Cancer enhanced,Detected in many,,thyroid cancer: 8.7,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in many,,,Group enriched,Detected in some,7,HUVEC TERT2: 49.1;TIME: 13.6,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA037417,Approved,,Approved,"Nucleoplasm,Cytosol",Secreted - unknown location,NA,NA,,,Nucleoplasm,Cytosol,HPA037417: AB_10672384,unprognostic (3.24e-1),unprognostic (4.95e-2),unprognostic (7.06e-2),unprognostic (1.63e-1),unprognostic (1.80e-1),unprognostic (6.80e-3),unprognostic (7.24e-2),unprognostic (3.07e-3),unprognostic (3.10e-2),unprognostic (8.22e-2),unprognostic (4.04e-2),unprognostic (8.29e-2),unprognostic (2.40e-2),unprognostic (7.31e-2),unprognostic (1.62e-1),unprognostic (3.33e-3),unprognostic (1.33e-2),23.2,9.8,9.3,3.4,8.6,1.2,21.1,7.7,10.7,12,9.2,7.4,3.4,12.2,4.4,5.1,12.6,7,19.7,8.1,8.1,10.5,5.9,20.8,3.9,9,9,7,7.7,3,4.9,3.8,16.6,8.7,8.2,4.3,0.6,5.4,4.2,7.1,6.3,9,8.1,7.8,21.5,5.5,22.3,9.6,2.7,22.3,11.4,2.3,9.8,10,9.2,0.1,0,0.1,0,0,0,0.1,0,0,0,0,0,0.5,0.1,4.6,0,0,0,0.4,0,0,0,0,0,0.1,0.1,0,0.3,0,0,0,0,0,0,49.1,0,0.1,0.1,0,0,0,0.7,0.5,0,0,0,0,0.2,0,0,0,0,1,0.1,0,0.5,0,1,13.6,0,0.3,1.4,0,0.1,0.2,0.1,0,1,0,0.5,0.3,0.2,1.5,1.5,1.1,0.9,0.6,0.6,0.1,0.9,0.8,0.9,2.4,1.7,1.1,4,0,0.5,9.3,8.6,7.7,10.7,8.1,8.1,9,9,7,8.7,7.8,9.6,9.2,56.9,0,23.4,3.9,0.3,3.3,0.4,0.3,1.2,0.1,0.4,1.3,4.4,1.5,1.3,1.8,0,0,0.2,0,0,0.1,13,0.4,0.3,64.4,0,2.7,0.3,0,0,6.7,0,0.5,3.8,2.1,85.3,3.4,1.4,0,0.3,0,0,26.7,6.6,23,1.5,2,0,26.2,0,0.2,0,0,0,0,0,0.4,3.7,0.7,0,0.1,0,0.4,0,3.3,2.2,30.6,13,0.3,1.6,0.1,0.7,0.3,0,0.3
ENSG00000248771,SMIM31,LINC01207,Small integral membrane protein 31,A0A1B0GVY4,4,164754064-164803795,Predicted secreted proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in some,,gallbladder: 7.9;intestine: 24.8;prostate: 11.1,Group enriched,Detected in some,5,Exocrine glandular cells: 93.3;Pancreatic endocrine cells: 139.7,Cancer enhanced,Detected in many,,prostate cancer: 8.8,Not detected,Not detected,,,Immune cell enhanced,Detected in single,,basophil: 1.1,Low lineage specificity,Detected in single,,,Cell line enhanced,Detected in single,,RPTEC TERT1: 1.1,Not detected,Not detected,,,Low region specificity,Detected in some,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (2.84e-1),unprognostic (1.18e-1),unprognostic (2.47e-2),unprognostic (1.87e-4),,,unprognostic (2.95e-2),unprognostic (1.78e-1),,,unprognostic (4.17e-2),unprognostic (4.82e-1),,unprognostic (9.47e-2),,,unprognostic (5.63e-3),0.1,0.1,0.4,1.5,0.3,1,1,0.5,0.6,5.1,0.3,15.6,22.2,0.3,1,0.1,0.1,7.9,0.1,0.3,0.2,0.1,0.1,0.4,0.3,0.4,0.2,0.4,0.1,0.5,0.1,0,0.1,0.5,11.1,15.7,0.2,1.2,0.1,0.2,0.2,24.8,0.7,0.1,0.1,0.6,0.1,0.3,0,0.1,0,0.1,1.7,0,0.9,0.1,0.8,0,0.2,0,0.1,0.2,0.1,0,0,0,0.3,0.1,0.1,0,0,0,0.2,0,0.1,0,0,0.1,0,0.1,0,0.1,0.1,0.2,0,0,0,0,0,0,0.1,0.1,0.3,0,0.1,0.1,0.3,0.1,0.4,0,0.1,0,0.3,1.1,0.1,0.1,0,0.1,0.1,0.1,0.1,0.1,0.2,0.1,0.1,0,0.2,0.1,0.4,0.1,0.1,0.1,0.2,0.3,1.1,0.1,0.1,0.1,0,0,0.1,0,0.1,0,0.2,0.1,0.1,0.6,0.3,0.1,0.3,0,0,0.4,0.3,0.5,0.6,0.3,0.2,0.4,0.2,0.4,0.5,0.1,0.3,0.9,0.1,0,1.1,0,0,0,0,0,0,0,4.5,1.1,0,0,9.3,3.7,0,0.1,0,0,0,3.8,0,2.5,2.2,0.3,0,0,0,93.3,0,0.2,0,22.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,139.7,0,0,0,0,0,0.8,10.2,0,0,0,0.2,0,0,0,0,0.1,0.3,0.2,0,0
ENSG00000196800,SPINK14,SPINK5L2,Serine peptidase inhibitor Kazal type 14 (putative),Q6IE38,5,148169733-148175398,Predicted secreted proteins,,"Protease inhibitor, Serine protease inhibitor",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in some,,brain: 3.0;intestine: 1.0;liver: 1.1,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,4,OE19: 1.4,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (4.98e-2),,unprognostic (3.44e-1),,,,unprognostic (1.94e-2),unprognostic (2.96e-2),,,,unprognostic (5.69e-1),,unprognostic (1.48e-3),,,,0,0,1.4,0,1,0,0.8,0.4,3,0.5,0,0.5,0,0,0,0,0,0.2,0,0.8,0.8,0,1.1,0.1,0,1.6,2,0.9,0,0,0,0,0.2,2.1,0.1,1,0,0.5,0,0,0,0,0,1.2,0,0.5,0,1.3,0,0,0,0,0.1,0,2.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4,1,0.4,3,0.8,0.8,1.6,2,0.9,2.1,1.2,1.3,2.1,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1
ENSG00000178172,SPINK6,"BUSI2, MGC21394, UNQ844",Serine peptidase inhibitor Kazal type 6,Q6UWN8,5,148202794-148215137,Predicted secreted proteins,,"Protease inhibitor, Serine protease inhibitor",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,,lymphoid tissue: 4.9;salivary gland: 6.9;vagina: 10.2,Cell type enhanced,Detected in some,,Basal keratinocytes: 1.5;Hofbauer cells: 2.8;Oligodendrocyte precursor cells: 1.0;Prostatic glandular cells: 5.2,Group enriched,Detected in many,6,cervical cancer: 21.4;head and neck cancer: 21.0,Region enhanced,Detected in some,,cerebellum: 2.7,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,74,HeLa: 3708.0;SiHa: 2339.1,Not detected,Not detected,,,Not detected,Not detected,,,HPA011039,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA011039: AB_2668412,,unprognostic (2.92e-2),unprognostic (2.97e-2),unprognostic (2.65e-1),unprognostic (4.87e-2),prognostic favorable (7.16e-4),,unprognostic (2.49e-2),unprognostic (4.04e-1),,unprognostic (1.80e-2),unprognostic (2.09e-2),,unprognostic (2.22e-2),,unprognostic (1.29e-2),unprognostic (7.29e-2),0.6,0.2,0,0,0.5,0,0.2,2.7,0.8,2.7,0,1,0,0,1.2,2.4,0,0,0,0.2,0.2,0,0.1,0.1,0,0.5,0.6,0.1,0,0,0,0,0,0.8,0.1,0.5,0.3,6.9,0,0,0.6,0,0.3,0,0,0,0,0.3,4.9,0,0.1,0,0.6,10.2,1.7,0,0,0,0.6,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,4.1,0,0,0,0.5,3708,4,0,0.6,0,0,28.2,0,0.1,0,0,0,0.1,0.1,0,0,0,0,0.1,0,1,0,0.3,0,0,1,0,0,2339.1,0,0,0,0.3,0,0,0.3,0.3,40.8,0.2,0.1,0,0.7,0.2,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.5,2.7,0.8,0.2,0.2,0.5,0.6,0.1,0.8,0,0.3,1.7,0,0,0,0,0,1.5,0,0.2,0,0,0.1,0.1,0,0,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0,0.1,0,0,0.1,0,0,0,0.3,2.8,0,0.1,0,0,0.6,0,0.1,0.3,0.2,0,0,0,0,0,1,0.2,0,0,0.4,0,5.2,0,0.1,0,0,0,0,0.2,0,0.4,0,0.1,0.1,0,0,0,0.1
ENSG00000101955,SRPX,ETX1,Sushi repeat containing protein X-linked,P78539,X,38149336-38220924,"Plasma proteins, Predicted secreted proteins",Cell adhesion,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,adipose tissue: 182.3,Cell type enhanced,Detected in many,,Fibroblasts: 256.9;Granulosa cells: 138.9;Hepatic stellate cells: 418.7;Leydig cells: 110.3;Peritubular cells: 95.2,Group enriched,Detected in all,5,glioma: 64.2;melanoma: 70.1,Low region specificity,Detected in all,,,Immune cell enriched,Detected in single,49,plasmacytoid DC: 7.8,Lineage enriched,Detected in single,49,dendritic cells: 7.8,Cell line enhanced,Detected in many,,ASC diff: 3742.4;ASC TERT1: 827.3;HSkMC: 1258.3;HUVEC TERT2: 803.2,Low region specificity,Detected in single,,,Region enhanced,Detected in many,,spinal cord: 12.4,,,,,,Secreted - unknown location,NA,NA,,140000,,,,unprognostic (2.35e-1),unprognostic (1.09e-3),unprognostic (1.08e-3),prognostic unfavorable (1.18e-4),unprognostic (6.48e-2),unprognostic (3.83e-3),unprognostic (3.50e-2),unprognostic (2.31e-1),unprognostic (4.00e-1),unprognostic (1.10e-1),unprognostic (1.30e-1),unprognostic (2.22e-2),prognostic unfavorable (7.80e-13),unprognostic (6.94e-3),unprognostic (3.90e-2),unprognostic (2.71e-2),prognostic unfavorable (3.36e-4),182.3,37.5,8.9,22.6,11,0.1,149.2,18,7.5,45.1,7.5,70.2,8,56.6,39.9,37,114.4,58.6,75.7,6.9,25.1,7.3,17.9,47,5,13.5,13.1,3.5,21.6,24.1,2.8,4.6,89.6,14.8,18.4,25,1.6,23.1,15.4,15.7,28,53.1,53.4,14.8,1.7,42.9,6.8,13.9,19.4,59.6,13.8,5.3,104.7,43.2,16.5,0.3,5,12.1,0.2,3742.4,827.3,0.9,35.3,67.8,11.9,20.2,0.5,3.6,0.1,0.3,74.3,119.9,1.9,2,30.8,9.8,0.2,13.8,0.1,1,0.4,167.8,3,0.4,1258.3,2.6,114.9,58.3,132.8,803.2,1.4,0.1,0.2,130.1,1.7,0.5,0.1,10.2,1.8,26.2,0,43.5,6.4,0.8,2.3,2.3,2.3,1.7,0.1,170.1,31.2,0,0.4,349.1,82.2,42.3,108.8,103.7,0,0.1,0.1,239,3.1,106.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,7.8,0,0.1,8.9,11,18,7.5,6.9,25.1,13.5,13.1,3.5,14.8,14.8,13.9,16.5,28.7,3.2,1.3,17,0.6,15.3,2.2,2.8,7.4,0.4,2.9,8.6,14.2,0,0.2,1.8,0,3.6,2.1,2.5,0,0.3,0.7,1.1,35.1,67.2,0,2.7,1.9,0.4,5.4,256.9,1.5,0.8,0,138.9,418.7,2.5,6.1,0,2.7,5.8,0,11.4,15.2,4.9,110.3,1.6,74.7,1,0,0.2,0,2.5,0.3,0.8,1.8,95.2,0.2,1.6,0.4,0.2,0,0.4,26.3,4.8,54.6,0.7,2.3,1.7,7.2,7.1,1.9,21.4,0.5,0.8
ENSG00000146700,SSC4D,"S4D-SRCRB, SRCRB-S4D, SRCRB4D",Scavenger receptor cysteine rich family member with 4 domains,Q8WTU2,7,76389334-76409697,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in some,,kidney: 2.6;parathyroid gland: 7.1;pituitary gland: 2.6,Cell type enhanced,Detected in some,,Collecting duct cells: 11.0;Distal tubular cells: 3.9;Hepatocytes: 3.7;Spermatogonia: 3.5,Low cancer specificity,Detected in many,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,11,EFO-21: 6.7;Hep G2: 9.6;SuSa: 10.7;U-2 OS: 25.2,Low region specificity,Detected in many,,,Not detected,Not detected,,,HPA062611,Uncertain,,,,Secreted - unknown location,NA,NA,,980000,,,HPA062611: AB_2684807,unprognostic (3.39e-2),unprognostic (1.78e-1),unprognostic (1.20e-2),prognostic unfavorable (2.83e-6),prognostic unfavorable (7.08e-4),unprognostic (3.52e-2),unprognostic (3.78e-2),unprognostic (2.28e-1),unprognostic (1.49e-2),unprognostic (8.49e-3),unprognostic (3.18e-1),unprognostic (3.72e-2),prognostic unfavorable (4.71e-4),unprognostic (2.59e-1),unprognostic (3.90e-1),unprognostic (2.56e-2),unprognostic (1.73e-2),0.5,0.3,0.2,0,0.3,0,0.3,0,0.3,0.3,0.6,0.1,0,0,0,0,0.1,0,0,0.2,0.1,2.6,0.4,0.1,0,0.3,0.1,0.2,0.7,2.2,7.1,2.6,0,0.4,0,0,0,1,0,0.1,0,0,0,0,0.1,0,0,0.2,0,2.2,0,0,0,0,0.3,0.1,0.2,0,0.2,0,0,0.1,0,0,0,0,0,0.2,0,6.7,0,0,0.2,0,0,0,0,0.4,0,0.3,9.6,0,0,0,0,0,0,0.1,0.7,0,0,1.1,0.1,0,0.5,0,0,1,0,0.3,0,0.8,0.2,0,0,0.1,1,0.5,0,0,10.7,0.2,0,0,0,25.2,0,0,0.1,0.1,0,0,0.1,0,0,0.1,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0.3,0,0.3,0.2,0.1,0.3,0.1,0.2,0.4,0,0.2,0.3,0.1,0,0.5,1.6,0.1,0,0.5,0,0.6,0.4,1.4,1.4,2.1,0,0,11,0,0.3,0,0.2,3.9,1.9,0.1,0.5,0.1,0.3,0,0,1.6,1.7,1.4,0.4,0,0.4,0,0.7,1.1,3.7,2.8,1.7,1.4,0.1,0,0.6,0,0.4,0.9,0.9,0,0,0,2.4,0,0,0.8,0.4,0.1,0.4,0,0.4,0.4,1.3,0,0.2,0,0.8,0.6,0.6,3.5,1,0,0.3,0.1,0.6,0.2,0.4
ENSG00000130193,THEM6,"C8orf55, DSCD75",Thioesterase superfamily member 6,Q8WUY1,8,142727223-142736927,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Low cell type specificity,Detected in many,,,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in all,,,Cell line enhanced,Detected in all,,MCF7: 82.4;RT4: 114.0,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA023255,Uncertain,,Approved,"Nuclear speckles,Cytosol",Secreted - unknown location,NA,NA,,,"Nuclear speckles, Cytosol",,HPA023255: AB_1845782,unprognostic (6.20e-3),unprognostic (2.21e-1),unprognostic (9.10e-2),unprognostic (5.33e-2),unprognostic (3.44e-2),unprognostic (1.00e-2),unprognostic (1.74e-2),unprognostic (6.47e-2),unprognostic (2.76e-1),unprognostic (1.44e-1),unprognostic (4.91e-2),unprognostic (6.76e-2),prognostic favorable (6.66e-7),unprognostic (7.02e-3),unprognostic (3.55e-2),unprognostic (2.39e-2),prognostic favorable (4.49e-4),13,17.4,13.4,4.4,12.5,5.3,15.7,12.7,18.4,9,10,10.7,11.6,7,3.5,21.1,9.5,7.4,14.4,14.6,13.1,21.5,47.4,10.7,6.5,19.1,13.4,13,4.4,23.3,15.8,12.6,8.4,16,12.6,5.2,1.4,16.5,10.4,12.5,15.9,11.7,3.5,13.1,11.1,15.7,3.8,14.4,6.9,14.3,7.3,4.1,17.3,11.6,13.3,28.5,23.1,3.5,23.9,10.9,3.8,16.6,14.3,11.8,21.5,14.9,14.2,41.5,11.9,31.8,5.4,8,64.4,10.2,31,3.5,9.9,28.2,9.1,12.3,28.9,11.9,5.3,9.2,5.5,10.9,4.2,6,4.3,18.4,16.6,4.3,5.9,3.7,82.4,21.7,1.3,5.4,53,74.5,24.9,2.4,27.4,25.9,114,53.1,20.8,21.9,64.7,18.6,3.2,31.9,4.3,10.7,9.2,6.7,26.8,2.5,3.8,5.6,5.2,9.5,25.7,11.6,7.2,4.9,2.6,10.9,9.2,16.6,5.1,11.6,14.1,4.7,6.7,13.6,12.9,0.7,11.1,9,3.6,11.6,9.1,13.4,12.5,12.7,18.4,14.6,13.1,19.1,13.4,13,16,13.1,14.4,13.3,35.4,9.6,5.8,6.2,6.7,3.6,7.5,5.7,2.8,10.4,24.7,25.3,7.4,11.5,7.8,18.4,6.2,18.3,11.5,16.6,5.9,13.7,3.3,5.5,3,14.6,31.8,11.6,11.3,11.6,10.1,4.8,7.7,9,0,6.6,19.2,20.8,11.4,16.8,7.8,13.5,6.1,3.1,1.4,15.7,2.8,3.9,5.4,2.8,2.3,13.5,16.5,11.6,7.3,9.4,9,4.1,3.7,10.7,29,16.2,2.4,11.3,0,6.1,4.3,2.7,5.7,18.4,7.7,3.4,10.3,8.2,22.4,25.1
ENSG00000144115,THNSL2,"FLJ10916, SOFAT, TSH2",Threonine synthase like 2,Q86YJ6,2,88170295-88186636,"Predicted intracellular proteins, Predicted secreted proteins",,"Cytokine, Lyase",,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Distal tubular cells: 58.7;Proximal tubular cells: 87.2,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,HHSteC: 31.6;MCF7: 12.2;SK-MEL-30: 12.6;SuSa: 15.0,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA035395,Approved,,,,Secreted - unknown location,NA,NA,,,,,HPA035395: AB_10601600,unprognostic (1.51e-2),unprognostic (1.03e-1),unprognostic (2.14e-1),unprognostic (1.14e-1),unprognostic (4.53e-2),unprognostic (8.73e-2),unprognostic (6.64e-2),unprognostic (7.26e-2),unprognostic (1.93e-1),unprognostic (3.47e-1),unprognostic (1.59e-1),unprognostic (1.97e-2),unprognostic (2.01e-3),unprognostic (6.98e-2),unprognostic (8.81e-2),unprognostic (1.40e-1),unprognostic (1.24e-2),14,22.8,14,2.4,14.7,0.9,16.6,14.2,15.8,13.3,13.6,15.3,5.6,11.3,22.8,6.6,19.3,7.7,17.3,12.4,18.3,28.3,50.4,7.2,2,16.3,14.5,12.3,15,14.3,32.5,29.3,8.7,14.7,22.5,3.7,7.4,13,13.6,50.5,9.4,12.7,6.4,14.7,7.6,13.6,13.1,14.7,1.1,22.1,36.1,1.8,12.6,9.9,16,0.3,0,0,0,2.7,0.9,1.5,4.6,5,6.4,8.3,6.6,7.7,0,2.2,0,0,0,0,0.2,3,0,0.1,0,0,0,31.6,0,0.6,5.1,10.3,1.9,0,0.5,0,0,0,0,4.7,12.2,0,0.1,6.2,7.1,0.6,0,0,0,5.2,0.5,0.3,0,5.4,0.4,12.6,15,8.8,2,0,1.4,1.1,0,0,0,0,0,0,0,2.3,0,0.2,0.3,0.3,0.4,0.2,0.4,0.1,0.2,0.4,0.7,0.2,0,0.1,0,0.2,0,0,0.2,14,14.7,14.2,15.8,12.4,18.3,16.3,14.5,12.3,14.7,14.7,14.7,16,2.8,3.2,9.3,13.1,3.1,6.6,8.6,8.3,9.6,12.8,23.2,20.2,17.3,20,2.9,14.7,0,42.5,0.4,9.2,58.7,14.8,1.3,14.5,8.9,3.6,2.4,6.1,2.8,3,15.7,13.8,6.6,8.4,0,8.1,7.9,43.6,4.6,13.5,3,6.8,4.1,10.7,4.6,4.2,9,2.8,14.2,5.6,11.3,43.5,3.1,4,16.7,5.4,8.9,9.8,1.7,6.3,13.4,87.2,5.2,7.3,0,8.9,6.4,3.7,11.4,3.7,5.1,23.9,1.7,13.8,6.2,5.6
ENSG00000187720,THSD4,"ADAMTSL6, FLJ13710, FVSY9334, PRO34005",Thrombospondin type 1 domain containing 4,Q6ZMP0,15,71096952-71783383,"Predicted membrane proteins, Predicted secreted proteins",,Hydrolase,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,cervix: 104.6,Cell type enhanced,Detected in many,,Basal prostatic cells: 106.4;Basal squamous epithelial cells: 449.0;Microglial cells: 247.3;Squamous epithelial cells: 141.5,Cancer enhanced,Detected in many,,ovarian cancer: 18.1,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,A549: 45.3;BJ hTERT+: 53.0;T-47d: 43.3;TIME: 66.6;U-2197: 44.4,Low region specificity,Detected in all,,,Region enriched,Detected in many,4,spinal cord: 39.0,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (1.59e-1),unprognostic (4.38e-2),unprognostic (3.14e-2),unprognostic (1.04e-1),unprognostic (1.52e-1),unprognostic (2.82e-2),unprognostic (2.63e-2),unprognostic (1.14e-1),unprognostic (7.80e-2),unprognostic (2.51e-2),unprognostic (1.13e-1),unprognostic (9.67e-2),unprognostic (1.43e-1),unprognostic (3.64e-1),unprognostic (1.30e-1),unprognostic (1.33e-2),unprognostic (3.01e-3),2.7,8.5,9.8,1.6,6.7,0,14.9,5.9,8.3,104.6,9.8,7,7.9,22.4,7.9,60.8,37.3,11,33.5,8.4,7,8.9,7.1,10.4,0.9,8.3,8.9,4.2,3.1,6.4,0.8,9.8,3.6,7.9,34.3,7,1.2,11.5,15.2,3,8,8.8,10.4,6.8,1.9,12.1,3.1,14.2,1.6,8.8,2.6,2.5,13.4,38.9,7,6,45.3,0.8,13,6.7,40.2,0.2,22,53,11.2,5.8,0.3,8.7,0,17.7,7.8,38.5,17,1.8,9.1,6.8,2,2,0,4.4,0,4.3,0,0,3,6.7,6.7,26.6,30.5,20.7,0,0,0.5,9.2,9.1,0,0.1,3.9,0.1,7.8,0,0.7,0.8,29.5,6,0.7,5.5,8.8,10.9,0,5,43.3,0.1,66.6,0.2,1,44.4,11.8,0,0.3,0,10.4,0,6.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.8,6.7,5.9,8.3,8.4,7,8.3,8.9,4.2,7.9,6.8,14.2,7,1.1,19.2,9,6.5,0,13.9,106.4,11.3,449,3,48.7,43.9,60.1,58.6,7.5,5.5,6.2,0.4,0.8,16.2,1.9,18.3,7.5,19.3,13.2,9.8,3,0,17.1,1.8,0.4,12.5,2.6,31.8,0,0.3,6.1,12.3,0.2,0,19.1,6.1,0,0,2.1,16.9,17.4,1.6,8.8,247.3,0,0.3,0,8.5,6.7,13.6,11,74.4,1.2,94.6,29.3,0.5,11,0.9,0,16.8,6.6,0.9,1.7,141.5,10.9,0.8,3.1,42.2,13.2,29.7
ENSG00000095587,TLL2,,Tolloid like 2,Q9Y6L7,10,96364608-96513926,Predicted secreted proteins,Differentiation,"Developmental protein, Hydrolase, Metalloprotease, Protease",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,,brain: 3.8;heart muscle: 2.0;tongue: 1.9,Cell type enriched,Detected in some,4,Granulosa cells: 82.4,Low cancer specificity,Detected in single,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,10,RPTEC TERT1: 20.1,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,,,,,,Secreted - unknown location,NA,NA,,,,,,unprognostic (1.28e-2),unprognostic (7.54e-4),unprognostic (1.50e-1),unprognostic (3.31e-3),unprognostic (2.67e-1),unprognostic (2.14e-3),unprognostic (1.31e-2),unprognostic (3.52e-4),unprognostic (7.08e-2),unprognostic (2.50e-1),unprognostic (6.71e-2),unprognostic (3.37e-2),unprognostic (4.98e-4),unprognostic (2.90e-1),unprognostic (8.41e-2),unprognostic (1.95e-4),unprognostic (2.30e-1),0,0.1,1.3,0.1,1.7,0.2,0,0.8,1.7,0,0.4,0.1,0.3,0.1,0.1,0,0,0.3,2,1.4,1.8,0,0,0,0.1,2.5,1.4,1.4,0.1,0.2,0,0.4,0.1,3.2,0.1,0.1,0.2,0.2,0,0.9,0,0.4,0.1,1.5,0.1,0.3,0.1,3.8,0,0.1,1.9,0,0,0,2.1,0.2,0.1,0.4,0.2,0.1,0,0,0.1,0,0,0,0,0.1,0.3,1,0.1,0.2,0.1,0.2,0.1,0,2,0.4,0,0.1,0,0,0,0.1,0.1,0.1,0,0,0,0,0.2,0,0,0,0,0.1,0,1.2,0.6,0.1,0.1,0.4,0,20.1,0,0.7,0,0.1,0,0.1,0.5,0,0,0,0,0.3,0,0,0.1,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.3,1.7,0.8,1.7,1.4,1.8,2.5,1.4,1.4,3.2,1.5,3.8,2.1,0.4,0,1.1,0.3,0.7,0.1,0.5,1.9,0,0,0,0,5.5,1.5,1,0,0,2.4,0.1,0,0,0.2,6.9,0.2,0.1,1.4,0,0,1.9,0.6,0.1,2.4,1.5,0.5,0,82.4,0,0,0.3,0,5.6,1.7,2,0.3,1.4,5.5,0.3,0.3,0,0,0,0,0,1.5,18.6,0.7,0,0,1.4,0.8,1,0.2,0.2,0,0,0.7,0.4,0.2,2.6,0,0.4,3.4,0.3,0.1,0.2,0.6
ENSG00000215788,TNFRSF25,"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR",TNF receptor superfamily member 25,Q93038,1,6460786-6466175,"Predicted membrane proteins, Predicted secreted proteins",Apoptosis,Receptor,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,lymphoid tissue: 44.3;pituitary gland: 30.1;skin 1: 25.5,Cell type enhanced,Detected in many,,Distal enterocytes: 34.1;Excitatory neurons: 37.5;T-cells: 41.4,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Group enriched,Detected in many,5,MAIT T-cell: 5.6;memory CD4 T-cell: 4.4;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.4;T-reg: 7.9,Lineage enriched,Detected in many,7,T-cells: 7.9,Cell line enhanced,Detected in many,,HDLM-2: 20.5;RPMI-8226: 25.7,Group enriched,Detected in some,6,amygdala: 1.2;cerebral cortex: 1.4;hippocampal formation: 2.0,Not detected,Not detected,,,HPA069834,,,Approved,"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites",Secreted - unknown location,NA,NA,,,"Plasma membrane, Actin filaments, Focal adhesion sites",Nucleoplasm,HPA069834: ,unprognostic (8.09e-3),unprognostic (6.91e-3),prognostic unfavorable (4.46e-4),unprognostic (1.97e-1),unprognostic (9.63e-3),prognostic favorable (3.09e-4),unprognostic (2.16e-1),unprognostic (1.46e-1),unprognostic (2.04e-1),unprognostic (2.07e-1),unprognostic (6.01e-2),unprognostic (3.98e-2),prognostic unfavorable (1.65e-7),unprognostic (1.21e-1),unprognostic (1.61e-1),unprognostic (3.44e-1),unprognostic (8.68e-3),5,4.2,3.5,3.2,3.4,0.8,4.1,10.4,6.2,4.8,4.1,4.6,3,3,0.6,10.3,5.7,2.2,5.8,4.3,3.5,3.3,1.2,2.5,4.4,3.2,3.8,4.2,3.1,1.5,0.9,30.1,4.5,7.3,5.2,1.4,1.2,3.3,2.3,1.1,25.5,5.1,0.5,2.7,44.3,2,0.9,3.2,2,3.2,1.3,2.8,2.5,4.7,4.5,1.8,0.4,1.1,2,0,0.6,1.3,1.5,0.6,0.3,0,1.7,2.8,0,2.5,0,1.3,4.2,0.6,4.7,0,20.5,1.5,0.6,1.7,0.1,0.7,0,0.1,0,3.2,1.5,4.1,2.7,4,1.1,0,0,0,2.2,0,8,1.4,1.4,3.4,0.6,0.3,25.7,1.3,0.7,3.4,5.3,0,2.5,0.1,0.6,2,2.9,2.5,1.3,2.1,0,2,0,3.5,0,2.4,0,0,0,0,0,1,0.2,5.6,0,4.4,2.2,0.5,0,4.4,0.7,0,0.8,1,0,7.9,0.9,3.5,3.4,10.4,6.2,4.3,3.5,3.2,3.8,4.2,7.3,2.7,3.2,4.5,19,3.2,5,3.9,2.5,24.6,2.3,5.6,11.4,3.1,4.2,5.5,1.1,1.5,3.3,1.8,2.1,0.7,12.8,34.1,0,0.2,0.2,4.1,11.2,11.5,6.7,3,37.5,0.4,2,2.3,5.6,6.9,7,4.8,7.9,1.1,4,5,21.6,20.3,0,1.2,6.6,0.3,2.8,4,7.2,14,3,10.2,10.3,7.5,2.1,1.4,16,9.4,3.2,3.7,9.8,0.6,4.8,9.1,0,2.6,2.6,0.4,1.2,8.6,28.6,0.1,41.4,0.7,25,6.8
ENSG00000188056,TREML4,TLT4,Triggering receptor expressed on myeloid cells like 4,Q6UXN2,6,41228339-41238882,"Predicted membrane proteins, Predicted secreted proteins","Immunity, Innate immunity",,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,choroid plexus: 1.3,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4,eosinophil: 4.5;neutrophil: 8.1,Lineage enriched,Detected in many,5,granulocytes: 8.1,Cell line enriched,Detected in single,6,HEL: 1.1,Not detected,Not detected,,,,,,,HPA065044,Uncertain,,Approved,Plasma membrane,Secreted - unknown location,NA,NA,,,Plasma membrane,,HPA065044: AB_2685411,unprognostic (1.49e-1),unprognostic (1.51e-1),unprognostic (5.58e-2),,unprognostic (2.07e-1),unprognostic (2.12e-1),,unprognostic (1.03e-1),,unprognostic (5.50e-2),unprognostic (9.50e-3),,unprognostic (1.18e-4),unprognostic (1.05e-3),unprognostic (1.32e-1),unprognostic (5.26e-2),unprognostic (1.21e-2),0,0,0,0.3,0.1,0.7,0,0,0.3,0,1.3,0,0,0,0,0,0,0,0,0.1,0.1,0,0,0.1,0,0.2,0.1,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0.1,0.3,0,0,0.1,0,0,0.1,0,0.1,0,0.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,1.1,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.5,4.5,0,0.4,0,0.1,0,0,0.5,0.9,0,0,8.1,0,0.4,0.7,0,0.4,0,0.1,0,0.3,0.1,0.1,0.2,0.1,0,0.3,0.1,0.1,0.7,0,0,0,0,0.2,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
ENSG00000143367,TUFT1,,Tuftelin 1,Q9NNX1,1,151540305-151583583,"Predicted intracellular proteins, Predicted secreted proteins",Biomineralization,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,,skin 1: 106.9,Cell type enhanced,Detected in many,,Basal keratinocytes: 69.2;Glandular and luminal cells: 76.8;Suprabasal keratinocytes: 66.5,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Immune cell enhanced,Detected in some,,basophil: 5.2,Group enriched,Detected in many,5,granulocytes: 5.2;T-cells: 3.5,Low cell line specificity,Detected in many,,,Low region specificity,Detected in all,,,Region enriched,Detected in all,6,cerebellum: 41.7,"HPA028112, HPA054301",Approved,Approved,Approved,Vesicles,Secreted - unknown location,NA,Yes,,,Vesicles,,"HPA028112: AB_10603224, HPA054301: AB_2682442",unprognostic (6.16e-2),unprognostic (3.76e-1),unprognostic (1.38e-1),prognostic unfavorable (4.83e-4),unprognostic (4.49e-3),unprognostic (1.12e-1),unprognostic (2.30e-2),unprognostic (1.37e-2),unprognostic (8.29e-3),unprognostic (9.06e-2),unprognostic (6.70e-3),unprognostic (7.88e-2),unprognostic (2.58e-3),unprognostic (1.41e-1),unprognostic (1.32e-1),unprognostic (1.82e-3),unprognostic (4.53e-2),5.1,6.9,4.5,2.9,4.5,6.8,10.2,5.2,5.3,14.2,3.5,11.3,7.5,5.3,6.4,48.5,5.2,5.9,4.6,3.9,5.4,14,7.1,8.5,1,4.2,4.1,4.3,7.4,17.4,11.5,7.2,13.4,4.7,9.7,13.1,2.2,18.4,9.3,2.6,106.9,10.9,6.2,3.8,1.5,12.9,5.4,5.5,2.2,5.7,2.7,6.2,12.5,27.1,4.9,40.7,13.7,10,11.5,2.3,1.9,63.1,10.7,9.5,41.3,39.6,43.6,31.5,3.5,64.6,12.5,19.5,46.4,17.6,16.2,30.1,27,8.7,2.2,23,6.7,32.2,0.8,4.7,6.5,18.9,32.5,71.6,24.5,3.4,5,3.6,26.8,12.8,16.8,2,0.5,11.7,29.6,11.4,0.1,28.1,14.2,34.7,61.8,19.5,8,68.2,45.8,8,29.4,36.5,2.1,8.6,7.4,51.7,46.2,71.7,6.6,13.7,0.5,6.3,0.9,4.7,5.2,0.6,0.7,0.3,0.1,0.7,0.6,1,0.5,0.9,0.2,0.8,0.3,2.5,0.1,0.3,0.1,3.5,0.5,4.5,4.5,5.2,5.3,3.9,5.4,4.2,4.1,4.3,4.7,3.8,5.5,4.9,2.1,25.6,2,1.6,3.8,69.2,35.2,14.7,35.9,2.5,28.8,20.2,9.8,8.6,19,14.7,0,28.1,6.6,59.5,13.7,18.2,2.7,43.2,8.9,2.7,32.2,2.7,4.4,15.2,13.9,7,46.9,76.8,4.5,9,1.1,10.5,4,0,9.3,39.1,20.3,0,12.7,3.2,2.5,6.5,8.8,1,2,2.1,0,8.5,1.8,47.4,34.6,5.3,7.7,21.7,15.4,11.2,15.9,0.5,6.6,4.1,5.5,0.6,3.5,39.6,66.5,56.8,5.8,10.9,35.7,35.6
ENSG00000128791,TWSG1,TSG,Twisted gastrulation BMP signaling modulator 1,Q9GZX9,18,9334767-9402420,Predicted secreted proteins,,Developmental protein,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,,,Cell type enhanced,Detected in many,,Early spermatids: 141.2;Peritubular cells: 95.2,Low cancer specificity,Detected in all,,,Low region specificity,Detected in all,,,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in all,,,Low cell line specificity,Detected in all,,,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA014898,Uncertain,,Supported,"Centrosome,Cytosol",Secreted - unknown location,No,No,,3500000,"Centrosome, Cytosol",,HPA014898: AB_1858467,unprognostic (2.55e-1),unprognostic (3.17e-2),unprognostic (7.31e-2),unprognostic (8.95e-3),unprognostic (2.92e-3),unprognostic (1.83e-1),unprognostic (8.29e-2),unprognostic (5.88e-2),unprognostic (6.33e-2),unprognostic (1.05e-2),unprognostic (3.10e-2),unprognostic (1.21e-1),unprognostic (1.40e-1),unprognostic (4.36e-2),unprognostic (8.73e-2),unprognostic (1.79e-1),unprognostic (1.32e-2),23.9,19.7,9,16.9,10.5,8.2,17.7,10.8,12.4,40.9,14.4,19.9,11.2,51.8,46.2,26.3,30.8,36.6,18.8,8.6,12.7,36.6,10,19.8,11.9,11.9,10.6,7.8,32.5,9.8,33.5,9.8,25,11.3,43.4,22.6,5.8,11.2,65.2,5.7,13,12.6,80.8,11.3,13.7,15,11.9,10.1,7.1,35.2,16.6,15,35,16.3,12.3,57.3,19.9,57.6,28.6,111.2,99.7,26.6,107.2,132.4,57.6,81.9,21.2,73.5,8.2,52.7,142.5,37.4,19.5,57.1,42.4,105.3,22,15.4,14.7,15.9,10.8,98.7,10.8,29.4,102,34.1,48.3,23.3,78.7,90.8,7.8,22.7,14.6,149.2,17,11.9,13.2,18.9,33.6,16.1,20.7,58.7,5,65.7,75.2,7.4,20,83.3,23.1,22.9,23.9,26.1,25,75.6,104.9,52.4,99.5,67.5,21.2,20.1,15.1,64.5,14.9,37.9,8.3,2.7,4,4.3,1.5,2.8,2.1,2,4.5,5.5,1.6,2.3,4.8,1.2,2.9,0.5,5.3,1,2.1,9,10.5,10.8,12.4,8.6,12.7,11.9,10.6,7.8,11.3,11.3,10.1,12.3,9,25.6,18.4,13.1,8.1,39.6,21.3,18.5,51.2,4.8,18.5,11.6,7.8,10,21,75.4,0,6.3,12.1,12.1,1.9,9.1,141.2,13.3,38.6,18.1,6,9.9,28,7.6,18.3,61.9,10.2,23.4,6.3,31.6,17.2,7.5,16,3.3,31,8.2,57,9.4,30.1,30.7,37.6,12.2,23.2,17.8,15.3,16.1,7.2,29.1,31.6,9.2,10.7,95.2,17.8,46.3,1.3,12.6,12.4,5,72.3,28.9,56.6,24.6,9.6,26.6,26.9,4.7,10.1,20.4,12.2,27.1
ENSG00000188958,UTS2B,"U2B, URP, UTS2D",Urotensin 2B,Q765I0,3,191267168-191330536,Predicted secreted proteins,,Hormone,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in many,,retina: 15.1,Cell type enhanced,Detected in some,,Alveolar cells type 1: 3.2;B-cells: 2.6;Early spermatids: 8.3;Late spermatids: 2.3;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 2.6;Spermatogonia: 2.1,Not detected,Not detected,,,Low region specificity,Detected in many,,,Group enriched,Detected in some,4,memory B-cell: 2.8;naive B-cell: 1.8,Lineage enriched,Detected in single,5,B-cells: 2.8,Cell line enhanced,Detected in some,,PC-3: 3.3,Region enriched,Detected in some,9,pons and medulla: 11.3,Region enriched,Detected in single,46,spinal cord: 6.0,HPA026992,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA026992: AB_1858703,unprognostic (1.73e-2),unprognostic (4.38e-2),unprognostic (1.22e-1),unprognostic (3.41e-1),unprognostic (1.92e-1),unprognostic (2.17e-2),unprognostic (2.77e-2),unprognostic (2.14e-2),unprognostic (3.09e-1),unprognostic (2.63e-2),unprognostic (3.39e-2),unprognostic (2.63e-1),unprognostic (1.11e-1),unprognostic (7.58e-2),unprognostic (2.08e-1),unprognostic (1.29e-1),unprognostic (3.10e-2),1,1.2,1,0.8,0.7,0.5,1.2,4.3,1.6,0.2,0,0.5,5.4,0.7,0.5,0.7,1,1.2,0.7,0.9,0.7,0.6,3.2,0.5,1,0.7,0.7,0.6,1.1,0.5,0.2,0,0.4,1.8,0.6,0.4,15.1,0.6,0.2,0.6,1.1,3.2,0.5,0,0.6,1.6,2.4,0.6,0.1,0.5,0,0.3,0.4,0.1,1.1,0.4,1,1.3,0.6,0.3,1.6,0.4,1,0.5,0.3,0.2,0.7,0.5,0.7,0.5,0.4,2.6,0.5,0.4,0,1.6,0.6,0.5,0.6,1.4,2.9,0.3,0.8,0.4,0.6,0.2,0.2,0.3,0.9,0.3,0.6,0.4,0.6,0.5,0.6,0.2,0.5,0.7,1.3,3.3,0.9,1.5,0.2,0.2,1.6,0.7,0.5,0.6,0.7,0.4,0.5,0.5,0.5,1.4,0.7,0.4,1.3,0.4,1.1,0.6,0.6,0.9,0.5,0.5,0,0,0,0,0,0,2.8,0,0,0,1.8,0,0,0,0,0,0.5,0,0,1,0.7,4.3,1.6,0.9,0.7,0.7,0.7,0.6,1.8,0,0.6,1.1,0.2,3.2,1.1,0.7,2.6,0,0.1,0,0,0,0.1,0,0.2,0,0,0,0,0,0.1,0.2,0,0.1,8.3,1.4,0.4,0.1,0,0,0.4,0,0,0.2,0,0.1,0,0.4,0,0,0.1,0,1.1,0,0,0,0,2.3,0,0.2,0,0,0,0,0,3,0.2,0.1,0,0.7,1.6,0,0.2,0.1,1.5,0,0,0.1,0.2,2.6,2.1,0,0.3,0.3,0,0.1,0,0.1
ENSG00000168140,VASN,SLITL2,Vasorin,Q6EMK4,16,4371848-4383538,"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Endometrial stromal cells: 58.7;Fibroblasts: 104.2;Leydig cells: 50.1;Peritubular cells: 60.9;Sertoli cells: 98.6;Smooth muscle cells: 80.9,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,BJ: 21.8;MCF7: 18.4;U-2197: 78.4,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA011246, HPA016992",Uncertain,,Approved,"Nucleoplasm,Nucleoli,Mitochondria",Secreted - unknown location,NA,Yes,,2000000000,Mitochondria,"Nucleoplasm, Nucleoli","HPA011246: AB_1858720, HPA016992: AB_2732418",unprognostic (2.20e-1),unprognostic (2.75e-1),unprognostic (9.22e-2),prognostic unfavorable (6.24e-5),unprognostic (2.35e-3),unprognostic (8.91e-3),unprognostic (3.15e-3),unprognostic (5.92e-2),unprognostic (2.22e-1),unprognostic (1.24e-2),unprognostic (1.08e-1),unprognostic (1.28e-1),unprognostic (1.81e-1),unprognostic (8.82e-3),unprognostic (4.23e-2),unprognostic (4.95e-3),unprognostic (5.27e-2),47.8,15.6,1.6,5.8,2.2,2.8,31.8,1.6,3.1,43.7,2.6,12.1,3.5,30.5,0,34.4,24.8,7.4,23.7,1.1,1.2,55.7,32.1,45.3,2.9,5.9,3.4,0.1,40.3,10.4,0,12.9,10.5,2.4,18,0,0.3,16,0,7,34.1,11.3,0,1.7,13.2,13.5,16.9,3.2,0,27,0,0,26.7,39.2,2.8,4.2,0,0.6,0.5,0.2,0.2,12.6,21.8,0.1,0,0,1.9,5.5,0,4.5,0.3,2.6,0.3,0,0,0,13.7,2.2,0.9,15.9,14.9,0.6,0,0.4,7.9,0,0.3,0,3.1,0,0.1,3.1,0.8,0,18.4,1,5.3,2.2,0.4,2.4,1,0,0,0,0.1,1.4,9.3,6.5,13.5,0.6,2.2,6.8,2.5,0,17.5,12.5,78.4,4.6,0,0,0.3,0,0,2.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.6,2.2,1.6,3.1,1.1,1.2,5.9,3.4,0.1,2.4,1.7,3.2,2.8,10,6.4,13.1,5.5,1.4,9.6,7.8,4.2,9.1,0.5,21.9,10.9,16.2,32.9,6.4,23.9,0,5.4,2.8,1.5,7.9,13.1,1.1,12.1,58.7,4.6,0,0,1.1,2.9,7.2,104.2,16.8,20.5,3.8,4.6,2.9,15.3,3.4,0,0.9,2,2,0.6,21.7,2.8,50.1,2,14.2,2.8,0,18.3,0,0.5,0.3,28.3,1.2,60.9,0.8,6.4,0.2,12.3,2.7,0.7,98.6,12.6,80.9,0.8,4.1,3.7,7.5,10,3.5,2.3,0.8,4.9
ENSG00000132821,VSTM2L,"C20orf102, dJ1118M15.2",V-set and transmembrane domain containing 2 like,Q96N03,20,37903111-37945350,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,brain: 89.0;heart muscle: 50.1,Cell type enhanced,Detected in many,,Cardiomyocytes: 25.2;Cholangiocytes: 61.5;Club cells: 28.7;Inhibitory neurons: 44.0;Respiratory ciliated cells: 83.0,Group enriched,Detected in all,5,lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,CAPAN-2: 67.2;HDLM-2: 98.8;hTCEpi: 23.4;SH-SY5Y: 22.5;SK-BR-3: 81.0,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA043832,Uncertain,,,,Secreted - unknown location,NA,NA,,,,,HPA043832: AB_10968449,unprognostic (1.43e-1),unprognostic (1.38e-1),unprognostic (2.33e-2),prognostic unfavorable (1.63e-5),unprognostic (4.96e-3),unprognostic (1.56e-1),unprognostic (1.83e-2),unprognostic (1.39e-1),unprognostic (1.52e-1),unprognostic (2.34e-3),unprognostic (9.86e-2),unprognostic (2.00e-1),unprognostic (1.85e-3),unprognostic (1.29e-3),unprognostic (1.68e-1),unprognostic (9.66e-2),prognostic unfavorable (8.14e-4),0.7,6.2,32.5,0.8,32.5,0,0.5,1.4,79,12.6,0,2.8,1.2,1.7,9.8,1,15.6,17.7,50.1,89,34,1.4,3,11.6,0.4,16.2,26.7,38.1,0.3,2.6,0,17.5,0.8,20.5,9.2,0.4,3,7.4,16.3,1.1,0.8,1.2,0.9,16.8,29.8,7.9,4.9,28.4,3,1.7,0,1,0.7,0.6,20.3,0,0.8,7.7,0.3,0.3,0.4,0.2,0.9,0,0,0,0.3,67.2,0,0.4,0.6,0.3,0.2,0.1,3.2,0,98.8,1.9,0.1,0.1,0,3.6,0.1,2.5,3.2,23.4,0.1,0.7,2.4,0,0.1,0,0,8.4,0,0.1,0.1,0.2,2.3,20.1,0,0,0.3,0.1,0,2.6,22.5,2.7,81,0.8,0,0.4,0,4.6,0,0.6,0.2,1.5,0.2,0.1,0,0.5,0,3.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,32.5,32.5,1.4,79,89,34,16.2,26.7,38.1,20.5,16.8,28.4,20.3,0.1,6.4,1.8,2,0.1,0.4,1.2,10.7,1.8,8.5,1,0,25.2,61.5,28.7,0,8.4,0.6,1.3,0.2,0,3.7,0.4,0.1,0.5,0.3,18.6,0,17.8,0.2,0.2,1.8,4.1,0,0,1.5,2.9,1.3,0,13.5,44,1.2,10.2,0.8,1.5,0.9,5.3,0.9,0,1.9,0,0.9,0,3,3.2,7.9,2.6,16.1,0.1,5.3,0.1,1,83,4.6,0,0,2.9,0.2,0.8,0.1,0.6,0.1,1.2,3.5,0.2,0.7
ENSG00000165633,VSTM4,"C10orf72, FLJ31737",V-set and transmembrane domain containing 4,Q8IW00,10,49014236-49115522,"Predicted membrane proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,,,Cell type enhanced,Detected in many,,Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7,Cancer enriched,Detected in all,5,thyroid cancer: 22.1,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA017279,Uncertain,,Approved,"Nucleoplasm,Vesicles",Secreted - unknown location,NA,NA,,,"Nucleoplasm, Vesicles",,HPA017279: AB_10959519,unprognostic (8.46e-2),unprognostic (5.41e-1),unprognostic (1.89e-1),unprognostic (2.07e-1),unprognostic (1.80e-1),unprognostic (2.84e-2),unprognostic (1.20e-1),unprognostic (6.70e-2),unprognostic (1.93e-2),unprognostic (2.81e-2),unprognostic (3.03e-1),unprognostic (1.95e-2),unprognostic (2.56e-3),unprognostic (1.06e-2),unprognostic (1.62e-2),unprognostic (1.48e-1),prognostic unfavorable (4.25e-4),18.8,41.9,7.1,3.3,8.5,0.3,9.9,8,6.9,22.5,8,6.8,2.5,12.4,7.4,7.9,8.6,10.6,12.3,6.3,7.6,12.5,3.9,10.9,3.5,8.8,9.2,5.8,35.5,1.6,27,5.1,10.5,9.3,13.6,5.6,2.3,3.5,11.8,5.6,5,5,11.5,8.8,2.3,5.7,9.4,8,6.6,28.1,6,4.6,12.1,7.6,9.4,0,0,3.1,0.1,1.3,0.7,0.1,2.6,4.1,0.9,0.2,0,0.1,0.1,0.1,6.1,3.4,0.1,0.2,0,0.4,3.2,1.4,0.2,0.1,0.1,0.1,0.1,0,4.7,0,4.2,0,0,0,0.8,8.6,0.1,0.8,0.1,0,0.2,0.6,0,0,0,9.3,5,0,0.1,0.1,7.9,0.1,0,0,0.4,0.1,0.3,0,10.6,1.2,24,0.1,0,6.8,0,11.6,0.1,0.1,0.5,0.1,0.1,0.1,0,0.1,0.1,0,0,0,0.3,0.1,0.1,0.5,0.3,0.1,0.1,0,0,7.1,8.5,8,6.9,6.3,7.6,8.8,9.2,5.8,9.3,8.8,8,9.4,9.4,3.2,17.5,17.3,1.3,6.5,1.6,0.1,0.6,5.4,1.2,1.1,16.7,0,9.4,0,2.1,0.4,3.7,0.2,1.9,0.1,88.5,0.8,10.7,6.2,0,0,11.1,0,0.3,29.7,0,0.7,12.6,96.9,5.3,5,0.7,5,7,0,0,2.2,11.1,140.6,9.6,2.9,7.2,4.7,1,9.1,2.1,20.1,33.3,0.2,0.1,14.7,0.7,0.8,0,9.4,3.8,2.9,59.2,20.6,37.7,1.3,4.4,0.4,4.3,0.4,2,44.7,0,0.7
ENSG00000175267,VWA3A,"FLJ40941, FLJ46765",Von Willebrand factor A domain containing 3A,A6NCI4,16,22092538-22156964,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in some,,brain: 24.8;choroid plexus: 45.1;fallopian tube: 40.0,Cell type enhanced,Detected in some,,Astrocytes: 25.5;Club cells: 16.7;Endometrial ciliated cells: 45.6;Excitatory neurons: 33.8;Late spermatids: 15.2;Respiratory ciliated cells: 88.0,Group enriched,Detected in some,4,endometrial cancer: 3.2;glioma: 1.4;ovarian cancer: 1.3,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,U-266/84: 1.2,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,"HPA041696, HPA042044",Uncertain,,,,Secreted - unknown location,NA,NA,,,,,"HPA041696: AB_10964202, HPA042044: AB_10968997",unprognostic (2.69e-2),unprognostic (1.54e-1),unprognostic (9.75e-4),prognostic favorable (8.15e-4),unprognostic (2.70e-1),unprognostic (4.46e-2),unprognostic (1.65e-2),unprognostic (6.79e-3),unprognostic (5.55e-2),unprognostic (2.67e-1),unprognostic (6.81e-2),unprognostic (1.40e-1),unprognostic (2.16e-5),unprognostic (1.08e-1),unprognostic (2.97e-1),unprognostic (6.24e-2),unprognostic (3.06e-4),0.3,0.3,24.8,0,11.8,0.4,0.4,8.2,13.3,6.2,45.1,0.3,0.1,2.5,0.1,0.1,40,0,0.5,6.8,14.5,0.5,0.1,8.9,0.1,17.3,23.3,6.5,0.5,0.4,0.1,16.7,0.1,13,0.4,0.1,0.3,0.1,0.1,0.1,2,0.3,0.1,20.5,0.3,0.2,8.3,9.9,0.1,0.5,0.2,0.2,0.1,0.1,10.8,0,0.3,0.2,0.2,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0.1,0,0.1,0,0.2,0,0,0,0,0,0.2,0.7,0,0.1,0,0,0,0,0,0,0.3,0,0.2,0,0,0,0,0,0.3,0,0,0,0.1,0,0,0,0,0.5,0.1,0.1,0,0,0,0.1,0,0,0.6,1.2,0,0.1,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.8,11.8,8.2,13.3,6.8,14.5,17.3,23.3,6.5,13,20.5,9.9,10.8,0.3,0,1.1,25.5,0,0,0,2.2,0,0,0,0,0.6,0,16.7,0,0,0,0,0,0,0,12.7,45.6,0.3,0,0,0,33.8,0,0,0.4,0,1.5,0,0,0,0,0,0,3.5,0,0,0,0,15.2,0.3,0.2,0,3.7,0,0,0,4,2.4,0,0,0,0,0.1,0,0.1,88,0,0,0,1.2,1.2,0.2,0,0,0,0.1,0,0,0
ENSG00000204396,VWA7,"C6orf27, G7c, NG37",Von Willebrand factor A domain containing 7,Q9Y334,6,31765590-31777328,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in many,,pituitary gland: 21.5,Cell type enhanced,Detected in some,,Enteroendocrine cells: 4.2;Gastric mucus-secreting cells: 8.2;Proximal enterocytes: 5.0;Proximal tubular cells: 2.4,Low cancer specificity,Detected in many,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,A549: 1.2;HMC-1: 1.3;Karpas-707: 1.1;U-266/84: 1.6,Group enriched,Detected in some,5,cerebellum: 7.0;pons and medulla: 3.9,Low region specificity,Detected in many,,,"HPA046954, HPA054262",Approved,,Approved,"Plasma membrane,Cytosol",Secreted - unknown location,NA,NA,,9200,"Plasma membrane, Cytosol",,"HPA046954: AB_2679875, HPA054262: AB_2682430",unprognostic (9.13e-2),unprognostic (8.60e-4),unprognostic (9.99e-2),unprognostic (2.43e-1),unprognostic (2.85e-3),unprognostic (4.96e-3),unprognostic (6.38e-2),unprognostic (4.40e-2),unprognostic (2.68e-1),unprognostic (5.84e-2),unprognostic (1.65e-2),unprognostic (9.25e-2),prognostic favorable (4.35e-8),unprognostic (3.75e-2),unprognostic (2.37e-1),unprognostic (9.48e-2),unprognostic (7.66e-2),0.2,0.3,1.1,0.1,0.2,0,0.7,0.1,2.5,0.6,0,1.1,1.1,4.6,0,0.4,7.3,0.7,4.2,0.6,5.9,5.7,1.4,1.4,0.1,4.8,1.1,0.4,0.5,2.6,1.7,21.5,0,4.9,0.8,0.4,0.2,1.5,1.3,6.6,0.7,2.3,0,0,0.5,3,0.7,4.7,0,1.8,0,0.1,0.6,0.7,6,0.8,1.2,0.3,0,0,0,0.1,0,0,0.1,0,0,0,0.3,0.6,0,0,0.7,0.5,0.2,0,0,0,0,0,0,0,0,1.3,0,0.7,0,0,0.1,0,0.9,0,1.1,0,0.1,0,0,0.1,0.6,0.1,0.3,0,0.9,0,0,0,0,0,0,0,0,0.1,0,0.1,0,0.5,0,0,0,1.6,0,0,0.7,0,0.5,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,1.1,0.2,0.1,2.5,0.6,5.9,4.8,1.1,0.4,4.9,0,4.7,6,0,0,1.1,0,0.6,0.1,0.4,0.5,1.2,0.5,0.1,0.3,0.8,0,0.3,1.8,0,0,0.2,1.4,1.9,0.6,0,1.5,0.1,0.1,4.2,0,1.5,0.5,0,0.1,8.2,0.4,0,0,0,0.1,0.1,0,0.1,0.3,0,0,0,0,0,0,0,1,0,0,0,0,0,0.6,2.1,0,0.4,0.3,5,2.4,1.6,0.8,0,0,0.2,0,0,0.4,0,0.3,0.4,0,0.5,0.4
ENSG00000174453,VWC2L,,Von Willebrand factor C domain containing 2 like,B2RUY7,2,214411054-214578976,Predicted secreted proteins,,Developmental protein,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,7,brain: 2.9;retina: 1.4,Group enriched,Detected in some,21,Excitatory neurons: 67.4;Inhibitory neurons: 132.4,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,"HPA044815, HPA059414",Uncertain,,,,Secreted - unknown location,NA,NA,,,,,"HPA044815: AB_10962359, HPA059414: AB_2684007",unprognostic (8.77e-2),,,,unprognostic (2.83e-3),,,unprognostic (2.05e-2),,unprognostic (8.49e-2),unprognostic (1.51e-3),unprognostic (4.36e-1),unprognostic (2.56e-2),unprognostic (2.05e-1),,unprognostic (3.89e-1),,0,0,1.7,0,1.8,0,0,0.2,1.9,0,0,0,0,0,0,0,0,0,0,2.9,1.9,0,0,0,0,0.9,1.3,1.2,0,0,0,0.3,0,1.8,0,0,1.4,0,0,0,0,0,0,0.1,0,0,0,2.8,0,0,0,0,0,0,2.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.7,1.8,0.2,1.9,2.9,1.9,0.9,1.3,1.2,1.8,0.1,2.8,2.5,0,0,0,2.9,0,0,0,0,0,3.2,0,0,0.5,0,0,0,0,0,0,0,0,0,0.1,0.1,0,0,0,0,67.4,0,0,0.1,0,0,0,0,0,0,0,0,132.4,0,0,0,0,0,0,0,0,4.7,0,0.1,0,4.5,2.7,0,1.1,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0.1,0,0
ENSG00000167992,VWCE,"FLJ32009, URG11, VWC1",Von Willebrand factor C and EGF domains,Q96DN2,11,61258286-61295316,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,liver: 14.4;ovary: 8.0,Cell type enhanced,Detected in many,,Astrocytes: 19.2;Cone photoreceptor cells: 29.2;Hepatocytes: 16.4;Rod photoreceptor cells: 21.1,Low cancer specificity,Detected in many,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,CACO-2: 7.2;Hep G2: 26.3;HSkMC: 13.4;REH: 14.0,Not detected,Not detected,,,Low region specificity,Detected in some,,,"HPA040401, HPA043921",Uncertain,,Supported,"Nucleoplasm,Vesicles,Cytosol",Secreted - unknown location,NA,NA,,2200000,Nucleoplasm,"Vesicles, Cytosol","HPA040401: AB_2676963, HPA043921: AB_2678731",unprognostic (3.09e-2),unprognostic (1.10e-1),unprognostic (3.58e-2),unprognostic (1.15e-1),unprognostic (3.96e-3),unprognostic (9.27e-4),unprognostic (1.21e-2),unprognostic (4.01e-4),unprognostic (3.04e-2),unprognostic (3.42e-2),unprognostic (6.58e-4),unprognostic (7.20e-2),unprognostic (3.01e-1),unprognostic (1.25e-2),unprognostic (1.92e-1),unprognostic (2.34e-1),unprognostic (2.30e-1),2.3,1.1,0.8,0.1,1,1.7,1.6,0.3,1.6,2.2,0,0.6,0.3,1.3,0.6,0.9,3.6,0.6,0.7,1,0.8,0.5,14.4,0.3,0.2,0.6,0.9,0.8,8,0.3,0.1,0.6,2.4,0.5,1,0.4,0.9,0.9,0.5,0.7,0.6,0.4,0.5,0,0.4,0.4,1.8,0.5,2.5,0.8,0.4,0.1,0.6,1.2,0.4,0,0.1,1.5,0.2,0.2,1.8,0.6,0.2,2,0,0.3,7.2,0,0.5,0,0.4,0.1,0,2.3,0,0.1,0.4,0,0.8,0,26.3,1.2,0,0.3,13.4,0.6,0.7,0,0.1,2.3,3.3,0.2,0.3,0.3,0.1,5.5,0,2.2,0,0,14,0.2,0,0.1,0.1,0.6,1,0,0.1,0.7,2.4,0.9,0,0.8,0.3,0.3,0.5,0.2,0.2,0.6,1.2,0.9,0.3,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.8,1,0.3,1.6,1,0.8,0.6,0.9,0.8,0.5,0,0.5,0.4,2.1,3.2,1.7,19.2,0.3,1.8,1.8,3.8,3.4,3.6,1.7,0.5,1,1.5,2.3,0,29.2,1,0.5,0.2,0,0.1,0.5,2.9,1,5.5,1.8,6.1,7.5,0.5,5,2.6,0,1.8,3.8,6.5,2.5,16.4,1.2,0,5.8,0.1,2,3.5,2.4,0.8,6.8,2.6,1.8,2.8,2.3,2.3,1,2.5,1.4,0,0,1.9,0.4,1.1,0.1,0.3,5.4,21.1,0,0.9,1.1,1.1,3.4,1.3,2.3,4.4,0.9,7.7,0.3,0.7
ENSG00000146530,VWDE,FLJ14712,Von Willebrand factor D and EGF domains,Q8N2E2,7,12330885-12403941,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in some,,epididymis: 4.3;salivary gland: 3.3;thyroid gland: 3.2,Cell type enhanced,Detected in some,,Cardiomyocytes: 8.8;Excitatory neurons: 11.8;Granulosa cells: 5.4;Inhibitory neurons: 11.6,Low cancer specificity,Detected in many,,,Not detected,Not detected,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in many,,HeLa: 5.0;K-562: 13.0;NTERA-2: 4.8;SCLC-21H: 7.0,,,,,Low region specificity,Detected in many,,,"HPA026619, HPA036044, HPA036045",Uncertain,,Approved,Cytosol,Secreted - unknown location,NA,NA,,,Cytosol,,"HPA026619: AB_2671920, HPA036044: AB_2674916, HPA036045: ",unprognostic (6.39e-2),unprognostic (1.65e-3),unprognostic (5.36e-3),unprognostic (1.78e-4),unprognostic (1.39e-2),unprognostic (4.19e-3),unprognostic (2.38e-1),unprognostic (1.85e-1),unprognostic (1.78e-1),unprognostic (6.25e-2),unprognostic (1.68e-1),unprognostic (6.72e-2),unprognostic (1.84e-1),unprognostic (2.11e-3),unprognostic (1.58e-1),unprognostic (1.10e-1),unprognostic (2.73e-1),0,0.3,0.5,0.1,0.7,2.3,1.6,0,0.5,0.1,0,0.3,0.1,0.4,4.3,0.1,1.1,0.4,2,0.3,0.3,0.2,0.1,0.2,0.1,0.3,0.5,0.1,0,0,0.3,0.4,0.1,0.4,1.1,0.1,0,3.3,1.6,0,0.4,0.1,0.1,0.1,0.1,0.7,0.3,0.3,0.1,3.2,0,0,0.4,0,0.4,0,0.8,0,1.2,0,0.2,2.4,0,1.5,0.5,0.7,0.3,2.4,0.1,0,0,0.9,0.7,1.7,1.6,1.1,2.7,2.4,3.4,5,0,0,1.9,1.5,0.1,0.2,0,1.1,2.4,1,1.3,13,0,0,1.6,0,0,4.8,0,0.8,0,0,1.1,0.4,1.2,7,1.5,0,1.4,0,1.7,0,0.8,0.1,0,0.9,0,1.5,2.2,0.3,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.5,0.7,0,0.5,0.3,0.3,0.3,0.5,0.1,0.4,0.1,0.3,0.4,0.1,0,1.5,0.3,0,0.3,2.1,0.9,2.8,0,1.6,1,8.8,0,1.2,0,0,0.3,0,0.2,0,0.1,1.2,0.7,0.2,0.2,0,3,11.8,0,0.5,1.1,0,1.8,0,5.4,0,0,0.1,0,11.6,0.1,2,0,0,0.1,0,0,0,0,0.2,0,0,0,0.2,0.4,1.2,0,0,2.9,0,0,1.5,0,0,0,0.2,0.4,0.4,0.7,0.1,0.1,0.7,0.4,0.5,1.8